Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdTCR [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
CIDEC	"CIDE-3, FLJ20871, Fsp27"	ENSG00000187288	"Cell death inducing DFFA like effector c"	Q96AQ7	3	9866711-9880254	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	16	"adipose tissue: 129.9;breast: 63.7;intestine: 60.5"	"Cell line enriched"	"Detected in some"	4	"ASC diff: 192.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.2;plasmacytoid DC: 1.8"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA018837, HPA020553"	Approved									"HPA018837: AB_1846767, HPA020553: AB_1846769"	"unprognostic (1.83e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.26e-5)"	"unprognostic (9.03e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.48e-3)"	"unprognostic (8.14e-2)"	"unprognostic (5.37e-5)"	"unprognostic (9.47e-3)"	"unprognostic (2.02e-1)"	"unprognostic (7.46e-3)"	"unprognostic (2.94e-2)"	129.9	1.1	0.1	5.3	0.1	0.0	63.7	0.1	0.1	0.4	44.3	0.1	0.9	13.5	0.5	0.6	0.1	0.2	5.3	2.3	0.1	0.0	0.6	2.6	0.1	2.7	0.1	0.1	0.1	1.4	0.0	0.1	0.1	0.1	0.4	0.8	0.1	2.9	0.8	1.7	2.4	60.5	0.8	0.1	0.1	0.8	0.4	0.1	0.1	0.4	1.9	0.2	2.4	1.1	2.2	1.8	0.1	0.5	0.2	0.2	0.2	0.0	0.0	0.0	0.0	192.5	43.4	0.1	0.0	0.0	0.0	0.0	0.8	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.3	0.0	0.0	25.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.5	0.0	2.2	0.1	0.0	0.5	0.6	0.0	0.2	0.0	0.2	0.4	1.8	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
LEP	"OB, OBS"	ENSG00000174697	Leptin	P41159	7	128241284-128257628	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"adipose tissue: 85.2;breast: 63.7;placenta: 24.3"	"Group enriched"	"Detected in some"	9	"BEWO: 6.8;HSkMC: 2.8"	"Cancer enhanced"	"Detected in some"		"breast cancer: 1.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 3.8"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 3.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB010490	Approved				"Secreted to blood"	26000000	26000000			"CAB010490: AB_2296951"	"unprognostic (8.19e-3)"	"unprognostic (5.33e-1)"	"unprognostic (1.60e-4)"	"unprognostic (1.19e-1)"	"unprognostic (7.99e-3)"	"unprognostic (1.83e-1)"		"unprognostic (6.56e-3)"	"unprognostic (1.98e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.84e-2)"	85.2	0.3	0.0	1.5	0.0	0.0	63.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.7	0.0	0.0	0.1	0.0	0.4	2.0	0.0	0.0	0.1	0.7	0.0	0.0	24.3	0.0	0.0	0.1	0.0	0.4	0.0	0.6	1.1	0.4	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	1.5	2.1	0.4	0.4	3.8	0.5	0.5	0.3	0.2	0.0	0.2	0.2	0.4	0.3	0.0	6.8	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.2	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.1	0.3	2.8	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.4	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.3	0.2	0.3	0.2	0.4	0.1	0.3	0.1	0.0	0.2	0.3	0.5	0.2	0.2	0.1	0.3	0.4	0.2	0.4	0.9	0.5	0.3	0.3	0.3	0.2	0.2	0.2	0.2	0.1	0.4	0.2	0.3	3.8	0.5	0.4	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TUSC5	"BEC-1, IFITMD3, LOST1"	ENSG00000184811	"Tumor suppressor candidate 5"	Q8IXB3	17	1279663-1300987	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"adipose tissue: 79.1;breast: 63.0"	"Cell line enriched"	"Detected in single"	262	"ASC diff: 26.1"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA050825	Approved									"HPA050825: AB_2681252"	"unprognostic (5.84e-2)"	"unprognostic (7.21e-2)"		"unprognostic (1.15e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.79e-2)"	"unprognostic (1.90e-3)"	"unprognostic (6.26e-2)"	"unprognostic (3.12e-1)"	"unprognostic (5.10e-1)"	79.1	0.9	0.0	2.1	0.0	0.1	63.0	0.0	0.1	0.2	4.1	0.0	0.0	0.1	0.1	0.9	0.2	0.2	3.4	5.2	0.0	0.0	0.4	0.1	0.1	2.2	0.0	0.0	0.2	0.5	0.1	0.0	0.1	0.0	0.1	0.2	0.0	2.5	1.4	4.4	0.8	1.1	0.2	0.0	0.1	0.2	0.2	0.0	0.0	0.6	2.7	0.1	0.8	2.5	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	26.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
AL845331.2		ENSG00000259916			2	94588522-94604573	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	13	"adipose tissue: 12.1"	"Cell line enriched"	"Detected in single"	11	"ASC diff: 6.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (1.97e-1)"				"unprognostic (1.24e-1)"		"unprognostic (8.07e-3)"	"unprognostic (1.39e-1)"		"unprognostic (1.85e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.15e-3)"	"unprognostic (6.22e-2)"		"unprognostic (4.66e-2)"		12.1	0.1		0.0		0.0	0.2		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.1			0.9	0.2	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PLIN1	PLIN	ENSG00000166819	"Perilipin 1"	O60240	15	89664365-89679427	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"adipose tissue: 187.5;breast: 62.6"	"Cell line enriched"	"Detected in single"	176	"ASC diff: 68.8"	"Cancer enhanced"	"Detected in many"		"breast cancer: 8.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA024299, CAB033821, CAB037333"	Enhanced		Uncertain	Peroxisomes		8900	8900	Peroxisomes	Peroxisomes	"CAB033821: AB_2252681, CAB037333: , HPA024299: AB_1855467"	"unprognostic (4.62e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.51e-3)"	"unprognostic (9.89e-3)"	"unprognostic (3.54e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.13e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.28e-3)"	"unprognostic (2.62e-6)"	"unprognostic (5.56e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.85e-2)"	187.5	2.6	1.8	7.1	1.3	0.3	62.6	0.8	0.8	0.3	10.6	1.6	0.4	0.4	0.3	1.9	0.5	0.4	7.4	8.3	2.7	0.6	0.6	5.8	0.3	2.8	0.8	1.5	0.4	1.4	0.3	0.1	0.3	1.0	0.4	1.1	0.0	7.6	1.5	7.2	2.2	2.2	0.6	0.4	0.3	0.5	1.6	1.8	0.0	0.7	8.0	0.3	1.5	1.5	0.0	0.0	0.6	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	68.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.8	1.3	0.8	0.7	2.7	0.6	0.8	1.5	1.0	1.8
SLC15A5		ENSG00000188991	"Solute carrier family 15 member 5"	A6NIM6	12	16188485-16277685	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"		"Group enriched"	"Detected in some"	12	"adipose tissue: 1.9;brain: 1.6;breast: 1.2;testis: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041638	Uncertain									"HPA041638: AB_2677590"	"unprognostic (3.68e-3)"				"unprognostic (1.64e-1)"								"unprognostic (4.89e-6)"		"unprognostic (1.34e-1)"	"unprognostic (1.72e-3)"		1.9	0.0	1.1	0.0	0.7	0.0	1.2	0.3	1.3	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.1	0.0	0.0	1.6		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
HEPACAM	"FLJ25530, GLIALCAM, hepaCAM"	ENSG00000165478	"Hepatic and glial cell adhesion molecule"	Q14CZ8	11	124919193-124936412	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"adipose tissue: 17.3;brain: 64.7;liver: 19.6"	"Cell line enriched"	"Detected in single"	31	"Hep G2: 24.3"	"Cancer enriched"	"Detected in some"	12	"glioma: 29.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017613, CAB025486"	Enhanced		Approved	Vesicles				Vesicles	Vesicles	"CAB025486: , HPA017613: "	"unprognostic (3.22e-3)"	"unprognostic (1.06e-2)"		"unprognostic (1.64e-1)"	"unprognostic (6.41e-2)"		"unprognostic (1.47e-1)"		"unprognostic (9.16e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.06e-6)"	"unprognostic (2.62e-1)"	"unprognostic (3.21e-1)"			17.3	1.8	25.6	1.7	25.7	1.5	2.6	8.5	64.7	1.6	1.8	55.4	0.0	1.6	1.6	1.7	1.6	1.6	1.6	1.7	31.0	10.8	1.6	19.6	1.6	1.7	30.3	22.4	1.5	1.6	1.5	0.6	1.5	27.9	1.6	1.8	0.0	1.7	2.1	1.6	1.6	1.6	1.6	21.5	1.5	1.6	1.7	35.5	0.0	1.6	0.0	2.3	1.5	0.3	1.5	1.2	3.0	1.4	2.0	1.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	24.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.0	1.1	1.2	1.1	1.2	1.5	1.5	1.4	1.0	1.2	1.3	1.7	1.5	1.3	2.0	1.4	1.0	1.1	1.5	25.6	25.7	8.5	29.7	31.0	10.8	30.3	22.4	27.9	35.5
SAA1	"PIG4, SAA, TP53I4"	ENSG00000173432	"Serum amyloid A1"	P0DJI8	11	18266174-18269977	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"adipose tissue: 216.6;liver: 849.2"	"Cell line enriched"	"Detected in some"	5	"HBEC3-KT: 160.1"	"Cancer enriched"	"Detected in many"	16	"liver cancer: 1249.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"gdTCR: 1.1;intermediate monocyte: 2.6;memory B-cell: 2.1"	"Group enriched"	"Detected in many"	6	"B-cells: 2.1;monocytes: 2.6;T-cells: 1.1"														"Secreted to blood"	22000000000	22000000000				"unprognostic (2.86e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.63e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavourable (4.57e-12)"	"unprognostic (5.15e-2)"	"unprognostic (9.78e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.64e-1)"	216.6	4.3	0.8	17.4	0.8	0.0	31.9	0.8	0.8	28.5	3.2	0.8	0.8	0.0	0.8	1.1	1.0	1.0	2.9	1.0	0.8	0.0	1.1	849.2	1.7	2.4	0.8	0.8	0.8	4.7	0.0	1.0	0.9	0.8	1.1	0.3	0.8	50.3	1.0	11.5	1.2	1.2	1.5	0.8	0.8	0.6	0.8	0.8	1.0	1.0	1.1	1.1	1.1	1.3	2.1	0.3	0.0	2.6	0.0	1.1	0.0	10.8	0.0	0.0	0.0	7.9	0.0	4.3	0.3	0.2	0.0	0.0	0.0	3.8	0.0	8.8	0.0	10.3	0.0	160.1	0.0	0.1	0.0	0.1	0.0	0.0	34.9	0.2	0.0	14.2	19.0	0.0	18.5	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	6.4	0.2	0.0	0.0	0.9	1.2	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	1.1	2.6	0.0	2.1	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.8	0.8	0.8	0.0	0.8	0.8	0.8	0.8
FABP4	"A-FABP, aP2"	ENSG00000170323	"Fatty acid binding protein 4"	P15090	8	81478419-81483263	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"adipose tissue: 492.7;breast: 545.8"	"Group enriched"	"Detected in some"	325	"ASC diff: 275.5;RT4: 136.3"	"Group enriched"	"Detected in all"	7	"breast cancer: 42.1;cervical cancer: 141.7;head and neck cancer: 133.8;urothelial cancer: 65.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002188, CAB024961"	Enhanced					30000000	30000000			"CAB024961: , HPA002188: AB_1078822"	"unprognostic (4.81e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.64e-3)"	"unprognostic (2.63e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.70e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.13e-3)"	"unprognostic (4.48e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.39e-1)"	492.7	3.5	0.3	16.1	0.3	0.1	545.8	0.2	0.2	0.9	42.2	0.0	1.8	0.2	0.6	2.9	4.8	1.0	7.6	15.6	0.3	0.3	1.2	0.4	9.3	4.7	0.3	0.0	0.7	1.3	2.2	0.3	15.9	0.3	7.7	2.9	0.1	7.6	1.7	13.0	5.5	4.5	3.3	0.3	0.7	2.2	6.1	0.0	0.7	7.4	7.3	0.1	15.4	60.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	275.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	136.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.2	0.3	0.3	0.3	0.0	0.3	0.0
MRAP	"B27, C21orf61, FALP"	ENSG00000170262	"Melanocortin 2 receptor accessory protein"	Q8TCY5	21	32291813-32314784	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	9	"adipose tissue: 28.3;adrenal gland: 52.7;breast: 68.6"	"Group enriched"	"Detected in some"	6	"Hep G2: 4.5;HSkMC: 5.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"basal ganglia: 2.6"	"Cell type enhanced"	"Detected in many"		"NK-cell: 5.5"	"Low lineage specificity"	"Detected in many"											HPA011024	Uncertain									"HPA011024: AB_10599292"	"unprognostic (1.38e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.53e-1)"		"unprognostic (1.11e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.12e-1)"	"unprognostic (6.30e-6)"	"unprognostic (3.32e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.76e-2)"	28.3	52.7	0.0	1.6	2.6	0.0	68.6	0.3	0.1	0.0	3.0	0.7	0.0	0.1	0.1	0.2	0.0	0.0	0.4	1.6	0.0	0.0	0.1	0.6	0.2	1.8	0.2	0.1	0.8	0.1	0.0	0.0	1.1	0.3	0.1	0.1	0.2	1.7	0.0	0.9	0.2	1.1	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.8	0.1	0.6	4.3	1.8	1.5	0.0	0.5	5.5	1.8	0.1	0.0	0.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.8	0.0	5.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.2	0.1	0.0	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.9	0.5	0.7	1.8	0.7	1.2	0.5	1.4	0.8	1.6	0.0	5.5	0.3	1.5	1.8	0.1	0.0	2.6	0.3	0.1	0.0	0.0	0.2	0.1	0.3	0.0
AC083800.1		ENSG00000251012			3	119147375-119187807	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	8	"adipose tissue: 1.3;testis: 3.1"	"Cell line enriched"	"Detected in single"	38	"HEL: 3.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.2		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ADAMTS18	ADAMTS21	ENSG00000140873	"ADAM metallopeptidase with thrombospondin type 1 motif 18"	Q8TE60	16	77247813-77435114	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"adipose tissue: 16.1;brain: 31.9;placenta: 27.6"	"Group enriched"	"Detected in some"	8	"HUVEC TERT2: 12.1;TIME: 3.7;U-87 MG: 7.4"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in all"	5	"cerebellum: 31.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"cerebellum: 3.7"	"Not detected"	"Not detected"			HPA044326	Uncertain		Approved	"Midbody,Mitotic spindle"	"Secreted to extracellular matrix"			"Midbody, Mitotic spindle"	"Midbody, Mitotic spindle"	"HPA044326: AB_10961006"	"unprognostic (1.10e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.17e-4)"	"unprognostic (1.77e-5)"	"unprognostic (2.17e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.47e-4)"	16.1	0.6	1.1	0.8	5.1	0.4	3.2	31.9	3.3	2.2	0.4	8.2	0.0	0.5	1.6	0.4	0.5	0.7	1.1	0.4	2.0	1.3	0.5	0.3	0.5	0.5	1.8	1.4	0.5	0.8	0.4	1.4	27.6	6.4	1.0	0.4	0.2	2.1	0.5	1.0	0.4	0.4	1.2	3.7	0.3	0.3	0.7	2.4	0.0	0.4	0.0	0.3	0.8	0.4	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	3.7	0.1	0.0	0.0	0.0	0.0	0.0	0.3	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.1	5.1	31.9	3.3	2.0	1.3	1.8	1.4	6.4	2.4
SLC25A18		ENSG00000182902	"Solute carrier family 25 member 18"	Q9H1K4	22	17563439-17590994	"Plasma proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"adipose tissue: 13.1;brain: 49.0;liver: 50.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 5.6;BEWO: 12.7;REH: 4.1"	"Group enriched"	"Detected in some"	5	"glioma: 10.6;liver cancer: 11.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"eosinophil: 2.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"																		"unprognostic (2.15e-1)"	"unprognostic (6.07e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.72e-2)"	"unprognostic (8.70e-4)"	"unprognostic (1.44e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.62e-1)"	13.1	2.2	33.2	1.5	28.0	1.2	2.7	7.5	49.0	1.4	1.4	13.3	0.0	1.5	1.7	1.4	1.5	1.7	2.1	2.3	33.3	15.7	1.8	50.0	1.5	1.5	25.6	19.1	1.9	1.8	1.7	0.0	1.3	17.8	4.8	1.3	0.0	1.6	1.6	2.5	1.4	1.4	1.8	14.9	1.9	1.5	3.4	21.6	0.0	1.5	0.0	1.3	1.4	0.0	0.4	0.4	2.1	0.6	0.0	0.5	0.1	0.4	0.9	3.3	0.6	5.6	0.0	12.7	0.4	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.0	1.1	0.1	0.0	0.0	0.4	1.4	0.5	0.4	0.8	2.3	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.6	0.1	0.7	2.8	2.1	4.1	1.2	0.0	0.1	0.6	1.1	0.5	0.4	0.6	1.0	3.6	1.4	0.2	0.2	0.5	0.3	0.4	1.3	1.7	0.0	2.7	0.3	0.5	0.0	0.4	2.1	0.4	0.6	0.0	0.4	0.5	0.1	0.3	0.2	0.1	0.3	0.5	0.0	0.2	0.4	0.1	0.1	33.2	28.0	7.5	25.7	33.3	15.7	25.6	19.1	17.8	21.6
CIDEA	CIDE-A	ENSG00000176194	"Cell death-inducing DFFA-like effector a"	O60543	18	12254319-12277595	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adipose tissue: 79.9;breast: 32.6"	"Cell line enriched"	"Detected in single"	8	"hTEC/SVTERT24-B: 5.6"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"basal ganglia: 1.7;cerebral cortex: 1.9;olfactory region: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"pons and medulla: 12.2"												"unprognostic (2.96e-2)"	"unprognostic (2.43e-2)"			"unprognostic (1.74e-1)"	"unprognostic (1.49e-1)"		"unprognostic (8.93e-3)"	"unprognostic (3.20e-2)"	"unprognostic (7.00e-2)"	"unprognostic (3.72e-2)"			"unprognostic (1.91e-3)"	"unprognostic (3.17e-2)"	"unprognostic (7.67e-3)"	"unprognostic (1.96e-1)"	79.9	1.5	0.1	5.8	1.7	0.2	32.6	0.0	1.9	1.1	8.0	0.0	0.6	0.2	0.2	0.2	2.1	0.2	4.9	2.4	0.2	0.0	0.2	0.3	0.2	0.3	0.1	1.5	0.2	0.5	0.2	0.0	0.2	0.3	0.3	0.5	0.0	2.1	0.3	1.0	3.0	0.8	0.3	0.0	0.2	0.2	0.3	0.0	0.0	0.3	3.4	0.3	0.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	1.9	0.2	0.0	0.1	1.5	0.3	0.0
KCNIP2	KCHIP2	ENSG00000120049	"Potassium voltage-gated channel interacting protein 2"	Q9NS61	10	101825974-101843920	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adipose tissue: 86.5;brain: 54.5;heart muscle: 74.8"	"Cell line enhanced"	"Detected in many"		"HEL: 19.7;HMC-1: 12.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"eosinophil: 1.9;intermediate monocyte: 1.2;memory B-cell: 2.9;naive B-cell: 4.6"	"Group enriched"	"Detected in many"	5	"B-cells: 4.6;granulocytes: 1.9;monocytes: 1.2"	"Group enriched"	"Detected in many"	5	"amygdala: 96.2;basal ganglia: 204.2;cerebral cortex: 97.2;hippocampal formation: 151.4;olfactory region: 172.7"	"Low region specificity"	"Detected in all"			HPA066717			Approved	Vesicles				Vesicles	Vesicles	"HPA066717: "	"unprognostic (5.92e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.48e-3)"	"unprognostic (5.77e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.31e-3)"	"unprognostic (8.80e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.14e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.18e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.49e-9)"	"unprognostic (9.85e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.37e-4)"	86.5	3.5	15.5	2.0	54.5	0.9	10.4	8.3	26.1	1.8	2.4	2.6	0.0	1.4	2.3	2.4	1.2	2.2	1.9	74.8	19.6	5.0	1.0	1.0	1.4	3.7	4.2	11.3	5.7	1.6	1.2	3.3	1.8	4.3	1.6	2.7	1.7	4.6	2.1	3.8	3.0	1.6	1.8	2.1	2.8	1.6	4.1	9.8	0.0	1.3	0.8	3.9	1.6	0.7	4.6	0.5	1.9	1.2	0.0	0.4	0.4	1.6	2.4	2.5	3.1	1.0	1.1	0.6	1.1	1.0	0.6	0.9	3.6	3.2	1.6	0.9	0.7	1.7	0.8	0.4	0.6	2.2	1.9	19.7	2.4	1.8	0.9	1.3	12.2	2.6	1.7	1.0	1.3	1.0	5.7	1.7	0.9	1.1	0.7	3.8	0.7	0.6	0.9	0.2	1.2	0.9	1.0	7.2	1.1	0.8	0.5	2.3	2.0	0.8	2.1	1.3	2.1	0.5	1.1	1.7	1.7	1.6	1.4	5.0	0.2	0.0	0.1	1.9	0.1	1.2	0.4	2.9	0.3	0.0	0.4	4.6	0.0	0.1	0.0	0.0	0.5	0.5	0.3	0.4	15.5	54.5	8.3	26.1	19.6	5.0	4.2	11.3	4.3	9.8
KLB		ENSG00000134962	"Klotho beta"	Q86Z14	4	39406853-39451536	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"adipose tissue: 17.3;liver: 49.2;pancreas: 21.4"	"Group enriched"	"Detected in some"	23	"ASC diff: 6.4;Hep G2: 22.9"	"Cancer enriched"	"Detected in some"	16	"liver cancer: 11.6"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA021136	Uncertain					290000	290000			"HPA021136: "	"unprognostic (1.03e-2)"	"unprognostic (1.61e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.30e-2)"	"unprognostic (7.02e-3)"	"unprognostic (2.46e-1)"	"unprognostic (9.92e-2)"	"unprognostic (6.99e-3)"	"unprognostic (4.51e-3)"	"unprognostic (3.02e-3)"	"unprognostic (8.90e-3)"	"unprognostic (1.73e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.09e-2)"	17.3	0.0	0.2	1.9	1.0	0.2	3.9	0.4	0.2	0.0	1.6	0.0	0.0	0.2	0.1	0.5	0.3	0.1	1.3	0.5	1.0	0.2	0.1	49.2	1.4	0.5	0.1	0.0	0.2	21.4	0.2	0.2	0.0	0.4	0.0	0.4	0.0	0.3	0.0	0.4	0.5	0.6	0.3	0.0	0.0	1.5	2.5	0.2	0.0	0.1	0.4	0.0	0.3	0.2	0.5	2.5	2.3	0.7	0.4	0.4	0.2	0.0	0.2	0.0	0.0	6.4	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	22.9	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.7	0.2	0.3	0.4	0.2	0.4	0.2	0.2	0.1	0.5	0.2	0.4	2.3	0.4	0.5	2.5	0.1	0.2	0.2	1.0	0.4	0.2	1.0	0.2	0.1	0.0	0.4	0.2
LIPE	HSL	ENSG00000079435	"Lipase E, hormone sensitive type"	Q05469	19	42401507-42427426	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adipose tissue: 207.4;breast: 65.1"	"Cell line enriched"	"Detected in many"	7	"ASC diff: 56.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006567, CAB017700"	Enhanced		Supported	Cytosol				Cytosol	Cytosol	"CAB017700: AB_2135504, HPA006567: AB_2667618"	"unprognostic (4.24e-2)"	"unprognostic (2.46e-2)"	"unprognostic (8.99e-3)"	"unprognostic (3.74e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.38e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.11e-1)"	"unprognostic (9.44e-2)"	"prognostic favourable (1.15e-4)"	"unprognostic (1.52e-1)"	"unprognostic (3.63e-10)"	"unprognostic (1.47e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.34e-3)"	207.4	6.0	3.2	2.9	9.4	2.1	65.1	2.0	6.8	1.2	6.7	19.6	0.8	2.4	1.7	1.3	2.2	1.6	3.6	4.8	6.2	4.2	1.5	1.1	1.4	2.7	18.0	2.3	1.5	2.2	2.2	0.8	1.7	9.9	1.7	1.3	3.7	5.4	1.7	3.7	2.9	3.4	1.7	19.2	3.1	1.6	9.0	10.8	1.7	1.5	1.8	1.9	2.0	3.7	6.1	4.8	10.8	12.1	4.1	5.2	4.0	4.8	3.7	2.4	0.9	56.0	0.5	0.0	2.3	1.2	3.7	3.4	0.9	1.8	8.0	2.5	0.7	2.1	1.4	4.5	0.4	1.5	2.4	2.2	1.8	0.1	1.1	0.0	5.5	0.4	4.3	0.6	0.8	1.0	1.0	5.1	0.4	0.0	5.6	0.2	0.3	1.1	4.6	0.4	2.6	1.0	5.1	3.4	3.5	2.0	2.3	2.1	0.6	2.9	1.8	1.0	3.2	0.4	2.0	3.8	3.1	5.9	2.5	0.2	3.4	10.8	12.1	4.7	3.6	6.0	3.3	4.8	4.6	5.2	4.8	6.1	4.1	3.7	2.0	4.1	3.3	3.9	3.9	4.0	3.2	9.4	2.0	6.8	6.2	4.2	18.0	2.3	9.9	10.8
AC009477.2		ENSG00000284479			2	131035092-131035262	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	6	"adipose tissue: 8.5;brain: 18.5"	"Group enriched"	"Detected in some"	12	"BJ: 2.8;HaCaT: 3.4;HEK 293: 5.0"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							8.5	0.9	7.3	0.9	11.6	0.9	0.9	0.0	18.5	0.9	2.0	4.0	0.0	0.9	0.9	1.2	0.9	0.9	1.2	0.9	8.1		1.1	0.9	0.9	0.9	1.3	9.7	0.9	0.9	0.9	1.0	0.9	5.5	1.2	0.9	0.5	0.9	0.9	2.2	0.9	1.7	1.9	0.8	0.9	0.9	1.1	1.8	0.0	0.9	0.0	0.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ADIPOQ	"ACDC, ACRP30, adiponectin, AdipoQ, apM1, GBP28"	ENSG00000181092	"Adiponectin, C1Q and collagen domain containing"	Q15848	3	186842690-186858463	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 176.7;breast: 79.4"	"Cell line enriched"	"Detected in single"	670	"ASC diff: 84.1"	"Group enriched"	"Detected in some"	8	"breast cancer: 6.5;pancreatic cancer: 1.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB046467, HPA051767"	Uncertain				"Secreted to blood"	1000000000	1000000000			"CAB046467: AB_1078104, HPA051767: AB_2681598"	"unprognostic (1.76e-2)"									"unprognostic (1.53e-1)"	"unprognostic (2.20e-2)"			"unprognostic (6.99e-3)"	"unprognostic (1.87e-1)"			176.7	1.9	0.0	16.7	0.0	0.1	79.4	0.0	0.1	0.1	23.2	0.0	0.4	0.1	0.1	1.3	0.3	0.1	13.2	5.8	0.0	0.0	0.5	0.1	0.1	6.1	0.0	0.0	0.2	1.3	0.1	0.0	0.1	0.0	0.4	1.4	0.0	14.7	0.6	2.0	1.5	2.1	0.4	0.0	0.1	0.6	0.1	0.0	0.0	0.7	9.5	0.3	1.0	0.9	0.8	0.6	2.4	0.4	0.7	0.5	0.1	0.0	0.0	0.0	0.0	84.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.4	0.6	0.4	0.3	0.3	0.4	0.3	0.3	0.1	0.8	0.3	0.5	1.9	0.7	0.4	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCL7	"FIC, MARC, MCP-3, MCP3, NC28, SCYA6, SCYA7"	ENSG00000108688	"C-C motif chemokine ligand 7"	P80098	17	34270221-34272242	"Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"adipose tissue: 11.5;bone marrow: 22.3"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 15.1;BJ hTERT+ SV40 Large T+: 3.2;BJ hTERT+ SV40 Large T+ RasG12V: 3.9;HSkMC: 4.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"classical monocyte: 1.1"	"Lineage enriched"	"Detected in single"	12	"monocytes: 1.1"	"Low region specificity"	"Detected in many"												"Secreted to blood"						"unprognostic (7.66e-2)"	"unprognostic (1.05e-2)"	"unprognostic (8.53e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.54e-2)"	"unprognostic (9.54e-2)"		"unprognostic (4.18e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.27e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.99e-8)"	"unprognostic (2.83e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.79e-2)"	11.5	0.6	0.0	2.6	0.0	22.3	0.3	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.3	0.0	0.1	0.5	0.7	0.9	0.1	0.1	0.5	0.2	1.2	0.0	0.1	0.0	1.3	0.4	0.0	0.1	1.7	0.3	0.5	1.0	0.0	0.2	0.0	0.1	0.2	0.2	2.2	0.1	0.1	1.2	0.5	0.0	1.4	0.3	0.0	0.0	0.5	0.4	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	2.3	0.0	1.7	15.1	3.2	3.9	0.0	0.0	0.0	0.5	1.0	1.4	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	4.6	0.0	1.3	0.0	1.4	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.3	0.0
FGR	"c-fgr, p55c-fgr, SRC2"	ENSG00000000938	"FGR proto-oncogene, Src family tyrosine kinase"	P09769	1	27612064-27635277	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 20.8;blood: 68.0;bone marrow: 73.6;lung: 30.9;lymphoid tissue: 54.3"	"Group enriched"	"Detected in some"	4	"Daudi: 29.4;U-266/70: 54.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA002024	Enhanced		Approved	"Plasma membrane,Aggresome"				"Plasma membrane"	"Plasma membrane"	"HPA002024: AB_1078503"	"unprognostic (2.66e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.32e-2)"	"unprognostic (9.74e-3)"	"unprognostic (6.66e-3)"	"unprognostic (6.71e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.94e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.12e-3)"	20.8	2.6	2.2	23.6	4.5	73.6	5.6	1.1	4.2	2.9	2.8	1.5	4.2	1.6	4.0	2.3	2.2	6.3	5.3	8.5	2.6	2.3	3.0	4.2	30.9	34.1	6.6	1.7	1.9	2.4	0.4	1.2	3.3	4.2	2.5	1.8	2.1	2.9	2.6	4.4	1.7	3.7	6.4	4.8	54.3	2.5	2.6	4.1	1.9	2.9	2.5	7.8	5.1	6.1	13.3	28.9	40.8	68.0	36.3	29.6	55.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.5	10.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	54.6	0.7	2.2	0.0	6.7	0.0	3.1	52.4	32.3	29.6	68.0	1.7	7.7	2.6	13.6	28.9	13.3	1.3	12.8	40.8	36.3	55.6	1.3	0.1	55.0	2.2	4.5	1.1	4.2	2.6	2.3	6.6	1.7	4.2	4.1
LRRN4	"C20orf75, dJ1056H1.1, NLRR4"	ENSG00000125872	"Leucine rich repeat neuronal 4"	Q8WUT4	20	6040778-6054049	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 9.5;kidney: 13.0;lung: 36.4"	"Cell line enriched"	"Detected in some"	13	"RPTEC TERT1: 39.4"	"Group enriched"	"Detected in many"	7	"lung cancer: 4.6;ovarian cancer: 3.6;renal cancer: 11.7"	"Region enriched"	"Detected in single"	5	"basal ganglia: 1.1"	"Cell type enhanced"	"Detected in single"		"gdTCR: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"									32000	32000				"unprognostic (6.16e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.40e-3)"	"unprognostic (9.04e-3)"	"unprognostic (5.95e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.59e-1)"	"unprognostic (8.94e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.44e-2)"	"unprognostic (2.79e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.15e-3)"	"unprognostic (2.33e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.31e-1)"	"unprognostic (9.84e-3)"	9.5	0.1	0.0	2.4	1.1	0.1	0.1	0.0	0.2	0.7	2.2	0.0	0.0	0.1	0.1	2.8	0.1	1.5	0.1	1.1	0.0	0.2	13.0	0.4	36.4	0.1	0.0	0.0	1.6	2.6	0.1	0.0	3.4	0.0	0.1	0.1	0.0	0.1	0.5	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.8	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.4	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.0	0.7	0.0	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	39.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.1	0.8	0.4	0.2	0.9	0.0	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0
MMP9	CLG4B	ENSG00000100985	"Matrix metallopeptidase 9"	P14780	20	46008908-46016561	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 64.0;blood: 63.2;bone marrow: 89.4;lymphoid tissue: 80.1"	"Cell line enriched"	"Detected in some"	12	"NB-4: 87.3"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	141	"neutrophil: 63.2"	"Lineage enriched"	"Detected in single"	339	"granulocytes: 63.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000348, HPA001238, HPA063909, CAB068199, CAB068200, CAB068201"	Enhanced		Approved	Cytosol	"Secreted to blood"	57000000	57000000	Cytosol	Cytosol	"CAB000348: , CAB068199: , CAB068200: AB_2665676, CAB068201: AB_2665677, HPA001238: AB_1079398, HPA063909: AB_2685150"	"unprognostic (4.62e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.85e-2)"	"prognostic favourable (2.55e-4)"	"unprognostic (6.65e-3)"	"unprognostic (2.82e-1)"	"prognostic unfavourable (7.19e-4)"	"unprognostic (1.54e-1)"	"unprognostic (8.57e-2)"	"unprognostic (3.21e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavourable (4.05e-5)"	"unprognostic (4.65e-1)"	"unprognostic (9.85e-3)"	"unprognostic (2.48e-2)"	"unprognostic (2.17e-3)"	64.0	0.5	0.6	38.6	0.7	89.4	4.3	0.4	0.6	0.8	1.2	0.1	0.0	2.8	0.6	0.2	0.9	1.5	0.6	4.0	0.5	0.6	1.4	2.0	13.3	80.1	0.6	0.0	2.7	1.4	0.0	0.8	2.6	0.5	0.6	0.8	0.5	12.5	0.0	1.3	1.3	4.2	0.3	0.5	53.7	2.5	2.7	0.0	23.6	1.3	2.3	44.5	4.5	2.9	0.0	0.0	63.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	7.3	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	87.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	2.6	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.2	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.4	0.6	0.5	0.6	0.6	0.0	0.5	0.0
PLIN4	"KIAA1881, S3-12"	ENSG00000167676	"Perilipin 4"	Q96Q06	19	4502180-4518465	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 155.0;breast: 80.6;skeletal muscle: 45.2"	"Cell line enriched"	"Detected in some"	9	"ASC diff: 75.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA044682, HPA054657"	Enhanced		Supported	"Vesicles,Lipid droplets,Plasma membrane,Cytosol"		11000	11000	"Lipid droplets, Plasma membrane"	"Lipid droplets, Plasma membrane"	"HPA044682: AB_2679044, HPA054657: AB_2682559"	"unprognostic (2.97e-2)"	"unprognostic (1.15e-2)"	"prognostic unfavourable (8.31e-4)"	"prognostic unfavourable (2.31e-4)"	"unprognostic (6.65e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.23e-2)"	"unprognostic (9.89e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.90e-1)"	"unprognostic (6.09e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.94e-3)"	155.0	1.2	0.9	7.4	0.8	0.8	80.6	0.5	0.9	2.4	8.5	0.6	2.4	0.8	3.7	2.2	3.8	2.5	8.3	15.5	0.6	0.1	0.6	11.1	0.4	2.0	0.8	0.8	2.9	3.3	0.3	0.2	0.3	0.9	2.8	1.2	0.7	6.8	3.9	45.2	1.8	2.4	10.3	1.3	0.4	3.5	0.7	0.8	0.1	0.7	8.2	0.7	5.9	3.9	0.0	0.4	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	75.1	0.5	2.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.4	1.1	0.0	0.0	2.4	1.4	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	8.5	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.4	0.1	0.0	0.9	0.8	0.5	0.9	0.6	0.1	0.8	0.8	0.9	0.8
ZNF385D	"FLJ22419, ZNF659"	ENSG00000151789	"Zinc finger protein 385D"	Q9H6B1	3	21412222-22373321	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 17.7;brain: 59.5;testis: 18.5"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.8;fHDF/TERT166: 2.4;RPTEC TERT1: 6.6;U-87 MG: 12.5"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in all"	7	"cerebellum: 59.5"	"Cell type enhanced"	"Detected in single"		"neutrophil: 2.0"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in all"			HPA036190	Uncertain									"HPA036190: AB_10602355"	"unprognostic (4.07e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.44e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.20e-2)"	"unprognostic (6.60e-2)"	"unprognostic (7.84e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.35e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.49e-7)"	"unprognostic (8.70e-3)"	"unprognostic (5.38e-2)"	"unprognostic (7.76e-3)"	"unprognostic (2.15e-5)"	17.7	1.1	4.0	2.2	5.9	1.1	5.3	59.5	9.1	4.3	2.2	0.1	1.2	1.2	2.3	3.9	4.0	2.3	4.7	3.9	3.9	3.6	3.2	0.9	1.9	2.0	7.4	4.0	1.7	2.5	1.3	0.5	0.7	4.1	3.0	1.8	4.1	1.9	3.2	2.8	2.4	1.3	3.5	1.9	1.3	1.3	18.5	1.7	0.1	1.5	5.2	2.0	4.0	5.7	0.7	0.3	2.0	0.2	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.5	4.8	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.3	1.4	0.0	0.0	0.0	6.6	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.4	0.2	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.0	0.7	0.0	0.1	2.0	0.1	0.0	0.3	0.0	0.2	4.0	5.9	59.5	9.1	3.9	3.6	7.4	4.0	4.1	1.7
ACACB	"ACC2, ACCB, HACC275"	ENSG00000076555	"Acetyl-CoA carboxylase beta"	O00763	12	109116595-109268226	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"adipose tissue: 104.5;breast: 67.4;liver: 42.0;skeletal muscle: 154.2"	"Cell line enriched"	"Detected in many"	18	"ASC diff: 71.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 15.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 15.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA006554	Enhanced				"Intracellular and membrane"					"HPA006554: AB_1844495"	"unprognostic (2.24e-1)"	"unprognostic (4.66e-1)"	"unprognostic (3.97e-2)"	"unprognostic (4.54e-6)"	"unprognostic (2.82e-1)"	"unprognostic (1.59e-2)"	"unprognostic (8.62e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.63e-2)"	"prognostic favourable (1.93e-4)"	"unprognostic (6.63e-2)"	"prognostic favourable (1.15e-5)"	"unprognostic (2.36e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.21e-3)"	"unprognostic (2.58e-2)"	104.5	8.2	4.3	10.6	4.0	1.6	67.4	3.3	3.5	3.5	19.3	3.2	6.2	3.8	4.6	4.3	4.9	3.9	10.5	12.1	4.5	2.0	5.4	42.0	3.1	4.0	6.4	2.7	6.8	8.5	8.9	7.1	1.3	3.7	3.6	3.9	4.0	5.8	9.0	154.2	2.8	4.8	7.5	6.5	2.5	5.6	1.6	4.9	0.4	6.2	12.5	1.7	7.3	6.3	2.5	0.2	15.5	0.4	0.1	1.7	0.1	0.2	1.7	1.1	2.1	71.5	0.5	0.8	0.2	0.4	0.3	0.2	1.2	0.3	0.8	0.5	0.3	1.4	0.9	0.4	0.2	1.1	1.6	2.0	1.8	1.2	0.3	1.7	0.5	0.8	0.4	0.7	0.1	0.1	0.2	0.1	0.2	0.5	1.2	1.6	1.2	3.8	0.6	1.5	0.4	0.5	0.6	0.7	1.7	1.8	0.8	1.1	0.8	1.7	0.1	0.7	0.4	0.8	0.6	2.7	1.5	1.2	1.7	1.3	0.5	4.1	0.4	15.5	1.1	0.1	0.6	1.7	1.0	0.3	0.2	2.5	1.7	0.9	0.6	0.1	0.2	0.2	0.6	0.1	4.3	4.0	3.3	3.5	4.5	2.0	6.4	2.7	3.7	4.9
ADH1B	ADH2	ENSG00000196616	"Alcohol dehydrogenase 1B (class I), beta polypeptide"	P00325	4	99304964-99352760	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 253.5;liver: 466.3"	"Cell line enriched"	"Detected in some"	7	"ASC diff: 385.0"	"Cancer enriched"	"Detected in many"	31	"liver cancer: 223.1"	"Group enriched"	"Detected in some"	5	"midbrain: 2.3;pons and medulla: 1.6"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"											"HPA047814, HPA060902"	Supported		Approved	"Plasma membrane,Cytosol"		16000000	16000000	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (5.13e-2)"	"unprognostic (9.80e-3)"	"unprognostic (6.59e-2)"	"unprognostic (5.56e-2)"	"unprognostic (9.49e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.47e-3)"	"unprognostic (7.79e-2)"	"prognostic unfavourable (7.87e-4)"	"unprognostic (4.60e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.60e-2)"	253.5	12.3	0.2	21.8	0.0	0.4	78.7	0.2	0.4	18.3	60.0	0.4	5.7	3.5	12.8	14.4	33.5	22.3	31.9	24.2	0.3	0.0	9.2	466.3	43.8	17.5	2.3	0.1	18.0	8.7	0.8	5.3	0.9	1.6	30.7	10.1	2.3	11.2	3.9	20.5	11.9	25.4	30.8	2.4	5.9	10.9	18.0	0.2	0.2	16.1	9.7	2.0	42.3	76.0	0.6	0.2	1.2	0.3	0.8	0.4	0.0	0.0	0.0	0.0	0.0	385.0	56.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.3	0.2	0.1	0.1	0.2	0.4	0.1	0.0	0.6	0.3	0.4	1.2	0.8	0.1	0.2	0.1	0.0	0.2	0.0	0.2	0.0	0.3	0.0	2.3	0.1	1.6	0.2
CALB2	CAL2	ENSG00000172137	"Calbindin 2"	P22676	16	71358713-71390438	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 50.6;brain: 118.9"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 8.1;HEL: 23.4;HMC-1: 51.0;U-2 OS: 14.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"cerebellum: 31.2;hypothalamus: 74.2;pons and medulla: 118.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000106, HPA007305, HPA007306"	Enhanced	Supported	Enhanced	Cytosol		6400	6400	Cytosol	Cytosol	"CAB000106: AB_2068519, HPA007305: AB_1078386, HPA007306: AB_1078385"	"unprognostic (1.10e-1)"	"unprognostic (1.90e-2)"	"prognostic unfavourable (5.78e-5)"	"unprognostic (1.75e-3)"	"unprognostic (5.80e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.55e-3)"	"unprognostic (4.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.06e-3)"	"unprognostic (1.35e-2)"	"unprognostic (5.54e-4)"	"unprognostic (1.97e-3)"	"unprognostic (6.30e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.04e-2)"	50.6	11.6	10.1	5.1	7.5	0.9	18.2	31.2	9.9	1.7	8.9	1.7	0.0	1.7	1.4	3.0	3.0	2.4	2.0	2.2	5.9	74.2	0.9	0.9	2.1	0.9	17.7	7.5	5.6	1.4	0.9	3.0	0.9	118.9	1.1	6.0	4.9	2.1	1.3	1.0	1.0	2.7	2.7	7.5	0.9	1.2	14.6	1.5	0.0	0.8	0.2	1.8	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.7	6.5	0.0	0.2	0.0	1.2	0.2	0.1	0.2	0.0	0.0	8.1	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	23.4	0.0	0.2	0.0	0.0	51.0	0.0	0.0	0.5	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	14.6	0.1	1.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	7.5	31.2	9.9	5.9	74.2	17.7	7.5	118.9	1.5
CDH20	"Cdh7, CDH7L3"	ENSG00000101542	"Cadherin 20"	Q9HBT6	18	61333582-61555773	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 8.8;brain: 32.8"	"Cell line enhanced"	"Detected in some"		"AF22: 3.1;ASC diff: 9.9;HHSteC: 4.6;SH-SY5Y: 6.7"	"Cancer enriched"	"Detected in single"	15	"glioma: 6.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	12	"basophil: 4.5"	"Lineage enriched"	"Detected in single"	39	"granulocytes: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015490	Uncertain									"HPA015490: AB_1845900"	"unprognostic (2.15e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.68e-3)"	"unprognostic (2.11e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.93e-1)"	8.8	1.2	13.4	1.1	13.7	1.0	1.2	6.9	32.8	1.5	1.1	16.8	0.0	1.0	1.1	2.3	2.5	1.3	1.1	1.1	16.0	7.3	1.2	1.0	1.0	1.1	20.4	9.8	1.0	1.3	1.0	1.1	1.1	12.6	1.5	1.0	0.5	1.0	1.1	3.4	2.0	1.0	1.1	12.8	1.2	1.1	1.4	18.9	0.0	1.2	0.5	1.0	1.1	0.0	0.0	0.0	4.5	0.0	0.0	0.1	0.4	0.0	0.0	3.1	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.7	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.4	13.4	13.7	6.9	14.0	16.0	7.3	20.4	9.8	12.6	18.9
DCSTAMP	"DC-STAMP, FIND, TM7SF4"	ENSG00000164935	"Dendrocyte expressed seven transmembrane protein"	Q9H295	8	104339087-104356689	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"adipose tissue: 28.8;lung: 18.2"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 1.1;RPMI-8226: 1.2;U-87 MG: 4.4;U-937: 1.6"	"Cancer enriched"	"Detected in some"	46	"thyroid cancer: 45.3"	"Region enriched"	"Detected in single"	4	"amygdala: 3.5"	"Cell type enriched"	"Detected in single"	8	"non-classical monocyte: 1.5"	"Lineage enriched"	"Detected in single"	16	"monocytes: 1.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (1.11e-2)"	"unprognostic (1.22e-2)"	"unprognostic (8.41e-2)"	"unprognostic (2.96e-2)"	"unprognostic (8.48e-4)"	"unprognostic (2.14e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.18e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.61e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.05e-2)"	"unprognostic (8.34e-3)"	28.8	0.1	3.5	0.3	0.2	0.4	1.2	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.3	0.3	0.0	0.8	0.2	0.1	1.0	18.2	0.8	0.2	0.0	0.8	0.2	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	4.4	1.6	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.9	3.5	0.2	0.0	0.6	0.8	0.2	0.2	0.0	0.2	0.0
GHR	GHBP	ENSG00000112964	"Growth hormone receptor"	P10912	5	42423777-42721878	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 44.4;breast: 31.5;liver: 82.4;skeletal muscle: 23.4"	"Group enriched"	"Detected in some"	5	"HSkMC: 13.3;T-47d: 33.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045339, HPA057705"	Enhanced		Supported	"Plasma membrane,Cytosol,Cytoplasmic bodies"	"Secreted to blood"	21000000	21000000	"Plasma membrane, Cytosol, Cytoplasmic bodies"	"Plasma membrane, Cytosol, Cytoplasmic bodies"	"HPA045339: AB_2679294, HPA057705: AB_2683507"	"unprognostic (2.18e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.57e-1)"	"prognostic favourable (2.73e-6)"	"unprognostic (1.06e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.73e-2)"	"unprognostic (6.15e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.67e-3)"	"unprognostic (4.29e-4)"	"unprognostic (7.82e-2)"	"unprognostic (7.33e-4)"	"unprognostic (8.35e-6)"	44.4	2.8	0.7	5.4	1.3	0.3	31.5	0.4	1.4	4.0	6.9	0.5	1.7	0.6	5.7	3.9	2.4	2.5	3.9	6.0	1.3	1.6	5.3	82.4	2.3	2.2	1.2	1.4	5.0	1.3	3.6	2.0	4.0	2.0	8.7	2.5	2.4	2.3	7.4	23.4	3.0	2.4	5.2	1.0	2.6	3.5	1.6	0.2	0.1	2.9	4.3	0.5	3.8	8.4	0.6	0.3	1.8	0.5	0.4	0.3	0.1	0.0	0.0	0.3	3.0	2.0	0.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	2.5	0.0	0.0	1.6	0.0	0.0	0.0	0.4	0.0	0.0	13.3	4.3	0.0	0.6	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	2.1	33.9	0.0	1.8	3.0	1.3	1.6	0.3	0.3	0.0	0.0	0.3	0.0	1.5	1.8	0.3	0.4	0.2	0.2	0.1	0.3	0.2	0.1	0.1	0.6	0.2	0.3	1.7	0.4	0.5	0.3	0.2	0.1	0.7	1.3	0.4	1.4	1.3	1.6	1.2	1.4	2.0	0.2
ITLN1	"FLJ20022, hIntL, HL-1, ITLN, LFR"	ENSG00000179914	"Intelectin 1"	Q8WWA0	1	160876539-160885170	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 119.2;heart muscle: 48.6;intestine: 157.9;lymphoid tissue: 40.1"	"Cell line enhanced"	"Detected in some"		"HEL: 4.3;HHSteC: 1.9;HL-60: 3.1;RPMI-8226: 1.7;U-937: 11.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 61.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"intermediate monocyte: 6.9;non-classical monocyte: 17.3"	"Lineage enriched"	"Detected in many"	15	"monocytes: 17.3"	"Not detected"	"Not detected"							"CAB012652, HPA063275, HPA067326"	Enhanced				"Secreted to blood"	160000000	160000000			"CAB012652: , HPA063275: AB_2684974, HPA067326: "	"unprognostic (9.69e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.28e-1)"		"unprognostic (1.79e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.66e-2)"	"unprognostic (4.38e-1)"	"unprognostic (9.96e-2)"	"unprognostic (3.67e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.34e-2)"	119.2	0.0	0.2	40.1	0.2	0.0	0.2	0.2	0.2	0.4	52.5	0.2	1.0	31.9	0.5	8.8	0.7	1.2	8.7	48.6	0.2	0.0	0.5	2.6	13.9	0.2	0.2	0.3	4.3	0.2	0.0	0.4	0.4	0.3	3.0	157.9	0.2	2.6	0.6	1.5	0.1	48.6	0.8	0.2	0.6	1.9	2.7	0.2	0.4	0.2	1.4	1.5	1.6	0.8	0.0	1.1	0.1	17.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.3	0.0	0.0	1.9	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.7	0.0	0.3	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	11.9	0.0	0.0	0.3	0.0	0.0	6.9	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.1	0.0	17.3	0.0	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.3	0.3	0.2
LGALS12	GRIP1	ENSG00000133317	"Galectin 12"	Q96DT0	11	63506084-63516774	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 45.1;blood: 90.2;breast: 28.6"	"Group enriched"	"Detected in some"	14	"ASC diff: 11.6;HL-60: 19.9;NB-4: 39.2;U-937: 42.1"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"basal ganglia: 1.1"	"Cell type enriched"	"Detected in some"	19	"eosinophil: 90.2"	"Lineage enriched"	"Detected in many"	19	"granulocytes: 90.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"														"unprognostic (3.89e-2)"	"unprognostic (4.40e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.26e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.13e-3)"	"unprognostic (4.69e-2)"	"unprognostic (3.08e-1)"	"prognostic unfavourable (4.60e-7)"	"unprognostic (2.72e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.22e-2)"	"unprognostic (8.60e-2)"	45.1	0.5	0.1	5.8	1.1	10.1	28.6	0.0	0.1	0.1	10.6	0.0	0.0	0.3	0.2	1.1	0.1	0.7	7.7	2.2	0.1	0.1	0.4	0.2	1.4	5.3	0.1	0.0	0.5	0.5	0.0	0.1	0.1	0.2	0.7	0.4	0.1	5.9	1.6	1.6	0.6	1.4	0.6	0.2	0.8	0.4	0.1	0.0	0.1	0.5	2.4	0.2	0.9	0.2	0.0	1.2	90.2	4.7	0.0	0.0	2.8	0.0	0.0	0.0	0.0	11.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	19.9	1.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	42.1	0.0	1.8	4.7	90.2	0.0	0.5	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	2.8	0.1	1.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.0
MSR1	"CD204, SCARA1, SR-A, SR-AI, SR-AII, SR-AIII"	ENSG00000038945	"Macrophage scavenger receptor 1"	P21757	8	16107878-16567490	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"adipose tissue: 88.1;lung: 70.4"	"Group enriched"	"Detected in many"	7	"BJ hTERT+: 47.1;REH: 17.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 16.0"	"Lineage enriched"	"Detected in many"	5	"monocytes: 16.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA000272, CAB032491"	Enhanced					25000	25000			"CAB032491: AB_672722, HPA000272: AB_1846269"	"unprognostic (8.19e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.10e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.32e-2)"	"unprognostic (5.85e-3)"	"unprognostic (2.89e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.62e-2)"	"unprognostic (7.19e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.16e-2)"	"unprognostic (7.39e-2)"	"unprognostic (6.85e-2)"	"unprognostic (4.69e-2)"	88.1	9.0	2.2	6.1	4.5	3.7	6.9	10.4	3.3	4.5	3.1	1.8	1.0	2.1	3.1	6.2	2.4	4.5	11.4	8.0	3.8	3.1	9.5	13.6	70.4	6.9	4.3	0.8	6.7	3.8	1.2	2.6	10.4	7.7	3.2	3.9	4.5	6.2	2.3	3.2	1.6	4.0	6.5	11.9	10.9	2.5	4.9	3.1	1.5	2.2	1.7	0.7	10.8	1.8	1.5	1.0	3.0	16.0	0.3	1.3	0.5	0.6	0.9	1.3	0.6	0.6	0.6	0.6	0.3	47.1	0.1	0.2	1.6	0.1	1.5	2.4	0.4	0.3	0.3	0.4	0.9	0.2	1.9	1.9	1.8	1.8	0.4	1.0	1.1	0.3	0.3	0.3	0.7	0.0	0.7	1.4	0.9	1.8	0.6	0.6	0.2	0.6	17.8	1.0	0.4	0.9	2.7	1.0	0.5	0.4	1.2	0.1	0.1	0.5	1.1	1.2	0.5	4.9	1.2	4.8	3.7	3.2	0.5	0.6	1.0	1.1	3.1	0.5	0.9	16.0	0.4	0.9	0.7	0.7	1.0	1.5	1.3	0.9	3.0	0.3	7.8	0.5	0.6	0.5	2.2	4.5	10.4	2.7	3.8	3.1	4.3	0.8	7.7	3.1
MYMX	MINION	ENSG00000262179	"Myomixer, myoblast fusion factor"	A0A1B0GTQ4	6	44216939-44218236	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	5	"adipose tissue: 27.4;blood: 12.2;pancreas: 9.0"	"Cell line enriched"	"Detected in some"	31	"RH-30: 55.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"					"Cell type enriched"	"Detected in single"	115	"plasmacytoid DC: 12.2"	"Lineage enriched"	"Detected in single"	121	"dendritic cells: 12.2"	"Not detected"	"Not detected"							HPA051451	Approved		Approved	Vesicles,Mitochondria,Cytosol				Vesicles	Vesicles	"HPA051451: "	"unprognostic (1.24e-1)"	"unprognostic (8.55e-2)"	"unprognostic (6.86e-2)"	"unprognostic (6.51e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.27e-2)"	"unprognostic (2.10e-3)"	"unprognostic (4.32e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.71e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.01e-4)"	"unprognostic (1.63e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.67e-1)"	27.4	0.0	0.0	1.0	0.0	0.0	2.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.1	0.8	0.0		1.1	0.0	0.5	1.4	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	1.4	0.0	0.4	1.7	0.0	2.2	0.0	0.1	0.0	0.0	1.8	3.2	0.6	0.0	2.8	0.4	0.0	0.4	0.5	0.0	0.0	12.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	55.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	12.2	0.0	0.1										
PRKAR2B	PRKAR2	ENSG00000005249	"Protein kinase cAMP-dependent type II regulatory subunit beta"	P31323	7	107044649-107161811	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"adipose tissue: 80.2;breast: 114.1"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 19.7;Daudi: 27.0;K-562: 16.3;U-698: 69.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008421, HPA063879"	Enhanced		Uncertain	Mitochondria		1600000	1600000	Mitochondria	Mitochondria	"HPA008421: AB_1855421, HPA063879: "	"unprognostic (3.18e-1)"	"unprognostic (2.48e-2)"	"prognostic favourable (6.38e-4)"	"unprognostic (1.63e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.43e-3)"	"unprognostic (2.76e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.97e-2)"	"prognostic favourable (4.03e-4)"	"unprognostic (1.50e-1)"	"unprognostic (5.12e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavourable (8.74e-4)"	"unprognostic (7.15e-2)"	80.2	21.5	9.4	6.0	17.2	8.4	114.1	4.5	17.0	3.9	9.1	1.9	2.4	3.1	5.1	3.9	8.4	3.4	4.7	9.0	8.8	8.6	4.5	2.4	3.2	3.0	8.4	12.1	19.5	6.5	5.6	8.1	10.7	3.0	6.4	5.5	2.6	6.8	3.9	2.2	1.6	4.7	7.4	3.4	11.1	4.1	14.5	4.6	0.8	1.6	2.8	3.3	8.4	11.8	0.2	3.1	1.3	1.5	0.5	0.1	2.5	0.0	0.4	2.5	19.7	10.6	0.0	0.0	1.0	3.2	0.8	0.7	0.0	0.0	27.0	0.2	0.6	0.0	1.9	0.0	1.5	0.7	2.2	9.0	0.0	0.0	2.9	0.1	1.2	0.1	0.0	0.0	0.0	11.9	16.3	0.8	0.0	2.0	3.7	0.1	4.8	0.7	1.0	0.0	0.0	0.0	0.0	3.2	4.7	1.4	0.3	1.0	0.6	1.9	6.7	0.9	2.6	0.0	1.9	0.6	0.0	69.4	0.7	4.7	9.4	1.3	1.5	0.0	0.0	1.4	0.1	0.2	0.0	0.0	3.1	0.0	0.1	0.1	0.7	0.5	0.7	1.1	0.0	2.5	9.4	17.2	4.5	17.0	8.8	8.6	8.4	12.1	3.0	4.6
TIMP4		ENSG00000157150	"TIMP metallopeptidase inhibitor 4"	Q99727	3	12153051-12159351	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 72.2;breast: 97.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 53.4;ASC TERT1: 13.3;HSkMC: 23.2;NTERA-2: 13.3;U-87 MG: 13.6"	"Cancer enriched"	"Detected in many"	13	"glioma: 66.4"	"Region enriched"	"Detected in all"	5	"cerebellum: 17.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in all"		"cerebellum: 118.9"	"Region enriched"	"Detected in all"	6	"cerebellum: 100.1"						"Secreted to extracellular matrix"						"unprognostic (2.99e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.97e-4)"	"unprognostic (9.33e-3)"	"unprognostic (4.26e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.78e-1)"	"unprognostic (6.81e-2)"	"unprognostic (4.99e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.66e-5)"	"unprognostic (2.86e-1)"	72.2	4.3	1.9	2.2	1.6	0.7	97.5	17.8	11.2	2.6	11.7	2.4	0.7	1.1	1.9	0.9	3.2	1.6	2.9	10.9	1.7	1.5	1.9	0.8	2.6	6.0	3.1	1.5	1.2	1.5	1.2	3.2	4.6	3.8	2.9	2.4	2.4	3.1	1.6	7.7	1.7	2.4	2.4	2.9	0.8	2.3	1.8	1.2	0.1	6.1	3.8	0.6	3.7	9.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	5.9	0.2	0.0	53.4	13.3	6.6	0.2	2.1	0.2	0.3	0.1	0.0	0.0	0.5	0.2	0.2	0.0	0.1	0.1	0.2	0.0	0.0	3.4	0.2	8.3	0.0	0.0	23.2	0.5	1.4	0.0	0.0	0.1	4.3	0.0	0.1	0.0	0.0	13.3	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	13.6	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.6	17.8	1.3	1.7	1.5	3.1	1.5	3.8	1.2
TM4SF19		ENSG00000145107	"Transmembrane 4 L six family member 19"	Q96DZ7	3	196319342-196338503	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	5	"adipose tissue: 69.9"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 11.6;hTERT-HME1: 19.6;PC-3: 22.2;U-138 MG: 11.8;U-87 MG: 12.6"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 3.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"gdTCR: 14.8;memory CD8 T-cell: 3.8;naive CD8 T-cell: 5.4"	"Lineage enriched"	"Detected in single"	19	"T-cells: 14.8"																				"unprognostic (9.90e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.19e-2)"	"unprognostic (8.90e-5)"	"unprognostic (8.86e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.06e-3)"	"unprognostic (4.23e-2)"	"unprognostic (4.20e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.18e-3)"	69.9	0.4	0.4	0.7	0.4	0.9	4.5	0.4	0.5	2.1	0.4	0.4	0.4	0.0	0.4	0.6	5.0	0.3	0.8	0.4	0.4	0.1	0.4	0.8	4.9	0.6	0.4	0.4	1.2	0.4	0.0	0.4	1.1	0.4	0.6	0.1	0.4	2.2	0.4	2.1	3.2	0.4	0.4	0.4	0.8	0.6	8.2	0.4	0.5	1.0	2.0	1.3	0.9	2.1	0.3	0.5	0.6	0.4	0.8	14.8	1.4	9.1	4.3	0.2	0.3	0.5	3.0	0.3	0.0	2.7	1.0	1.8	0.1	5.0	0.1	1.6	0.0	1.3	0.0	1.0	0.7	0.3	0.1	0.3	1.2	0.0	0.6	0.5	0.3	0.3	0.8	11.6	19.6	0.0	5.7	0.5	2.9	0.7	0.1	0.5	0.0	22.2	0.1	2.0	0.5	0.0	0.2	0.2	0.0	1.6	0.0	0.4	0.4	0.1	0.8	11.8	9.7	1.8	5.4	0.3	3.1	0.2	12.6	0.4	0.3	0.6	0.3	0.4	14.8	0.4	0.1	0.1	1.4	3.8	0.1	0.3	0.8	5.4	0.6	0.8	0.1	0.5	0.3	1.4	0.4	0.4	0.4	0.5	0.4	0.1	0.4	0.4	0.4	0.4
UCP1	"SLC25A7, UCP"	ENSG00000109424	"Uncoupling protein 1"	P25874	4	140559434-140568805	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adipose tissue: 2.4;adrenal gland: 8.4;breast: 2.2;heart muscle: 7.1"	"Group enriched"	"Detected in some"	13	"BEWO: 9.6;HAP1: 7.0"	"Cancer enhanced"	"Detected in single"		"breast cancer: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																		"unprognostic (5.08e-3)"	"unprognostic (4.44e-1)"		"unprognostic (2.65e-2)"	"unprognostic (2.30e-1)"	"unprognostic (7.17e-2)"		"unprognostic (6.08e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.38e-1)"		"unprognostic (4.45e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.58e-2)"	2.4	8.4	0.1	0.1	0.1	0.0	2.2	0.1	0.1	0.1	0.7	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	7.1	0.1	0.7	0.1	0.1	0.2	0.1	0.1	0.1	0.6	0.2	0.0	0.1	0.8	0.1	0.1	0.0	0.1	1.1	0.1	0.1	0.0	0.4	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	9.6	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.7	0.1	0.1	0.1	0.1
AC002996.1		ENSG00000257767			12	111753890-111791418	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in many"	4	"adipose tissue: 27.0;blood: 29.9;skeletal muscle: 16.3;stomach 1: 8.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 8.8;EFO-21: 17.3;SK-BR-3: 8.5"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in many"		"classical monocyte: 29.4;myeloid DC: 29.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 29.9;monocytes: 29.4"																										"unprognostic (4.89e-1)"						"unprognostic (1.20e-1)"					27.0	2.5	0.7	0.8	1.3	0.0	0.4	1.3	1.3	0.6	4.8			4.4	0.2	0.0	0.5	0.3	0.0	0.5	0.6	0.4	4.0	1.6	2.1	0.0	0.5		1.0	0.6	0.0	0.4	0.0		0.3	0.0		2.4	0.5	16.3	0.9	1.7	0.0	0.8	0.4	8.0	0.0			0.3		0.0	0.8	0.6	1.1	29.9	6.2	29.4	0.3	0.2	14.8	3.3	0.0	0.0	0.9	0.0	1.4	8.8	0.9	4.2	1.6	0.8	0.0	2.0	0.0	17.3	1.8	3.0	0.0	0.7	0.1	0.5	0.4	0.0	2.5	0.0	0.0	0.3	0.0	0.0	2.0	1.8	0.0	4.3	1.5	0.2	0.7	0.0	0.0	0.6	5.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	4.7	0.0	8.5	0.1	6.2	3.3	0.0	0.0	2.0	0.2	0.0	1.3	1.9	4.5	2.5	0.1	0.0	0.4	29.4	6.2	0.1	13.0	0.2	1.1	0.0	0.0	29.9	0.4	0.0	0.0	1.1	0.3	3.9	8.0	0.1	14.8										
CD300LB	"CLM7, TREM5"	ENSG00000178789	"CD300 molecule like family member b"	A8K4G0	17	74521174-74531474	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"adipose tissue: 20.7;blood: 30.7;bone marrow: 8.8;lymphoid tissue: 10.9"	"Group enriched"	"Detected in some"	6	"HL-60: 4.5;NB-4: 5.9;THP-1: 4.6;U-937: 2.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"eosinophil: 30.7"	"Group enriched"	"Detected in many"	52	"dendritic cells: 10.5;granulocytes: 30.7;monocytes: 13.0"																				"unprognostic (1.39e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.39e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.41e-2)"	"unprognostic (7.69e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.95e-2)"	"unprognostic (6.24e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.49e-4)"	"unprognostic (2.92e-2)"	"unprognostic (1.79e-2)"	"unprognostic (7.08e-2)"	"unprognostic (4.01e-2)"	20.7	0.9	0.2	10.9	0.5	8.8	2.0	0.4	0.5	0.6	0.8	0.3	0.1	0.7	0.7	1.0	1.1	1.2	2.8	1.6	1.5	0.4	1.2	1.0	4.4	6.5	1.2	0.1	2.0	2.3	0.0	0.7	1.1	1.0	0.8	1.1	1.6	1.2	0.1	0.3	0.4	2.0	2.2	0.6	6.6	0.7	0.7	0.1	0.9	0.6	0.1	2.2	2.6	0.7	0.0	10.5	30.7	13.0	0.3	0.1	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.4	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.7	2.7	0.0	0.6	13.0	30.7	0.0	5.6	0.1	0.0	0.0	0.0	10.5	0.0	0.0	0.1	13.8	0.3	0.7	6.6	0.0	4.2	0.2	0.5	0.4	0.5	1.5	0.4	1.2	0.1	1.0	0.1
EN1		ENSG00000163064	"Engrailed homeobox 1"	Q05925	2	118842171-118847678	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adipose tissue: 5.6;brain: 11.4;skeletal muscle: 20.1;skin 1: 10.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 14.1;ASC TERT1: 6.4;fHDF/TERT166: 11.1;HSkMC: 11.9;PC-3: 6.6;U-138 MG: 8.6;U-2197: 9.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 5.6"	"Group enriched"	"Detected in some"	10	"midbrain: 11.4;pons and medulla: 8.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"midbrain: 5.9"	"Region enriched"	"Detected in some"	5	"midbrain: 23.9"	"CAB014884, HPA073141"	Enhanced		Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoli	"CAB014884: , HPA073141: AB_2686573"	"unprognostic (5.20e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.78e-2)"	"unprognostic (4.84e-7)"	"unprognostic (1.87e-3)"	"unprognostic (1.90e-1)"		"unprognostic (1.95e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.46e-1)"	"unprognostic (3.38e-9)"	"unprognostic (2.15e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.30e-3)"	5.6	0.1	0.0	0.1	0.4	0.0	2.7	0.9	0.4	0.0	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	2.4	11.4	0.0	0.1	0.0	0.1	0.0	0.0	8.8	0.1	0.1	0.2	0.7	0.1	20.1	10.0	0.1	0.1	2.7	0.1	0.1	0.4	0.1	0.2	0.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.2	0.5	0.2	14.1	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.4	0.5	0.0	0.0	0.0	1.1	0.0	0.6	0.0	0.1	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	8.6	0.8	9.6	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.4	0.2	0.1	11.4	0.0	8.8	0.1
GYG2	GN-2	ENSG00000056998	"Glycogenin 2"	O15488	X	2828788-2882820	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 76.7;brain: 21.2;breast: 30.4"	"Cell line enhanced"	"Detected in many"		"AF22: 17.7;BEWO: 12.8;CACO-2: 13.1;Hep G2: 14.2;NTERA-2: 17.4;SK-MEL-30: 37.7"	"Cancer enhanced"	"Detected in all"		"melanoma: 42.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA005495, HPA064686"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoli, Cytosol"	"Nucleoli, Cytosol"	"HPA005495: AB_1079035, HPA064686: AB_2685323"	"unprognostic (4.45e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.41e-3)"	"unprognostic (8.50e-2)"	"unprognostic (2.07e-3)"	"unprognostic (5.16e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.43e-3)"	"unprognostic (6.74e-2)"	"prognostic favourable (3.01e-5)"	"unprognostic (9.76e-2)"	"unprognostic (6.10e-5)"	"unprognostic (1.78e-1)"	"unprognostic (5.05e-3)"	"unprognostic (5.41e-2)"	"unprognostic (6.60e-2)"	76.7	1.4	4.6	1.3	4.6	0.5	30.4	2.1	3.7	2.1	3.5	8.2	0.7	1.2	4.2	0.9	1.0	3.6	1.7	1.7	3.9	2.9	1.4	9.9	0.7	0.7	5.5	2.9	1.9	3.2	0.4	0.5	1.6	12.9	2.7	2.0	4.2	2.8	4.4	0.5	1.2	1.3	2.8	21.2	0.5	2.2	0.8	5.1	0.0	1.3	0.5	0.6	2.9	1.4	1.0	0.6	0.6	0.4	1.2	0.7	0.0	0.0	5.4	17.7	0.0	10.6	0.0	12.8	0.5	3.1	3.1	3.9	13.1	0.3	0.0	1.4	2.2	0.0	10.0	0.2	3.0	0.1	2.8	0.0	0.2	14.2	3.1	0.0	4.3	3.8	0.1	0.3	0.0	0.0	0.1	0.0	3.2	0.8	0.0	0.4	17.4	0.1	2.9	5.9	0.0	0.0	0.0	0.0	0.3	0.0	0.1	37.7	1.7	10.7	0.0	0.0	3.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.2	0.7	0.5	0.4	0.3	0.1	1.0	0.3	0.2	0.6	1.2	0.4	0.6	0.4	0.0	4.6	4.6	2.1	3.7	3.9	2.9	5.5	2.9	12.9	5.1
HS3ST2	3OST2	ENSG00000122254	"Heparan sulfate-glucosamine 3-sulfotransferase 2"	Q9Y278	16	22814177-22916338	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"adipose tissue: 12.7;brain: 38.2;lung: 13.4"	"Group enriched"	"Detected in some"	5	"HaCaT: 10.2;SH-SY5Y: 18.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA017736	Approved									"HPA017736: AB_1851095"	"unprognostic (4.09e-2)"	"unprognostic (2.90e-3)"	"unprognostic (5.97e-3)"	"unprognostic (3.46e-3)"	"prognostic unfavourable (1.57e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.45e-1)"	"prognostic favourable (1.35e-4)"	"unprognostic (4.89e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.00e-2)"	12.7	1.7	3.8	1.1	6.5	1.1	2.4	0.5	38.2	2.0	1.4	0.3	0.3	1.0	1.0	1.0	1.2	1.0	1.1	3.8	7.8	4.3	1.0	2.2	13.4	2.1	2.2	8.4	4.5	1.0	1.0	0.4	1.2	1.5	2.0	1.4	5.0	2.9	1.1	1.0	2.0	1.0	1.2	1.0	1.1	1.1	1.1	0.0	0.0	1.8	0.4	1.0	1.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	6.5	0.5	19.1	7.8	4.3	2.2	8.4	1.5	0.0
IL2RA	"CD25, IDDM10, IL2R"	ENSG00000134460	"Interleukin 2 receptor subunit alpha"	P01589	10	6010689-6062370	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 16.5;blood: 55.4;lymphoid tissue: 56.7"	"Cell line enriched"	"Detected in some"	59	"HDLM-2: 153.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"pons and medulla: 2.4"	"Group enriched"	"Detected in many"	6	"basophil: 30.3;T-reg: 55.4"	"Group enriched"	"Detected in many"	12	"granulocytes: 30.3;T-cells: 55.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002419, HPA054622"	Enhanced					110000	110000			"CAB002419: AB_563538, HPA054622: AB_2682546"	"unprognostic (2.82e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.75e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.45e-3)"	"unprognostic (2.78e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.03e-2)"	"unprognostic (6.32e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavourable (2.08e-9)"	"unprognostic (2.10e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.22e-1)"	"unprognostic (5.10e-2)"	16.5	2.5	0.3	10.9	0.6	0.1	1.4	0.3	0.3	0.6	3.1	0.1	0.0	1.3	0.8	4.9	1.9	0.8	2.2	1.9	0.4	0.5	2.6	1.3	4.0	50.4	0.5	0.0	0.6	1.0	0.0	1.8	1.8	2.4	1.1	1.6	3.4	2.2	0.5	0.8	0.6	10.3	3.5	2.2	56.7	1.4	0.4	0.0	4.5	4.2	2.0	16.8	5.0	0.6	3.6	0.0	30.3	0.0	2.9	55.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	153.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	30.3	0.0	4.5	0.1	0.0	0.5	3.6	6.8	0.7	0.0	1.5	0.5	0.0	0.2	2.9	0.0	0.0	55.4	0.7	0.3	0.6	0.3	0.3	0.4	0.5	0.5	0.0	2.4	0.0
MUC16	"CA125, FLJ14303"	ENSG00000181143	"Mucin 16, cell surface associated"	Q8WXI7	19	8848844-8981342	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adipose tissue: 6.6;cervix, uterine: 19.3;fallopian tube: 6.7;salivary gland: 6.3"	"Cell line enhanced"	"Detected in some"		"A-431: 15.5;CAPAN-2: 5.5;HaCaT: 5.3;HeLa: 26.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 21.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB055172, HPA065600"	Enhanced				"Secreted in other tissues"					"CAB055172: AB_2148831, HPA065600: AB_2732736"	"unprognostic (8.66e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.37e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.01e-3)"	"unprognostic (3.83e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.60e-8)"	"unprognostic (3.50e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.68e-3)"	6.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	19.3	0.0			0.0	2.4	0.0	0.2	6.7	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0		0.0	0.0	0.0	0.0	0.3		0.0	0.0		6.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	15.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.4	2.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
NAT8L	"FLJ37478, Hcml3"	ENSG00000185818	"N-acetyltransferase 8 like"	Q8N9F0	4	2059512-2069089	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 45.9;brain: 45.9;testis: 11.8"	"Cell line enhanced"	"Detected in many"		"NB-4: 14.4;SCLC-21H: 18.6;SK-MEL-30: 14.8"	"Group enriched"	"Detected in many"	6	"endometrial cancer: 6.2;glioma: 17.2;melanoma: 14.6;ovarian cancer: 8.0;thyroid cancer: 7.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	28	"plasmacytoid DC: 3.8"	"Lineage enriched"	"Detected in single"	28	"dendritic cells: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040677			Approved	Mitochondria				Mitochondria	Mitochondria	"HPA040677: AB_2732486"	"unprognostic (1.32e-2)"	"unprognostic (8.62e-2)"	"unprognostic (3.02e-3)"	"prognostic unfavourable (1.01e-5)"	"unprognostic (2.56e-1)"	"unprognostic (2.63e-4)"	"unprognostic (6.58e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.54e-1)"	"unprognostic (3.70e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.78e-3)"	"unprognostic (7.24e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.35e-2)"	45.9	2.0	23.5	1.3	28.3	1.2	7.9	16.4	45.9	1.2	1.5	7.4	0.3	1.3	1.6	2.8	1.3	2.4	1.3	2.1	20.8	12.9	8.2	1.2	1.2	1.4	16.4	12.6	1.4	3.9	1.2	5.6	1.3	12.8	2.4	1.3	1.2	3.8	3.2	7.3	2.4	1.5	1.4	6.5	1.5	1.6	11.8	8.2	0.0	1.6	0.0	1.2	1.2	0.1	0.0	3.8	0.1	0.0	0.0	0.0	0.0	0.0	6.5	3.6	7.2	0.7	0.0	4.1	0.1	0.0	0.2	0.0	2.9	0.2	0.0	1.3	0.0	0.1	8.0	0.0	0.1	0.0	9.4	0.1	1.4	4.6	1.2	9.9	4.9	0.0	0.1	0.0	0.0	0.0	7.7	0.0	0.2	4.3	0.1	14.4	10.1	2.9	0.5	1.7	0.2	0.1	0.3	18.6	6.2	4.7	0.0	14.8	0.5	5.8	0.0	0.0	2.4	0.1	3.8	0.0	0.0	0.1	0.0	4.2	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	23.5	28.3	16.4	32.7	20.8	12.9	16.4	12.6	12.8	8.2
NMB	"MGC17211, MGC2277, MGC3936"	ENSG00000197696	"Neuromedin B"	P08949	15	84655129-84658563	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"adipose tissue: 37.2;brain: 28.5;breast: 59.9"	"Cell line enhanced"	"Detected in many"		"A-431: 27.5"	"Cancer enhanced"	"Detected in all"		"glioma: 93.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in many"	16	"olfactory region: 206.6"	"Group enriched"	"Detected in many"	6	"olfactory region: 80.6;pons and medulla: 17.5"	CAB019302	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"	"Secreted to blood"			"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"CAB019302: "	"unprognostic (2.44e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.34e-3)"	"unprognostic (3.79e-1)"	"prognostic favourable (3.43e-4)"	"unprognostic (3.81e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.36e-1)"	"unprognostic (7.24e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavourable (2.25e-4)"	"unprognostic (7.92e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.00e-1)"	37.2	8.0	4.6	2.8	7.5	3.3	59.9	2.4	28.5	4.0	6.5	13.7	1.0	2.3	3.1	3.2	2.5	5.0	4.5	7.0	7.0	12.2	4.4	1.9	3.8	3.6	6.6	3.5	3.4	3.3	2.7	4.2	1.4	5.6	1.9	2.1	2.6	4.6	1.8	2.0	1.8	1.4	2.9	9.9	2.0	2.5	6.4	4.8	2.2	8.9	4.9	1.9	4.7	8.5	7.0	10.4	5.9	0.8	1.3	6.4	2.6	27.5	10.5	1.9	0.4	5.5	2.4	0.2	1.7	3.3	3.7	5.1	3.7	7.6	1.2	4.4	4.4	4.9	10.6	2.1	2.1	10.3	13.3	4.2	4.1	17.1	1.4	2.8	4.6	2.5	0.8	5.8	2.2	5.4	0.0	0.4	2.0	16.1	2.6	9.3	7.8	3.0	8.3	0.0	12.2	3.5	2.2	1.0	12.0	2.7	1.6	12.5	1.8	11.0	1.3	0.7	3.7	3.5	2.6	0.2	3.0	2.6	8.5	15.9	4.4	0.0	0.8	5.9	6.3	0.6	2.3	4.9	5.0	6.4	3.5	7.0	4.8	3.6	1.2	1.3	0.3	10.4	5.6	2.6	4.6	7.5	2.4	8.5	7.0	12.2	6.6	3.5	5.6	4.8
PNPLA2	"ATGL, desnutrin, FP17548, iPLA2zeta, TTS-2.2"	ENSG00000177666	"Patatin like phospholipase domain containing 2"	Q96AD5	11	818902-825573	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"adipose tissue: 158.1;breast: 155.2"	"Cell line enhanced"	"Detected in all"		"ASC diff: 64.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055173, HPA062602, HPA075175"	Approved		Enhanced	"Nucleoplasm,Lipid droplets"				"Lipid droplets"	"Lipid droplets"	"HPA055173: AB_2682725, HPA062602: AB_2684804, HPA075175: "	"unprognostic (2.11e-2)"	"unprognostic (3.37e-2)"	"unprognostic (5.87e-3)"	"unprognostic (2.51e-2)"	"unprognostic (8.97e-3)"	"unprognostic (1.68e-2)"	"unprognostic (6.39e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.61e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.68e-1)"	"unprognostic (5.46e-1)"	"unprognostic (4.09e-1)"	"unprognostic (2.07e-2)"	158.1	7.2	1.6	9.4	1.8	11.2	155.2	2.7	2.3	4.1	35.9	1.5	3.8	5.6	4.5	7.8	8.6	4.3	7.2	12.6	1.7	1.1	15.6	7.4	11.3	4.5	1.6	1.6	4.9	11.8	2.5	4.2	11.6	1.8	5.2	1.5	1.9	8.1	8.1	25.0	6.1	23.1	3.0	2.1	4.9	8.2	4.0	1.5	1.5	11.3	4.8	5.1	13.0	18.6	4.2	6.5	18.7	8.5	3.6	5.3	3.6	10.4	8.2	1.7	4.4	64.1	5.7	11.0	11.1	9.0	7.0	6.2	6.9	10.5	6.2	6.6	8.3	9.4	2.5	4.6	2.1	7.9	22.7	8.5	3.6	11.1	21.0	5.8	10.8	11.2	6.0	4.7	5.4	5.7	7.2	6.3	6.2	6.1	7.8	12.9	4.9	17.6	7.6	3.7	13.8	6.8	2.4	6.3	8.4	20.6	17.6	6.4	7.5	6.8	10.2	6.3	4.9	4.1	5.0	24.3	15.0	5.2	15.8	8.4	4.4	9.3	8.5	18.7	3.6	5.5	3.5	4.2	4.6	5.2	5.7	3.6	5.3	4.3	7.7	3.6	6.0	6.5	3.9	3.6	1.6	1.8	2.7	1.9	1.7	1.1	1.6	1.6	1.8	1.5
SCD	"FADS5, SCDOS"	ENSG00000099194	"Stearoyl-CoA desaturase"	O00767	10	100347124-100364834	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 245.0;brain: 130.0;breast: 94.0;heart muscle: 109.2;liver: 130.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 199.5;CAPAN-2: 138.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA012107, HPA063921"	Approved		Enhanced	"Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA012107: AB_1856610, HPA063921: AB_2685154"	"unprognostic (2.10e-1)"	"unprognostic (2.62e-3)"	"unprognostic (7.86e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavourable (7.56e-5)"	"unprognostic (7.18e-2)"	"unprognostic (3.27e-1)"	"unprognostic (4.73e-2)"	"prognostic unfavourable (7.79e-5)"	245.0	21.3	59.8	11.4	32.7	5.5	94.0	12.7	83.9	5.3	10.8	63.6	0.1	21.4	3.7	7.0	13.4	1.7	18.3	109.2	61.5	43.4	5.0	130.8	32.2	23.1	65.1	23.6	12.7	6.1	7.7	1.5	5.3	34.5	24.4	10.1	4.5	24.9	3.7	2.4	3.4	6.1	4.6	130.0	4.2	5.9	12.2	35.4	1.4	2.0	6.9	5.4	3.7	5.0	2.0	5.3	0.2	3.3	2.9	5.1	2.1	30.4	28.0	59.8	40.9	199.5	115.1	12.2	3.2	72.1	7.8	41.8	24.1	138.2	12.8	2.6	7.6	54.4	32.9	116.8	6.9	4.3	13.6	7.2	17.8	48.2	38.6	10.0	7.8	62.6	35.4	30.4	53.6	14.8	20.0	39.2	3.1	47.6	11.3	12.0	20.7	8.1	5.3	22.1	40.2	34.2	34.1	3.7	14.4	6.4	30.5	62.7	34.2	21.6	5.9	0.7	9.3	0.7	6.7	11.0	5.8	19.8	14.3	31.3	5.0	0.0	1.5	0.0	3.0	3.3	5.1	1.3	1.2	1.6	5.3	2.0	1.0	2.9	0.2	2.9	0.0	3.0	0.0	2.1	59.8	32.7	12.7	27.9	61.5	43.4	65.1	23.6	34.5	35.4
SLAMF9	"CD2F-10, CD84-H1, SF2001"	ENSG00000162723	"SLAM family member 9"	Q96A28	1	159951492-159954254	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"adipose tissue: 20.3;blood: 5.5"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 6.5;HEL: 8.9;PC-3: 3.6;SK-MEL-30: 3.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	9	"myeloid DC: 5.5"	"Lineage enriched"	"Detected in single"	9	"dendritic cells: 5.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035153	Uncertain									"HPA035153: AB_10670586"	"unprognostic (1.05e-1)"	"unprognostic (1.54e-5)"	"unprognostic (6.12e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.54e-4)"	"unprognostic (5.27e-4)"	"unprognostic (5.47e-2)"	"unprognostic (6.17e-5)"	"unprognostic (8.97e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.37e-1)"	20.3	0.0	0.1	2.3	0.1	1.1	0.9	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.7	1.0	0.1	0.4	0.1	0.0	0.1	2.6	1.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.6	0.1	0.2	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.2	0.7	0.2	2.9	0.1	0.5	0.1	0.7	0.5	2.9	0.5	0.1	5.5	0.5	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	6.5	0.0	0.0	0.0	8.9	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.6	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.2	0.0	0.0	1.8	0.0	0.0	0.1	3.9	0.7	1.5	0.0	1.3	1.4	2.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	5.5	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SMIM3	"C5orf62, MSTP150, NID67"	ENSG00000256235	"Small integral membrane protein 3"	Q9BZL3	5	150777946-150796734	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"adipose tissue: 24.4;blood: 22.3;bone marrow: 11.4;pancreas: 45.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 63.1;ASC TERT1: 30.9;LHCN-M2: 28.6;U-87 MG: 46.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075345			Approved	Vesicles				Vesicles	Vesicles	"HPA075345: AB_2686744"	"unprognostic (2.33e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.70e-2)"	"unprognostic (9.45e-2)"	"unprognostic (5.65e-2)"	"unprognostic (4.57e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.05e-2)"	"unprognostic (9.71e-3)"	"unprognostic (3.46e-3)"	"prognostic unfavourable (1.15e-8)"	"unprognostic (3.87e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.46e-3)"	24.4	5.4	6.1	3.3	5.6	11.4	3.9	3.3	6.2	2.2	3.1	1.8	0.7	1.3	3.0	2.9	2.2	3.0	3.3	3.4	2.6	1.2	2.9	1.1	3.6	0.7	3.0	1.0	3.2	45.7	1.2	1.8	6.4	6.2	3.2	2.3	1.3	1.8	3.3	2.5	2.2	3.9	3.7	2.6	1.9	2.9	1.7	4.3	1.8	2.7	0.7	0.7	3.8	1.8	0.3	18.4	22.3	13.3	3.6	7.2	11.6	2.0	0.6	1.1	9.2	63.1	30.9	2.4	7.9	16.9	2.8	11.7	3.1	5.3	0.0	0.4	8.0	1.6	1.8	1.7	4.3	0.0	0.5	2.9	0.4	1.4	11.2	2.8	20.9	25.8	3.5	8.2	3.8	0.9	0.7	0.0	28.6	1.5	4.1	3.9	0.5	1.8	2.2	0.1	0.0	3.1	1.5	0.2	0.7	1.1	0.1	2.3	3.8	17.8	1.5	13.0	2.3	10.1	4.0	0.0	0.0	0.0	46.9	10.9	1.6	17.9	13.3	22.3	7.2	5.3	4.3	0.3	5.1	4.9	6.2	0.0	5.0	4.3	13.9	3.6	4.8	18.4	0.7	11.6	6.1	5.6	3.3	6.2	2.6	1.2	3.0	1.0	6.2	4.3
AADACL4		ENSG00000204518	"Arylacetamide deacetylase like 4"	Q5VUY2	1	12644547-12667086	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 2.8;epididymis: 3.5;vagina: 3.3"	"Cell line enhanced"	"Detected in single"		"REH: 1.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"																	"unprognostic (3.20e-1)"								"unprognostic (1.89e-2)"						2.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.8			0.0	0.4	3.5	0.0	0.7	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.7	0.0		0.1	0.2	0.0	0.0	0.7		1.1	0.0		0.0	1.4	0.2	0.0	0.0	0.5	0.0	0.6	0.4	1.4			0.0		0.0	0.4	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ABCA9	EST640918	ENSG00000154258	"ATP binding cassette subfamily A member 9"	Q8IUA7	17	68974488-69061064	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 42.5"	"Group enriched"	"Detected in some"	6	"ASC diff: 14.2;ASC TERT1: 30.4;HSkMC: 10.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052113, HPA054823"	Uncertain		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA052113: AB_2732573, HPA054823: AB_2682615"	"unprognostic (3.88e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.21e-1)"	"unprognostic (9.75e-2)"	"unprognostic (4.46e-1)"	"unprognostic (5.64e-3)"	"unprognostic (4.51e-4)"	"unprognostic (1.83e-2)"	"unprognostic (1.94e-3)"	"unprognostic (7.86e-2)"	"unprognostic (3.26e-3)"	"unprognostic (3.51e-1)"	"unprognostic (7.77e-6)"	"unprognostic (5.32e-4)"	"unprognostic (7.22e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.96e-3)"	42.5	4.2	1.2	5.5	2.8	1.7	14.1	2.7	2.6	13.4	17.4	2.6	6.8	1.7	15.5	11.8	25.5	8.8	7.2	15.0	2.1	1.9	2.5	7.6	5.6	2.1	7.8	2.0	25.2	2.3	1.7	2.8	1.1	4.4	13.9	3.8	4.1	5.7	4.7	12.4	5.4	3.7	11.9	3.8	1.6	4.8	10.9	2.1	1.0	7.6	9.9	2.5	20.4	18.7	1.8	0.9	2.9	0.8	1.2	1.3	0.0	0.2	0.4	0.5	0.6	14.2	30.4	0.5	0.3	0.3	0.0	0.2	0.3	0.4	0.4	0.1	0.5	0.4	0.2	0.5	0.2	0.2	0.4	0.5	1.2	0.4	1.5	0.6	0.9	10.8	0.4	2.2	0.2	3.0	0.5	1.0	0.2	0.2	0.2	1.4	0.3	0.3	1.4	0.1	0.2	0.1	1.3	0.5	0.4	0.4	0.3	0.2	0.3	0.5	1.3	0.9	0.4	1.6	0.3	1.0	0.3	0.3	0.3	0.3	1.4	1.7	0.8	1.4	1.3	0.6	1.3	1.1	0.8	0.5	0.9	1.8	1.3	1.3	2.9	1.2	0.5	0.7	0.4	0.0	1.2	2.8	2.7	2.6	2.1	1.9	7.8	2.0	4.4	2.1
ABCD2	"ALDL1, ALDR, ALDRP"	ENSG00000173208	"ATP binding cassette subfamily D member 2"	Q9UBJ2	12	39550033-39619751	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 24.1;brain: 30.1"	"Group enriched"	"Detected in some"	5	"ASC diff: 9.0;HDLM-2: 12.1;Karpas-707: 21.7;SH-SY5Y: 13.1;U-266/70: 7.4"	"Cancer enriched"	"Detected in single"	7	"glioma: 1.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Lineage enriched"	"Detected in many"	4	"T-cells: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.26e-3)"	"unprognostic (4.06e-4)"	"unprognostic (9.27e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.06e-1)"	"unprognostic (7.31e-5)"	"unprognostic (3.42e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.06e-3)"	"unprognostic (3.43e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.47e-4)"	"unprognostic (5.04e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.74e-2)"	24.1	3.6	6.8	3.5	6.8	0.9	5.5	30.1	13.4	10.6	1.7	1.3	0.0	1.4	5.4	1.0	1.3	5.2	1.4	7.4	5.1	4.1	1.4	0.7	1.4	4.8	4.8	8.4	0.7	0.7	0.7	5.1	0.5	11.4	1.2	1.7	2.9	4.6	1.6	0.7	0.7	1.7	5.1	2.1	3.0	1.6	0.9	2.6	0.9	1.0	0.6	3.2	2.8	1.9	0.8	0.8	0.1	0.0	1.4	6.5	1.8	0.0	0.0	0.1	0.0	9.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	21.7	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	7.4	0.9	0.1	0.0	0.2	0.0	0.0	0.0	0.0	2.4	0.0	1.9	0.8	4.3	5.7	0.2	0.4	5.0	6.5	0.1	1.4	0.0	0.8	5.1	1.8	6.8	6.8	30.1	13.4	5.1	4.1	4.8	8.4	11.4	2.6
AC012531.3		ENSG00000273049			12	53985845-54034888	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"adipose tissue: 8.6;kidney: 24.3;skeletal muscle: 10.3"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 13.3;fHDF/TERT166: 3.2;HDLM-2: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"gdTCR: 2.5"	"Lineage enriched"	"Detected in single"	26	"T-cells: 2.5"																																					8.6	0.9	0.1	0.1	0.2	0.0	1.2	0.1	0.1	1.0	0.4	0.0	0.0	0.2	2.0	4.5	0.8	2.8	0.0	0.4	0.1	0.1	24.3	0.3	0.3	1.2	0.1	0.0	3.2	0.5	0.8	0.2	1.1	0.1	0.7	0.0	0.0	0.3	0.0	10.3	0.8	1.2	1.3	0.4	0.3	0.7	1.1	0.0	0.0	0.4	0.0	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	2.5	0.4	0.6	0.8	0.0	13.3	1.1	0.0	0.0	0.2	0.2	0.6	0.2	0.0	1.2	0.0	0.3	3.2	1.5	0.0	0.0	0.0	4.8	0.0	0.0	0.3	0.3	0.3	0.0	0.3	0.4	0.0	0.4	0.4	0.0	0.2	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.2	0.7	0.1	0.3	1.3	2.4	0.1	0.0	0.8	1.8	1.2	0.3	0.0	0.0	0.0	0.2	0.1	1.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
AC064853.4		ENSG00000284643			2	227598893-227599255	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in single"		"adipose tissue: 1.0"	"Cell line enriched"	"Detected in single"	27	"HeLa: 2.6"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							1.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.5			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AC068987.5		ENSG00000284730			12	51813940-51814926	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"adipose tissue: 2.4;intestine: 1.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.6;SiHa: 1.8"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							2.4	0.0		0.0		0.0	0.0		0.3	0.0	0.2			1.7	0.0	0.0	0.0	0.0	0.0	0.0			0.5	1.5	0.0	0.0			0.0	0.2	1.1		0.0		0.0	0.0		0.2	0.5	0.0	0.0	0.3	0.0		0.7	1.6	1.2			0.0		0.0	0.0		0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AC093155.3		ENSG00000267561			1	86993009-87169204	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"adipose tissue: 10.8"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 8.8;HEL: 12.9;HMC-1: 16.4;THP-1: 11.2"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"eosinophil: 4.6"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.6"									"HPA043069, HPA043603"	Approved		Uncertain	Mitochondria				Mitochondria	Mitochondria	"HPA043069: AB_10964127, HPA043603: AB_10963432"	"unprognostic (4.41e-1)"				"unprognostic (3.13e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.85e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.51e-2)"	"unprognostic (5.19e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.14e-1)"			"unprognostic (2.54e-1)"	10.8	3.2	0.6	0.9	0.8	0.0	3.7	0.8	0.6	2.1	1.3			0.6	0.8	0.5	1.1	0.5	2.1	4.1	0.6	0.6	0.8	4.3	2.5	0.3	0.7		3.7	0.6	0.0	0.5	2.7		0.6	1.2		0.9	0.7	1.6	0.6	1.0	2.0	0.8	0.8	0.7	2.4			0.6		0.0	2.2	0.6	0.1	0.9	4.6	0.1	0.4	0.2	0.1	0.0	0.1	0.8	1.9	2.3	8.8	0.2	0.0	0.1	0.0	0.3	0.6	0.8	0.0	0.2	0.0	0.1	0.3	0.1	0.4	0.1	0.5	12.9	0.3	0.1	0.1	0.3	16.4	1.4	0.3	0.2	0.0	0.1	0.1	0.3	0.2	0.0	0.2	0.2	0.3	0.0	0.2	0.3	0.0	0.4	0.4	0.1	0.4	0.3	0.0	0.4	0.2	11.2	0.0	0.3	0.7	0.1	1.3	0.9	3.4	0.0	0.6	0.0	0.4	2.0	0.1	4.6	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.2	0.1	0.0	0.4	0.0	0.9	0.0	0.1										
ACKR1	"CCBP1, CD234, DARC, Dfy, FY, GPD"	ENSG00000213088	"Atypical chemokine receptor 1 (Duffy blood group)"	Q16570	1	159203307-159206500	"Blood group antigen proteins, CD markers, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 109.8"	"Group enriched"	"Detected in some"	6	"HEL: 22.0;HSkMC: 23.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016421, HPA017672"	Enhanced									"HPA016421: AB_1849219, HPA017672: AB_1849221"	"unprognostic (8.74e-3)"	"prognostic favourable (2.52e-5)"	"unprognostic (9.73e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.34e-3)"	"unprognostic (3.84e-3)"	"prognostic favourable (1.48e-4)"	"unprognostic (7.80e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.82e-3)"	"unprognostic (5.17e-3)"	"unprognostic (2.40e-1)"	"prognostic unfavourable (9.76e-4)"	"unprognostic (2.30e-2)"	109.8	4.0	6.7	16.2	4.2	5.7	54.5	23.3	5.4	40.1	13.1	2.4	10.2	6.5	28.8	23.0	32.6	27.1	26.9	47.1	9.1	3.4	5.7	1.3	27.8	36.8	19.2	0.6	22.3	8.1	3.9	2.0	5.8	14.0	29.1	7.1	5.3	12.8	9.8	38.3	19.8	11.5	36.6	9.4	25.0	13.0	21.6	6.4	3.0	16.5	29.9	15.5	42.3	24.2	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	22.0	0.0	0.0	4.1	0.0	0.0	23.9	0.0	0.0	3.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	6.7	4.2	23.3	5.3	9.1	3.4	19.2	0.6	14.0	6.4
ACP5	"HPAP, TRAP"	ENSG00000102575	"Acid phosphatase 5, tartrate resistant"	P13686	19	11574660-11579008	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 117.9;lung: 151.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 14.3;RPMI-8226: 13.6;SK-MEL-30: 40.4;U-138 MG: 38.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 51.4"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB002584, HPA057655, HPA059463"	Enhanced		Approved	Cytosol	"Intracellular and membrane"	3700000	3700000	Cytosol	Cytosol	"CAB002584: AB_564039, HPA057655: AB_2683490, HPA059463: "	"unprognostic (4.27e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.93e-1)"	"unprognostic (8.60e-3)"	"unprognostic (2.96e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.21e-2)"	"unprognostic (5.17e-3)"	"unprognostic (5.13e-2)"	"unprognostic (3.80e-1)"	"unprognostic (3.66e-3)"	"unprognostic (9.09e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.19e-1)"	117.9	2.8	0.9	21.1	1.1	1.4	7.7	0.7	1.0	11.9	10.2	1.2	2.1	7.7	7.7	6.5	12.1	3.5	9.1	6.8	0.9	0.4	28.0	16.3	151.9	30.8	1.0	1.0	13.2	8.7	0.2	1.6	9.2	1.2	6.4	8.7	19.1	8.6	2.8	3.0	10.4	15.6	3.3	1.9	20.7	15.0	3.5	0.7	9.2	2.2	8.2	18.4	11.4	10.1	51.4	13.9	16.8	9.4	2.6	16.0	8.1	3.2	0.4	0.0	0.0	0.2	0.0	14.3	0.4	9.6	0.0	0.0	0.0	0.1	0.4	0.6	2.8	0.1	0.0	1.4	0.0	3.6	0.3	0.1	0.0	1.7	0.5	0.0	0.2	0.0	1.1	0.1	0.0	0.0	10.0	0.0	0.0	0.7	0.3	0.5	0.3	0.2	0.1	0.7	13.6	0.0	0.1	0.2	0.3	0.0	0.0	40.4	0.0	0.1	0.3	38.0	0.4	0.7	0.1	0.2	1.8	0.2	7.8	0.0	1.2	0.0	9.4	16.8	4.1	9.1	2.1	51.4	6.4	4.7	1.7	23.5	8.3	4.7	2.6	2.6	8.7	13.9	16.0	8.1	0.9	1.1	0.7	1.0	0.9	0.4	1.0	1.0	1.2	0.7
ACSL1	"ACS1, FACL1, FACL2, LACS, LACS1, LACS2"	ENSG00000151726	"Acyl-CoA synthetase long chain family member 1"	P33121	4	184755595-184826818	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 105.0;liver: 190.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 147.8;ASC TERT1: 35.9;HSkMC: 78.5;RPTEC TERT1: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"neutrophil: 80.2"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 80.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011316, HPA011964"	Enhanced		Supported	Nucleoplasm,Mitochondria				Nucleoplasm	Nucleoplasm	"HPA011316: AB_1844536, HPA011964: AB_1844537"	"unprognostic (1.10e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.64e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.82e-3)"	"unprognostic (2.75e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.89e-2)"	"unprognostic (9.83e-2)"	"unprognostic (3.15e-1)"	"prognostic favourable (1.25e-5)"	"unprognostic (2.77e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.25e-3)"	"unprognostic (3.13e-2)"	105.0	6.7	4.2	14.1	13.5	46.0	54.4	3.2	9.6	7.2	12.2	16.4	5.5	4.9	5.7	12.7	8.8	6.4	5.7	24.3	6.4	4.1	32.8	190.9	20.7	18.9	24.0	3.8	4.2	7.3	5.9	8.7	4.4	11.6	14.2	2.6	9.1	17.9	4.8	89.1	20.4	4.5	6.4	18.2	16.9	6.5	6.4	15.9	2.1	8.3	10.1	5.8	7.6	11.0	0.5	2.2	80.2	8.9	0.7	0.7	2.9	5.9	1.8	1.1	3.1	147.8	35.9	1.0	3.3	1.6	2.0	1.4	0.4	1.7	2.5	0.3	3.9	3.7	5.3	2.1	1.6	12.1	1.9	1.8	1.6	4.9	23.8	4.8	4.5	78.5	18.2	1.6	8.5	2.6	0.8	7.6	9.6	3.1	0.3	6.7	0.2	2.6	0.9	1.0	3.1	46.8	17.1	4.5	4.2	3.0	9.1	10.2	3.4	4.9	2.8	1.7	2.0	4.2	1.0	2.9	1.5	1.1	5.7	6.7	2.7	2.3	8.9	2.8	0.5	5.2	0.5	0.5	0.4	0.2	2.2	0.5	0.4	0.3	80.2	0.7	3.6	0.4	0.7	2.9	4.2	13.5	3.2	9.6	6.4	4.1	24.0	3.8	11.6	15.9
ACVR1C	"ACVRLK7, ALK7"	ENSG00000123612	"Activin A receptor type 1C"	Q8NER5	2	157526767-157629005	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 36.2;breast: 15.3"	"Group enriched"	"Detected in some"	4	"ASC diff: 15.1;HDLM-2: 6.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.8"	"Lineage enriched"	"Detected in single"	4	"T-cells: 2.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basal ganglia: 29.2;cerebral cortex: 8.1;hippocampal formation: 21.6"	"HPA007982, HPA011933"	Approved				"Intracellular and membrane"					"HPA007982: AB_1078134, HPA011933: AB_1844754"	"unprognostic (1.03e-1)"	"unprognostic (4.55e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.92e-1)"	"unprognostic (7.64e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.12e-3)"	"unprognostic (3.62e-1)"	"unprognostic (9.31e-6)"	"unprognostic (7.28e-2)"	"unprognostic (1.95e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.30e-1)"	36.2	3.7	3.9	2.7	10.3	0.7	15.3	1.6	4.4	0.9	9.4	2.7	0.0	5.5	0.7	1.0	0.8	0.8	1.8	1.0	9.2	3.1	1.1	3.3	0.8	1.2	3.7	3.1	5.1	2.4	0.5	12.0	0.7	3.5	0.9	4.4	0.0	1.5	1.0	1.3	0.7	4.4	0.8	2.8	0.8	3.4	1.1	4.0	0.0	0.9	0.5	1.0	0.6	2.9	0.6	0.0	0.0	0.0	0.0	2.8	0.4	2.0	0.0	0.0	0.1	15.1	0.4	0.3	0.4	0.4	0.1	0.5	2.2	0.2	0.0	0.2	1.2	0.0	0.1	0.0	0.3	6.6	1.0	0.0	0.0	0.5	0.0	0.0	1.1	0.1	0.0	0.4	0.0	0.0	0.0	0.4	0.4	0.2	0.0	0.0	1.3	0.7	0.0	0.8	0.1	0.0	0.0	0.4	0.0	0.0	0.0	2.3	0.0	0.3	0.0	0.8	0.2	0.0	0.2	0.8	2.4	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.5	0.0	1.0	0.6	1.8	1.2	0.0	0.5	2.8	1.1	0.0	0.0	0.0	0.0	0.0	0.4	3.9	10.3	1.6	4.4	9.2	3.1	3.7	3.1	3.5	4.0
ADAMTS15		ENSG00000166106	"ADAM metallopeptidase with thrombospondin type 1 motif 15"	Q8TE58	11	130448974-130476641	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 47.4"	"Cell line enhanced"	"Detected in some"		"ASC diff: 36.0;ASC TERT1: 21.7;EFO-21: 18.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA042867	Uncertain		Approved	Cytosol	"Secreted to extracellular matrix"			Cytosol	Cytosol	"HPA042867: AB_10794535"	"unprognostic (7.64e-2)"	"unprognostic (1.49e-3)"	"unprognostic (7.15e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.07e-3)"	"unprognostic (7.07e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (9.72e-4)"	"unprognostic (6.18e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.29e-2)"	"unprognostic (5.95e-3)"	"unprognostic (6.68e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (5.63e-5)"	47.4	1.1	0.2	1.7	0.3	0.1	14.5	0.1	0.8	3.4	3.8	0.8	3.0	0.6	3.7	9.8	3.8	9.3	9.1	12.6	0.4	0.3	9.1	0.4	6.6	5.6	0.8	0.2	7.0	1.6	0.9	1.0	16.4	1.3	3.7	2.1	10.9	1.0	1.3	1.6	4.1	3.1	6.9	1.4	1.9	4.9	2.4	0.6	0.7	9.8	2.5	0.8	8.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.8	0.4	36.0	21.7	0.0	1.3	2.5	0.5	0.1	0.2	0.6	0.0	18.1	0.1	3.3	0.3	0.3	0.1	0.0	0.8	0.0	1.6	0.0	0.3	0.0	0.0	7.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.6	2.7	0.0	2.0	0.0	0.0	0.0	0.3	0.0	5.8	0.0	0.0	1.9	0.0	0.0	0.3	4.3	3.4	1.6	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.7	0.4	0.3	0.8	0.2	1.3	0.6
ADAMTS4	"ADAMTS-2, ADMP-1, KIAA0688"	ENSG00000158859	"ADAM metallopeptidase with thrombospondin type 1 motif 4"	O75173	1	161184308-161199056	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 58.0"	"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 10.7;HUVEC TERT2: 12.9;SH-SY5Y: 7.2;TIME: 10.8;U-251 MG: 9.6"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basal ganglia: 20.7;cerebral cortex: 10.0;midbrain: 28.6;pons and medulla: 20.5;thalamus: 15.7"	"Cell type enriched"	"Detected in some"	8	"plasmacytoid DC: 8.0"	"Lineage enriched"	"Detected in many"	8	"dendritic cells: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB025876, HPA051296, HPA068374"	Uncertain		Supported	"Nuclear speckles"	"Secreted to extracellular matrix"			"Nuclear speckles"	"Nuclear speckles"	"CAB025876: , HPA051296: AB_2681426, HPA068374: "	"unprognostic (2.70e-2)"	"unprognostic (8.10e-3)"	"unprognostic (3.00e-3)"	"unprognostic (2.75e-1)"	"unprognostic (9.95e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (5.00e-4)"	"unprognostic (1.20e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavourable (7.27e-7)"	"unprognostic (1.10e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.44e-3)"	"unprognostic (3.13e-2)"	58.0	9.7	2.6	18.1	20.7	1.8	14.6	1.5	10.7	7.8	6.3	33.4	0.0	1.9	5.8	2.0	7.7	14.2	16.4	19.5	3.4	2.3	3.1	11.0	15.7	2.7	28.6	3.5	35.7	10.6	4.7	4.9	4.4	20.5	5.8	3.4	0.0	1.7	1.7	7.7	1.7	3.0	12.0	15.5	1.9	8.1	1.7	15.7	0.0	7.5	1.2	1.4	8.7	4.0	0.5	8.0	1.0	0.2	0.4	0.6	0.2	0.0	0.0	0.2	0.1	6.0	3.8	0.5	4.8	0.2	0.4	2.8	0.1	0.1	0.2	4.1	1.5	0.1	0.0	0.0	1.7	0.1	0.3	0.1	0.4	1.2	0.6	0.0	0.1	4.2	0.0	10.7	0.1	12.9	0.1	0.3	0.3	0.1	0.0	0.2	4.8	0.0	0.1	4.7	0.1	0.0	0.1	0.1	7.2	0.0	0.1	0.1	0.2	0.5	10.8	6.8	0.1	0.3	9.6	0.2	0.1	0.1	2.1	0.1	0.1	0.7	0.2	0.2	0.6	0.1	0.3	0.3	0.3	0.3	0.1	0.5	0.4	0.4	1.0	0.4	0.1	8.0	0.3	0.2	2.6	20.7	1.5	10.0	3.4	2.3	28.6	3.5	20.5	15.7
ADAMTS9	KIAA1312	ENSG00000163638	"ADAM metallopeptidase with thrombospondin type 1 motif 9"	Q9P2N4	3	64515654-64688000	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 51.4"	"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 52.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA028567, HPA028577, HPA028601"	Approved		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"			Vesicles	Vesicles	"HPA028567: AB_10599275, HPA028577: AB_10600330, HPA028601: AB_2672694"	"unprognostic (2.21e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.83e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.37e-2)"	"unprognostic (7.80e-3)"	"unprognostic (5.85e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.67e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.46e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.98e-3)"	"unprognostic (5.00e-3)"	51.4	4.7	5.6	12.0	11.5	0.5	15.2	3.9	8.0	10.4	10.4	2.8	7.2	1.6	13.9	5.6	6.8	7.7	8.2	29.6	5.7	2.7	9.0	3.1	11.5	7.7	6.8	0.3	17.4	9.9	17.2	2.4	30.5	12.4	7.4	3.2	0.7	3.5	4.3	10.8	2.6	3.2	12.2	12.6	4.4	4.6	3.1	5.9	0.0	6.4	3.7	1.6	19.6	29.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	5.6	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.9	0.1	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	3.5	1.0	0.0	0.0	0.2	9.4	0.2	0.0	0.1	0.0	0.0	0.0	3.0	0.0	0.0	0.9	0.0	11.2	0.1	0.0	52.2	0.0	0.0	0.0	0.0	0.2	2.1	0.3	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.6	11.5	3.9	8.0	5.7	2.7	6.8	0.3	12.4	5.9
ADGRL4	"ELTD1, ETL"	ENSG00000162618	"Adhesion G protein-coupled receptor L4"	Q9HBW9	1	78889764-79006718	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 98.9"	"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 63.2;TIME: 77.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025229	Supported					1800000	1800000			"HPA025229: "	"unprognostic (2.67e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.32e-2)"	"unprognostic (8.11e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.52e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavourable (1.60e-4)"	"unprognostic (5.32e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.45e-2)"	"unprognostic (3.85e-3)"	98.9	4.7	3.6	5.6	5.7	0.0	43.8	3.2	6.1	14.6	7.8	1.5	6.6	2.8	12.9	7.1	12.4	6.8	12.3	12.3	4.3	3.7	11.3	8.8	16.2	8.5	5.4	1.4	9.3	3.0	5.7	7.8	12.8	6.2	12.2	3.6	5.9	4.8	5.7	16.1	5.3	4.8	16.0	4.7	34.8	4.9	6.8	4.3	1.1	13.9	8.0	3.9	16.0	25.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	1.6	5.2	0.0	1.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	3.8	0.0	10.9	0.0	63.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	77.1	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	5.7	3.2	6.1	4.3	3.7	5.4	1.4	6.2	4.3
AGPAT2	"BSCL, LPAAT-beta"	ENSG00000169692	"1-acylglycerol-3-phosphate O-acyltransferase 2"	O15120	9	136673143-136687423	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 71.5;liver: 63.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 50.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA019544	Uncertain		Approved	Centrosome				Centrosome	Centrosome	"HPA019544: AB_1844646"	"unprognostic (3.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.01e-3)"	"unprognostic (9.26e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.30e-3)"	"unprognostic (5.06e-3)"	"unprognostic (8.98e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.61e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.93e-1)"	71.5	5.3	2.3	8.1	2.2	8.4	35.2	2.0	3.0	7.4	20.2	2.2	5.9	31.3	4.7	7.1	11.7	4.1	15.8	12.4	2.8	2.4	10.9	63.1	12.1	11.1	2.5	2.8	5.3	47.7	2.5	6.2	4.9	2.6	5.5	3.3	8.9	12.9	6.2	9.5	7.0	33.6	4.0	1.9	6.8	11.0	5.2	1.9	5.1	13.4	7.0	8.8	6.6	4.9	7.0	20.3	33.2	28.4	2.1	2.5	9.8	14.6	20.6	2.4	11.4	17.7	5.5	10.4	9.7	7.7	6.7	5.1	23.3	29.0	4.8	21.9	5.5	39.7	3.4	6.0	0.7	50.0	15.8	7.1	8.5	5.1	12.2	7.5	17.5	5.3	8.4	5.7	3.0	3.4	8.6	0.8	2.8	26.4	0.5	23.3	6.2	37.5	10.9	8.8	26.6	7.8	9.3	5.5	8.8	12.6	13.3	15.9	8.4	29.5	6.8	8.9	9.1	2.8	6.2	1.2	0.1	3.1	0.1	16.1	8.8	6.0	28.4	33.2	2.2	25.3	2.1	4.1	1.9	2.5	14.9	7.0	1.6	1.8	19.1	2.1	22.2	20.3	2.3	9.8	2.3	2.2	2.0	3.0	2.8	2.4	2.5	2.8	2.6	1.9
AL049634.2		ENSG00000260861			20	1540144-1620009	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"adipose tissue: 18.0;blood: 36.1;lymphoid tissue: 21.9"	"Cell line enhanced"	"Detected in some"		"HL-60: 5.2;HMC-1: 11.1;NB-4: 3.6;THP-1: 4.2;U-937: 3.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 22.5;neutrophil: 36.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 36.1;monocytes: 11.3"																																					18.0	2.4	0.9	6.0	3.8	6.4	0.8	0.7	7.5	0.8	0.8	1.1	0.0	0.6	0.9	1.0	0.8	0.7	0.9	5.2	1.4	1.1	0.8	5.4	14.7	14.8	4.7	0.1	1.0	1.0	0.0	0.7	2.5	2.4	0.8	0.3	0.9	0.9	1.0	0.9	0.8	1.5	1.4	5.2	21.9	0.8	4.6	2.6	1.5	0.8	0.0	1.8	1.6	1.0	0.0	3.8	36.1	11.3	0.0	0.2	5.9	0.0	0.0	0.1	0.0	0.4	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.3	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	5.2	11.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.3	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	4.2	1.4	0.0	0.0	0.3	1.6	0.1	0.0	0.1	0.1	3.1	0.1	0.2	11.1	22.5	0.2	8.2	0.1	0.0	0.0	0.1	3.8	0.0	0.0	0.0	36.1	0.0	11.3	3.4	0.0	5.9	0.9	3.8	0.7	2.0	1.4	1.1	4.7	0.1	2.4	2.6
ALOX15	15-LOX-1	ENSG00000161905	"Arachidonate 15-lipoxygenase"	P16050	17	4630902-4642294	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 27.9;blood: 89.8;lung: 24.4"	"Group enriched"	"Detected in some"	7	"HMC-1: 16.1;MCF7: 14.0;T-47d: 4.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	183	"eosinophil: 89.8"	"Lineage enriched"	"Detected in single"	183	"granulocytes: 89.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB004962, CAB004963, HPA013859"	Approved									"CAB004962: , CAB004963: , HPA013859: AB_1844758"	"unprognostic (5.31e-4)"	"unprognostic (1.43e-2)"	"unprognostic (2.81e-2)"	"unprognostic (8.36e-3)"	"unprognostic (2.22e-1)"	"unprognostic (8.60e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.59e-1)"	27.9	0.1	0.2	4.5	1.1	0.2	4.2	0.2	0.3	0.5	2.8	0.2	0.2	1.9	0.2	8.1	0.4	14.4	1.5	2.7	0.3	0.4	0.2	1.7	24.4	1.7	0.5	0.2	3.0	0.2	0.0	6.3	1.5	0.4	0.3	0.9	0.2	1.0	0.2	0.2	2.2	3.7	0.5	0.7	1.1	1.0	1.4	0.4	2.0	0.2	0.2	0.4	1.9	0.2	0.0	0.4	89.8	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.4	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.1	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	14.0	0.0	0.3	1.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	4.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0	89.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.2	1.1	0.2	0.3	0.3	0.4	0.5	0.2	0.4	0.4
ANGPT4		ENSG00000101280	"Angiopoietin 4"	Q9Y264	20	869899-916317	"Predicted secreted proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 18.7;breast: 12.3;cervix, uterine: 16.8"	"Group enriched"	"Detected in some"	80	"ASC diff: 21.1;BEWO: 30.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 2.4"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB013260, CAB013305"	Uncertain				"Secreted to blood"					"CAB013260: , CAB013305: "	"unprognostic (1.77e-1)"	"unprognostic (3.25e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.04e-3)"	"unprognostic (6.37e-2)"	"unprognostic (3.41e-1)"	"unprognostic (5.82e-4)"	"unprognostic (1.25e-1)"	"unprognostic (7.10e-2)"	"unprognostic (3.66e-4)"	"unprognostic (9.01e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.95e-4)"	"unprognostic (9.14e-2)"	18.7	0.7	0.1	0.1	0.3	0.1	12.3	0.0	0.5	16.8	1.4	0.6	2.1	0.2	7.1	4.9	1.2	3.5	2.5	1.1	0.1	0.3	0.4	0.1	2.6	0.1	0.3	0.0	4.8	0.2	0.1	0.0	0.4	0.3	1.8	0.1	2.4	1.3	2.2	0.2	1.4	0.3	2.6	0.1	0.1	0.4	3.7	0.0	0.0	2.1	1.6	0.4	1.3	2.2	0.3	0.6	2.4	0.9	0.2	0.3	0.5	0.1	0.0	0.0	0.0	21.1	0.0	30.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.9	0.4	0.2	0.5	0.0	0.1	0.2	0.3	0.6	0.3	0.1	0.2	0.8	0.2	0.6	0.2	0.0	0.5	0.1	0.3	0.0	0.5	0.1	0.3	0.3	0.0	0.3	0.0
ANGPTL4	"ARP4, FIAF, HFARP, NL2, PGAR, pp1158"	ENSG00000167772	"Angiopoietin like 4"	Q9BY76	19	8363289-8374373	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 55.5;liver: 68.4;pancreas: 51.7"	"Cell line enhanced"	"Detected in some"		"ASC diff: 16.1;HBEC3-KT: 64.0;LHCN-M2: 17.3;TIME: 32.2;U-138 MG: 19.0"	"Cancer enhanced"	"Detected in all"		"renal cancer: 212.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 5.8;neutrophil: 2.3"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 5.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA007879, CAB033770"	Approved		Approved	Nucleoplasm,Vesicles	"Secreted to blood"	1500000	1500000	"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"CAB033770: AB_2057427, HPA007879: "	"unprognostic (1.26e-1)"	"unprognostic (5.29e-3)"	"prognostic unfavourable (7.53e-4)"	"unprognostic (1.88e-2)"	"unprognostic (7.68e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.03e-2)"	"prognostic unfavourable (9.50e-4)"	"unprognostic (3.18e-1)"	"unprognostic (3.90e-3)"	"unprognostic (9.69e-3)"	"unprognostic (2.87e-1)"	"prognostic unfavourable (1.34e-5)"	"unprognostic (1.18e-3)"	"unprognostic (3.04e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.00e-2)"	55.5	9.6	23.3	13.5	24.7	2.3	33.0	5.1	37.6	3.3	11.8	9.2	0.3	10.6	5.9	1.5	11.8	3.2	8.8	11.4	17.1	5.5	9.4	68.4	9.0	2.7	21.4	3.1	2.9	51.7	2.3	3.3	21.4	36.8	6.7	2.1	2.5	3.9	3.7	5.9	6.5	23.5	6.0	20.6	2.5	4.4	3.7	27.7	0.0	7.1	2.5	3.5	10.7	6.0	0.5	0.3	5.8	0.4	0.8	0.6	0.2	0.0	0.6	0.3	0.9	16.1	3.5	0.1	1.2	0.1	0.2	0.0	0.0	5.9	0.0	8.8	2.4	0.8	0.0	64.0	0.1	0.5	0.1	0.1	0.2	0.1	0.3	0.0	0.0	1.6	0.2	9.8	0.2	4.9	0.3	0.2	17.3	0.5	0.0	0.5	0.1	0.5	0.3	0.0	0.2	3.2	1.1	0.0	0.1	7.4	0.7	1.1	1.9	0.1	32.2	19.0	0.1	9.5	0.0	0.0	0.0	0.0	13.0	0.0	3.5	5.8	0.4	0.9	0.4	0.2	0.3	0.5	0.5	0.4	0.2	0.4	0.3	0.3	2.3	0.8	0.2	0.3	0.6	0.2	23.3	24.7	5.1	37.6	17.1	5.5	21.4	3.1	36.8	27.7
ANGPTL5		ENSG00000187151	"Angiopoietin like 5"	Q86XS5	11	101890674-101916522	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 9.4;ovary: 24.9"	"Group enriched"	"Detected in some"	6	"ASC diff: 7.7;ASC TERT1: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.0"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in all"			HPA038516	Uncertain				"Secreted in other tissues"					"HPA038516: AB_10672749"	"unprognostic (8.28e-3)"	"unprognostic (3.08e-2)"		"unprognostic (1.21e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.23e-2)"		"unprognostic (2.18e-1)"		"unprognostic (4.88e-2)"	"unprognostic (6.74e-4)"	"unprognostic (1.96e-1)"	"unprognostic (1.53e-8)"	"unprognostic (3.40e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.17e-3)"	9.4	0.3	0.2	0.0	0.3	0.0	6.4	0.2	0.7	1.3	0.3	0.0	0.6	0.1	0.1	5.0	1.0	0.4	0.3	3.7	0.2	0.2	0.1	0.2	1.0	0.1	2.0	0.5	24.9	0.0	0.0	0.3	0.1	0.8	1.4	0.2	0.0	0.5	0.3	1.9	3.5	0.5	1.3	1.7	0.0	0.2	6.2	0.3	0.2	2.4	2.9	0.0	1.8	1.1	0.7	1.0	0.0	0.0	0.9	0.3	0.0	0.0	0.1	0.0	0.0	7.7	2.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.7	0.2	0.0	0.0	0.1	0.3	0.1	0.0	0.9	0.0	1.0	0.0	0.0	0.2	0.3	0.2	0.7	0.2	0.2	2.0	0.5	0.8	0.3
APOLD1	"DKFZP434F0318, FLJ25138"	ENSG00000178878	"Apolipoprotein L domain containing 1"	Q96LR9	12	12725917-12829975	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 109.5"	"Cell line enhanced"	"Detected in many"		"AF22: 26.1;HDLM-2: 13.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basal ganglia: 5.8;olfactory region: 24.7"	"Low region specificity"	"Detected in all"			"HPA052462, HPA058882"	Approved		Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA052462: AB_2681841, HPA058882: AB_2683844"	"unprognostic (1.98e-1)"	"unprognostic (8.36e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.58e-3)"	"unprognostic (8.07e-2)"	"unprognostic (3.46e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.23e-2)"	"unprognostic (4.30e-3)"	"unprognostic (3.42e-3)"	"unprognostic (1.81e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.15e-2)"	109.5	8.8	11.2	9.2	17.7	0.6	34.4	9.8	17.5	25.5	9.0	7.7	2.9	2.5	7.1	7.0	18.8	14.0	18.7	22.3	13.0	11.8	7.4	9.3	7.1	3.4	16.6	3.3	10.0	12.8	17.2	4.7	44.8	16.7	7.2	7.1	8.1	4.4	3.7	16.6	7.4	6.0	28.0	13.9	4.7	5.3	5.4	12.4	5.7	34.4	9.9	3.3	10.9	7.1	2.3	1.7	4.8	0.9	0.8	2.7	0.3	4.3	0.1	26.1	0.8	0.8	1.5	0.2	4.2	6.9	4.3	6.3	1.7	4.6	1.3	0.4	1.6	1.4	1.0	0.2	7.3	13.2	1.0	0.4	1.3	0.0	1.6	0.6	0.4	1.0	1.2	1.5	3.3	3.2	0.4	1.8	2.2	0.8	0.7	0.7	0.1	0.8	2.0	0.5	0.6	0.5	0.4	2.3	2.4	4.0	0.4	9.5	0.1	2.1	3.9	1.0	1.4	5.8	3.8	1.3	0.6	1.0	1.4	2.8	4.8	4.8	0.9	0.7	0.9	0.4	1.1	2.2	2.0	1.3	0.6	2.3	1.6	1.0	4.4	0.8	0.6	1.7	2.7	0.3	11.2	17.7	9.8	17.5	13.0	11.8	16.6	3.3	16.7	12.4
AQP7	"AQP7L, AQP9, AQPap"	ENSG00000165269	"Aquaporin 7"	O14520	9	33383179-33402682	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 72.7;breast: 25.6;heart muscle: 21.5"	"Cell line enriched"	"Detected in some"	52	"ASC diff: 77.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	6	"T-reg: 2.7"	"Lineage enriched"	"Detected in single"	15	"T-cells: 2.7"																				"unprognostic (3.25e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.25e-5)"	"unprognostic (7.22e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.32e-1)"	"unprognostic (4.67e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.65e-2)"	"unprognostic (8.56e-4)"	"unprognostic (1.21e-1)"	"prognostic favourable (9.21e-8)"	"unprognostic (2.42e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.12e-3)"	72.7	1.2	0.6	1.3	0.8	0.0	25.6	2.4	0.9	0.6	3.9	0.6	0.6	3.9	0.6	1.1	1.2	1.2	2.3	21.5	0.6	0.0	5.3	5.9	0.6	0.6	0.6	0.6	1.0	3.0	10.2	0.6	0.9	1.2	1.2	0.8	0.8	2.7	0.6	8.8	0.9	5.7	0.6	1.0	0.6	0.3	5.5	0.6	0.8	1.0	3.0	1.6	1.7	0.6	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.5	0.0	0.0	77.5	1.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.6	0.8	2.4	0.9	0.6	0.0	0.6	0.6	1.2	0.6
ARHGEF15	"ARGEF15, FLJ13791, KIAA0915, MGC44868, Vsm-RhoGEF"	ENSG00000198844	"Rho guanine nucleotide exchange factor 15"	O94989	17	8310241-8322516	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 47.3"	"Group enriched"	"Detected in some"	46	"HUVEC TERT2: 22.9;TIME: 30.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044443, HPA063495"			Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA044443: AB_10960424, HPA063495: AB_2685023"	"unprognostic (3.02e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.18e-2)"	"unprognostic (7.09e-3)"	"unprognostic (3.82e-1)"	"unprognostic (7.29e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.23e-3)"	"unprognostic (4.88e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.89e-1)"	"unprognostic (9.56e-3)"	47.3	3.6	1.5	4.6	2.6	0.3	24.7	0.9	2.8	9.6	5.7	2.0	3.3	3.1	19.9	4.9	5.0	5.9	7.5	18.5	3.8	1.4	9.7	4.2	19.4	3.0	2.2	1.5	6.8	2.8	4.2	3.0	14.1	3.1	8.7	2.1	10.7	3.4	5.1	15.0	4.9	4.1	7.0	1.7	6.9	4.4	2.7	1.1	0.6	8.7	8.4	2.9	9.4	32.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.6	0.9	2.8	3.8	1.4	2.2	1.5	3.1	1.1
AVPR2	"DIR, DIR3, V2R"	ENSG00000126895	"Arginine vasopressin receptor 2"	P30518	X	153902531-153907166	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 8.9"	"Cell line enhanced"	"Detected in some"		"EFO-21: 5.5;SCLC-21H: 6.5;U-266/84: 5.8;U-698: 6.1"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in some"	26	"intermediate monocyte: 6.2;non-classical monocyte: 5.3"	"Lineage enriched"	"Detected in single"	28	"monocytes: 6.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	18	"cerebellum: 7.9"												"unprognostic (3.05e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.99e-4)"	"unprognostic (2.50e-4)"	"unprognostic (2.76e-1)"	"unprognostic (7.10e-6)"	"unprognostic (3.80e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.56e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.38e-1)"	"unprognostic (9.83e-2)"	8.9	0.1	0.0	0.1	0.0	0.9	7.1	1.2	0.0	2.1	1.5			0.7	2.7	0.0	0.8	2.6	1.4	6.3	0.0	0.0	4.7	0.0	1.9	1.1	0.0		0.1	0.6	0.2	0.0	0.1		1.1	0.0		1.2	0.8	4.3	2.2	1.3	1.0	0.0	0.0	1.2	0.0			1.9		0.2	1.8	2.1	0.0	0.2	0.0	6.2	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.3	2.8	5.5	0.0	0.0	0.0	0.0	0.0	1.9	0.2	2.1	0.9	0.0	0.1	2.7	2.2	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.0	0.1	1.4	1.6	0.2	0.1	2.4	1.0	2.5	0.1	0.0	6.5	1.2	0.1	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.2	1.1	5.8	6.1	0.0	1.6	0.1	0.0	0.1	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.2										
BOK	"BCL2L9, BOKL, MGC4631"	ENSG00000176720	"BOK, BCL2 family apoptosis regulator"	Q9UMX3	2	241551424-241574138	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 56.0;brain: 64.1"	"Cell line enhanced"	"Detected in many"		"TIME: 26.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdTCR: 5.7"	"Lineage enriched"	"Detected in many"	4	"T-cells: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (6.16e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.24e-3)"	"unprognostic (6.30e-2)"	"unprognostic (8.63e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.16e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.27e-1)"	"prognostic favourable (1.09e-9)"	"unprognostic (9.48e-3)"	"unprognostic (6.81e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.09e-1)"	56.0	5.4	15.0	4.5	44.5	0.8	25.6	8.6	24.7	10.5	13.7	45.2	3.3	5.9	15.4	12.0	20.1	13.2	15.5	4.4	19.8	16.0	10.9	46.2	13.8	2.6	64.1	12.8	5.5	11.0	2.9	2.0	4.3	38.6	14.7	4.0	3.0	7.7	19.1	2.1	12.9	4.9	14.1	44.8	3.7	8.5	4.4	56.2	0.0	5.4	3.0	2.7	13.2	13.8	0.0	0.0	0.0	0.0	1.4	5.7	1.5	14.0	3.5	6.4	14.7	11.0	6.6	1.8	11.5	4.6	15.2	15.8	6.4	5.9	0.0	4.0	20.4	13.2	0.7	11.6	5.7	0.0	0.1	0.0	3.6	16.5	9.2	0.1	0.5	6.7	12.0	6.4	1.8	18.1	2.5	0.0	14.8	18.1	0.0	0.1	4.0	10.9	0.1	10.6	0.0	9.8	0.3	5.8	2.2	5.3	3.5	9.2	9.9	0.5	26.1	0.0	22.2	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	5.7	0.0	0.6	0.0	1.7	2.3	0.0	0.0	0.0	2.6	0.0	1.4	0.0	0.0	0.0	1.5	15.0	44.5	8.6	24.7	19.8	16.0	64.1	12.8	38.6	56.2
BTNL9	"BTN8, FLJ32535"	ENSG00000165810	"Butyrophilin like 9"	Q6UXG8	5	181040225-181061523	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 128.2;breast: 76.8"	"Cell line enriched"	"Detected in some"	6	"U-698: 28.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.8"	"Group enriched"	"Detected in many"	6	"B-cells: 3.8;granulocytes: 1.3"	"Not detected"	"Not detected"							HPA043429			Approved	"Nuclear membrane,Vesicles"				"Nuclear membrane"	"Nuclear membrane"	"HPA043429: "	"unprognostic (2.69e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.76e-2)"	"prognostic unfavourable (7.51e-4)"	"unprognostic (2.07e-1)"	"unprognostic (1.43e-1)"	"prognostic favourable (1.55e-9)"	"unprognostic (2.15e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.71e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.56e-2)"	128.2	2.5	1.5	5.3	1.7	0.3	76.8	1.0	1.8	3.2	11.3	0.8	3.5	0.7	3.9	3.7	2.9	6.0	3.7	11.0	3.4	1.3	3.4	3.0	25.4	2.7	2.5	1.2	1.0	2.0	3.0	1.6	4.3	1.5	3.4	1.5	3.8	3.0	3.5	34.4	2.0	1.9	3.2	2.1	12.7	2.0	3.0	0.9	1.1	6.1	4.0	5.5	3.1	18.3	3.8	0.4	1.3	0.3	0.3	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	2.6	0.0	0.2	1.1	0.0	0.2	0.5	0.0	0.0	0.2	2.8	1.1	0.2	0.1	0.0	0.5	3.3	0.0	0.1	0.0	0.0	0.0	0.7	0.3	0.0	0.1	0.1	0.1	0.1	1.8	0.0	0.2	0.1	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	4.3	0.1	0.0	0.2	0.1	28.0	0.1	0.0	0.0	1.0	0.3	0.5	0.2	0.1	0.1	3.8	0.2	0.2	0.1	1.9	0.2	0.2	1.3	0.3	0.1	0.4	0.0	0.1	1.5	1.7	1.0	1.8	3.4	1.3	2.5	1.2	1.5	0.9
C11orf91		ENSG00000205177	"Chromosome 11 open reading frame 91"	Q3C1V1	11	33698261-33700801	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 7.2;gallbladder: 7.2;testis: 16.6"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 14.9;hTERT-HME1: 9.6;HUVEC TERT2: 7.6;TIME: 11.6;U-2197: 9.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA047064, HPA050487"	Uncertain		Supported	Vesicles				Vesicles	Vesicles	"HPA047064: AB_2679920, HPA050487: AB_2681142"	"unprognostic (9.22e-3)"	"unprognostic (1.51e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.62e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.31e-1)"	"unprognostic (5.68e-3)"	"unprognostic (7.41e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.01e-1)"	"unprognostic (8.33e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-1)"	7.2	0.2	1.2	2.1	3.0	0.9	2.1	0.3	1.3	0.3	0.3	0.3	0.3	0.0	0.4	0.9	4.3	0.3	7.2	0.7	0.4	0.6	0.9	0.9	1.4	0.3	0.7	0.3	0.6	1.9	0.0	0.3	1.0	1.3	0.3	0.0	0.3	0.9	0.3	0.4	1.3	0.3	0.8	0.8	0.3	2.7	16.6	0.3	0.6	0.3	0.3	0.3	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	1.4	0.0	0.0	0.0	1.7	0.0	0.8	0.4	0.2	0.6	0.0	0.1	1.7	0.6	0.4	14.9	1.2	0.4	0.0	0.0	2.8	0.7	0.3	0.0	0.0	0.0	0.1	1.2	9.6	7.6	0.0	2.3	3.6	0.0	0.0	0.3	0.0	4.7	0.0	0.0	0.0	1.0	1.9	0.0	0.3	0.0	1.5	0.1	0.0	0.0	11.6	1.1	0.3	9.6	0.3	0.7	0.5	0.0	2.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	3.0	0.3	1.3	0.4	0.6	0.7	0.3	1.3	0.3
C14orf180	"C14orf77, NRAC"	ENSG00000184601	"Chromosome 14 open reading frame 180"	Q8N912	14	104579684-104590515	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 23.2;heart muscle: 55.1"	"Cell line enriched"	"Detected in single"	20	"ASC diff: 8.2"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.7"	"Region enriched"	"Detected in single"	11	"pons and medulla: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (2.48e-2)"				"unprognostic (1.55e-1)"		"unprognostic (1.53e-1)"	"unprognostic (1.57e-1)"		"unprognostic (1.60e-1)"	"unprognostic (3.19e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.12e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.80e-2)"		23.2	1.2	0.0	1.7	0.2	0.1	9.8	0.0	0.1	0.5	3.8	0.7	6.7	0.3	0.3	4.7	0.2	0.4	0.7	55.1	0.0	0.3	0.7	1.9	0.2	0.3	0.0	0.0	0.3	0.7	0.1	0.6	0.7	3.9	0.4	0.2	2.0	1.7	1.2	2.5	0.1	0.5	0.5	0.0	0.2	0.5	0.4	0.0	0.0	0.2	1.3	0.1	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	3.9	0.0
C19orf12	"DKFZP762D096, MGC10922, MPAN, NBIA4, SPG43"	ENSG00000131943	"Chromosome 19 open reading frame 12"	Q9NSK7	19	29698886-29715789	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 57.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046930	Approved		Supported	Cytosol				Cytosol	Cytosol	"HPA046930: AB_10962836"	"unprognostic (1.76e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.31e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.94e-3)"	"unprognostic (7.93e-3)"	"unprognostic (5.27e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.22e-3)"	57.4	14.7	11.9	7.6	11.3	2.3	33.9	10.5	14.3	7.2	7.7	5.8	5.4	10.8	7.1	7.6	7.5	6.2	8.7	14.0	9.5	11.6	11.5	36.9	5.6	11.4	10.3	10.7	7.8	9.6	7.7	6.9	7.4	11.1	6.7	5.5	10.5	9.5	7.6	27.5	8.2	9.6	7.6	6.5	7.5	6.0	4.2	5.2	8.9	5.4	9.2	7.4	7.2	11.0	3.7	4.3	2.3	2.1	5.6	14.3	6.0	10.3	20.5	10.1	12.6	25.1	15.6	15.6	12.3	12.3	12.3	16.1	9.8	4.3	8.5	13.1	15.5	4.6	8.4	5.2	8.4	22.2	14.8	9.5	6.8	16.9	14.2	7.3	12.6	17.8	11.0	7.4	6.0	11.1	7.2	11.0	12.8	7.2	5.1	5.3	6.0	5.1	10.1	10.4	6.4	9.4	10.4	6.2	13.1	7.3	9.7	19.2	4.1	8.2	11.1	26.2	20.4	10.6	11.1	15.5	13.7	6.3	15.6	4.4	10.9	0.9	2.0	1.0	14.3	2.1	8.2	3.7	8.1	10.2	1.8	3.2	8.5	10.5	2.3	5.6	2.1	4.3	9.7	6.0	11.9	11.3	10.5	14.3	9.5	11.6	10.3	10.7	11.1	5.2
C2orf66	UNQ6411	ENSG00000187944	"Chromosome 2 open reading frame 66"	Q6UXQ4	2	196805002-196810276	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 7.0;pituitary gland: 6.4"	"Group enriched"	"Detected in some"	4	"HEL: 9.2;RT4: 3.4;TIME: 3.8"	"Low cancer specificity"	"Detected in single"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA020869	Uncertain				"Secreted - unknown location"					"HPA020869: AB_1851545"	"unprognostic (1.19e-1)"	"unprognostic (4.85e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.61e-2)"	"unprognostic (6.80e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.10e-3)"	"unprognostic (4.54e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.75e-5)"	"unprognostic (1.84e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.86e-2)"	7.0	4.0	0.4	0.2	0.7	0.2	1.0	0.1	0.4	0.0	0.2			0.0	0.1	1.2	0.1	1.1	0.4	0.7	0.4	2.8	0.3	0.0	0.2	0.0	0.7		0.3	0.6	0.0	6.4	0.1		0.3	0.4		0.0	0.2	0.0	2.8	0.3	0.1	0.0	0.2	0.0	2.6			0.1		0.2	0.8	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.4	0.1	0.1	0.4	1.0	0.5	0.2	0.0	0.5	0.2	0.2	0.3	0.1	0.2	0.1	0.0	0.1	0.0	0.0	1.1	0.2	0.3	0.5	9.2	1.0	0.1	0.0	0.1	0.8	0.7	1.3	0.2	0.2	0.8	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	3.4	0.4	0.1	0.0	0.1	0.1	0.0	0.0	3.8	0.3	0.3	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.4										
CCDC178	"C18orf34, FLJ44050"	ENSG00000166960	"Coiled-coil domain containing 178"	Q5BJE1	18	32937402-33441101	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 23.3;breast: 18.4;testis: 16.4"	"Group enriched"	"Detected in some"	18	"HUVEC TERT2: 9.2;U-87 MG: 8.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"														"unprognostic (1.15e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.69e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.58e-3)"	"unprognostic (2.92e-1)"	"unprognostic (5.95e-4)"	"unprognostic (4.12e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.94e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.42e-3)"	"unprognostic (9.03e-3)"	23.3	0.2	0.1	0.6	0.3	0.0	18.4	0.1	0.6	7.1	3.2	0.1	3.5	0.5	2.7	3.0	2.9	1.3	2.7	1.0	0.3	0.2	3.0	0.1	2.0	1.0	0.2	0.1	4.8	0.1	0.0	0.6	0.5	0.2	8.6	0.4	0.1	0.9	2.3	3.2	0.7	0.6	1.7	0.2	9.8	0.7	16.4	0.1	0.3	1.5	0.5	0.5	3.0	3.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.3	0.3	0.2	0.2	0.1	0.2	0.1
CCRL2	"ACKR5, CKRX, CRAM-A, CRAM-B, HCR"	ENSG00000121797	"C-C motif chemokine receptor like 2"	O00421	3	46407163-46412997	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 31.4"	"Cell line enhanced"	"Detected in some"		"HEL: 16.3;PC-3: 12.6;RT4: 6.5;TIME: 12.3;U-266/84: 6.7;U-87 MG: 6.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			HPA043238	Approved									"HPA043238: AB_10794924"	"unprognostic (3.94e-1)"	"unprognostic (7.02e-2)"	"prognostic favourable (3.72e-5)"	"unprognostic (1.64e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.10e-2)"	"unprognostic (4.17e-2)"	"unprognostic (9.73e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.57e-1)"	"prognostic favourable (9.67e-5)"	31.4	1.4	1.3	9.2	1.5	6.0	9.0	0.6	1.2	1.8	9.5	0.9	2.8	9.5	3.5	1.4	1.8	1.3	4.5	2.3	1.5	1.3	2.0	3.4	13.7	4.3	1.9	0.9	2.3	4.8	0.3	1.3	3.9	1.8	2.4	8.8	1.7	1.4	0.7	2.6	1.1	16.9	1.9	2.9	11.2	4.5	2.3	1.2	9.4	1.9	1.3	3.0	3.6	3.5	2.5	7.7	5.6	16.7	5.4	3.9	3.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.5	3.7	0.0	16.3	0.0	0.0	0.0	1.0	0.2	0.0	0.0	4.2	0.2	5.9	2.2	0.1	4.2	0.0	1.3	2.1	0.0	12.6	0.3	0.2	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	2.7	12.3	0.5	0.2	0.6	0.2	0.0	6.7	0.2	6.4	5.0	0.0	5.6	12.1	3.2	2.4	16.7	2.9	1.4	1.4	3.9	7.7	2.5	0.9	2.2	2.0	5.4	7.8	2.4	3.7	3.6	1.3	1.5	0.6	1.2	1.5	1.3	1.9	0.9	1.8	1.2
CD300LG	"CLM9, Trem4"	ENSG00000161649	"CD300 molecule like family member g"	Q6UXG3	17	43847148-43863629	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 76.1;breast: 45.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.0;NB-4: 1.1"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 2.4"	"Low lineage specificity"	"Detected in many"																	870000	870000				"unprognostic (2.38e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.63e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.40e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.01e-2)"	"unprognostic (4.08e-3)"	"unprognostic (8.69e-4)"	"unprognostic (2.12e-5)"	"unprognostic (1.30e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.57e-1)"	76.1	0.9	0.1	2.8	0.2	0.0	45.4	0.1	0.5	2.2	6.1	0.1	1.2	0.0	1.7	5.4	1.5	1.8	1.7	10.5	0.1	0.0	1.9	1.4	4.6	0.5	0.1	0.2	0.8	1.1	0.2	0.1	25.2	0.2	2.6	0.1	1.4	1.7	0.8	8.2	3.1	0.9	0.3	0.1	1.1	1.0	16.0	0.1	2.1	1.2	1.7	0.2	1.5	7.8	0.5	1.6	2.4	0.2	0.6	0.2	0.1	0.1	0.0	0.1	0.3	0.0	0.0	2.0	0.3	0.0	0.6	0.2	0.0	0.2	0.0	1.0	0.0	0.1	0.0	0.4	0.3	0.4	0.0	0.5	1.0	0.4	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.7	0.0	0.1	0.2	0.2	0.1	0.0	0.2	0.6	0.4	0.3	0.1	0.6	0.3	0.4	0.1	0.1	2.4	0.2	0.2	0.1	0.1	0.1	0.1	0.2	0.2	1.6	0.5	0.2	0.2	1.2	0.6	0.1	0.4	0.1	0.1	0.1	0.2	0.1	0.4	0.1	0.0	0.1	0.2	0.2	0.1
CD36	"FAT, GP3B, GP4, GPIV, SCARB3"	ENSG00000135218	"CD36 molecule"	P16671	7	80369575-80679277	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 464.3;breast: 156.1"	"Group enriched"	"Detected in some"	5	"ASC diff: 80.8;HEL: 38.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"classical monocyte: 104.4;intermediate monocyte: 30.4;myeloid DC: 56.9"	"Group enriched"	"Detected in many"	45	"dendritic cells: 56.9;monocytes: 104.4"	"Low region specificity"	"Detected in many"							"HPA002018, CAB025866, HPA071026"	Enhanced		Enhanced	"Golgi apparatus"		92000000	92000000	"Golgi apparatus"	"Golgi apparatus"	"CAB025866: , HPA002018: AB_1078464, HPA071026: AB_2732170"	"unprognostic (7.16e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.06e-3)"	"unprognostic (6.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.63e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.84e-3)"	"prognostic unfavourable (4.47e-4)"	"unprognostic (7.05e-3)"	"unprognostic (4.87e-2)"	"unprognostic (2.73e-3)"	464.3	3.6	1.2	8.9	1.3	10.9	156.1	0.5	0.5	1.8	31.8	0.6	3.3	9.8	1.8	7.5	7.5	3.3	7.2	76.8	1.8	1.9	2.2	13.3	11.5	4.8	0.6	0.3	2.5	3.9	3.1	0.8	37.9	2.9	9.2	3.5	0.8	4.6	2.3	23.6	5.4	23.4	4.7	0.8	42.8	5.0	6.0	0.5	2.7	13.6	15.3	1.4	9.4	19.2	0.3	56.9	1.8	104.4	0.7	0.2	60.2	0.0	0.0	0.2	0.1	80.8	0.8	0.1	0.2	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	1.0	0.1	0.0	0.1	0.1	38.4	0.1	6.1	0.0	0.0	0.0	7.8	3.1	0.0	0.0	0.2	1.3	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.3	0.2	0.1	0.0	2.7	4.4	0.0	0.1	0.5	0.1	0.0	0.0	0.1	0.1	0.0	13.2	10.2	0.9	104.4	0.3	0.2	30.4	0.2	0.3	0.0	0.0	56.9	0.0	0.1	0.0	1.8	0.7	7.5	14.3	0.1	60.2	1.2	1.3	0.5	0.5	1.8	1.9	0.6	0.3	2.9	0.5
CHIT1	"CHI3, CHIT"	ENSG00000133063	"Chitinase 1"	Q13231	1	203212827-203273641	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 99.9;lymphoid tissue: 106.5"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.7;LHCN-M2: 1.7;RH-30: 1.7;U-266/70: 2.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 31.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"neutrophil: 2.9;non-classical monocyte: 1.1"	"Group enriched"	"Detected in many"	4	"granulocytes: 2.9;monocytes: 1.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA010575, HPA074844"	Supported				"Secreted to blood"	58000000	58000000			"HPA010575: AB_1078512, HPA074844: "	"unprognostic (5.80e-3)"	"prognostic favourable (2.02e-4)"	"unprognostic (2.58e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.87e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.55e-2)"	"unprognostic (6.36e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.56e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.95e-1)"	99.9	0.2	0.2	0.4	0.3	26.7	5.5	0.1	0.3	5.9	0.6	0.5	0.1	0.0	2.5	0.2	0.3	0.1	0.2	0.6	0.2	0.1	0.1	0.4	22.1	106.5	0.4	0.1	1.4	1.1	0.0	0.2	0.4	0.5	0.6	0.5	0.3	0.3	0.1	0.1	0.3	0.7	0.2	9.4	4.3	0.1	0.1	0.1	2.3	0.9	0.2	0.5	0.1	0.3	0.5	0.2	2.9	1.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	2.7	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.7	0.2	0.0	0.0	0.1	0.2	0.0	1.7	0.9	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	2.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.9	0.0	1.1	0.2	0.0	1.3	0.2	0.3	0.1	0.3	0.2	0.1	0.4	0.1	0.5	0.1
CLDN5	"AWAL, BEC1, CPETRL1, TMVCF"	ENSG00000184113	"Claudin 5"	O00501	22	19523024-19527545	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 101.1"	"Group enriched"	"Detected in some"	10	"HUVEC TERT2: 40.1;SCLC-21H: 25.2"	"Cancer enhanced"	"Detected in all"		"glioma: 32.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	18	"basophil: 7.4;naive CD4 T-cell: 3.4;neutrophil: 4.1"	"Group enriched"	"Detected in many"	20	"granulocytes: 7.4;T-cells: 3.4"	"Low region specificity"	"Detected in all"							CAB002607	Approved					730000	730000			"CAB002607: "	"unprognostic (1.26e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.77e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.05e-3)"	"unprognostic (6.00e-2)"	"unprognostic (4.98e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.33e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.29e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.96e-2)"	101.1	4.9	13.9	6.8	17.9	1.9	45.5	7.1	20.0	10.6	19.4	10.2	3.0	9.9	10.2	5.1	7.8	9.5	11.7	14.1	16.9	15.0	7.6	6.0	43.6	9.2	19.8	4.5	8.6	5.5	2.4	1.5	13.1	20.0	8.2	5.0	5.4	4.1	5.1	26.2	10.2	10.3	7.6	18.9	13.5	8.8	6.5	11.9	0.3	20.1	7.3	3.7	7.6	34.7	0.1	0.2	7.4	0.2	0.0	3.4	20.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	40.1	0.3	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.4	0.3	0.0	0.0	0.0	25.2	0.1	0.0	0.0	0.0	0.2	0.0	3.2	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.1	3.4	0.1	4.1	0.0	0.0	0.1	0.0	20.9	13.9	17.9	7.1	15.8	16.9	15.0	19.8	4.5	20.0	11.9
CNTFR		ENSG00000122756	"Ciliary neurotrophic factor receptor"	P26992	9	34551432-34590140	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 44.7;skeletal muscle: 33.6"	"Group enriched"	"Detected in some"	6	"AF22: 46.8;SH-SY5Y: 22.4"	"Cancer enhanced"	"Detected in many"		"glioma: 22.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025310	Approved					36000000	36000000			"CAB025310: "	"unprognostic (1.39e-1)"	"unprognostic (9.40e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.70e-2)"	"unprognostic (4.45e-3)"	"unprognostic (1.72e-2)"	"unprognostic (6.32e-2)"	"unprognostic (4.99e-3)"	"unprognostic (7.37e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.34e-1)"	44.7	9.4	17.0	2.2	27.9	0.7	17.3	30.6	28.7	11.1	5.8	8.2	1.1	3.4	2.6	2.9	3.9	5.6	5.7	10.1	18.6	11.7	1.9	6.5	2.2	1.5	15.5	9.8	4.5	2.4	0.8	2.5	4.8	12.0	5.3	2.5	7.5	9.0	7.6	33.6	4.4	6.0	1.8	6.3	16.1	3.0	4.9	10.9	0.2	3.2	3.8	1.0	1.4	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.8	0.0	6.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	22.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	27.9	30.6	22.0	18.6	11.7	15.5	9.8	12.0	10.9
COL5A3		ENSG00000080573	"Collagen type V alpha 3 chain"	P25940	19	9959561-10010471	"Cancer-related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 48.9"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 23.4;BJ: 13.5;BJ hTERT+: 15.1;BJ hTERT+ SV40 Large T+: 8.4;HSkMC: 16.8;WM-115: 15.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"MAIT T-cell: 1.7"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA048256	Approved				"Secreted to extracellular matrix"	210000	210000			"HPA048256: AB_2680330"	"unprognostic (1.17e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.24e-2)"	"unprognostic (6.84e-3)"	"unprognostic (3.01e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.09e-1)"	"prognostic unfavourable (7.17e-8)"	"unprognostic (3.25e-2)"	"unprognostic (7.31e-3)"	"unprognostic (6.00e-2)"	"prognostic unfavourable (6.87e-5)"	48.9	2.6	11.6	10.8	15.9	0.4	27.0	3.2	11.9	24.5	7.8	3.2	3.1	3.6	17.5	9.8	11.3	8.1	10.7	9.5	10.1	3.0	1.9	4.1	6.4	9.2	5.2	3.5	3.4	3.8	3.2	0.9	30.2	4.5	6.8	2.2	9.7	5.1	9.1	15.4	19.0	3.9	9.6	2.5	1.3	3.4	5.3	2.6	1.6	4.5	11.5	4.7	7.3	10.2	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.3	0.0	7.4	23.4	0.0	13.5	15.1	8.4	3.4	0.0	0.0	0.0	0.1	2.5	1.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	16.8	0.3	3.0	3.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.7	0.0	0.0	0.0	6.9	3.2	0.2	0.0	0.0	0.0	0.0	0.9	0.0	15.1	0.0	0.0	0.0	0.3	0.0	1.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	11.6	15.9	3.2	11.9	10.1	3.0	5.2	3.5	4.5	2.6
COMP	"EDM1, EPD1, MED, PSACH, THBS5"	ENSG00000105664	"Cartilage oligomeric matrix protein"	P49747	19	18782773-18791314	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 39.1;skeletal muscle: 59.6"	"Cell line enriched"	"Detected in some"	5	"fHDF/TERT166: 134.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebellum: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			HPA077555			Approved	"Golgi apparatus"	"Secreted to extracellular matrix"	1100000000	1100000000	"Golgi apparatus"	"Golgi apparatus"	"HPA077555: "	"unprognostic (1.26e-1)"	"unprognostic (7.22e-2)"	"prognostic unfavourable (9.08e-5)"	"prognostic unfavourable (2.04e-4)"	"unprognostic (8.05e-2)"	"unprognostic (8.45e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.85e-1)"	"prognostic unfavourable (1.52e-6)"	"unprognostic (5.96e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.87e-2)"	"prognostic unfavourable (6.95e-4)"	39.1	0.2	0.0	1.0	0.0	0.0	4.1	1.8	0.2	2.7	2.0	0.1	2.5	0.0	3.0	24.2	4.7	0.4	16.2	21.6	0.2	0.0	4.5	0.4	2.9	2.7	0.0	0.6	0.9	3.3	0.1	0.1	8.2	0.2	8.7	0.0	0.1	6.0	7.4	59.6	31.8	0.3	13.0	0.2	0.1	0.9	11.5	0.0	0.3	8.9	27.6	0.9	10.8	11.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	134.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.2	0.2	0.0	0.0	0.6	0.2	0.0
CPM		ENSG00000135678	"Carboxypeptidase M"	P14384	12	68842197-68971570	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 56.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 28.8;ASC TERT1: 20.5;HSkMC: 37.0;SiHa: 27.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 15.5;myeloid DC: 11.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 11.9;monocytes: 15.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002657, HPA077243"	Enhanced		Uncertain	Vesicles		5000000	5000000	Vesicles	Vesicles	"HPA002657: AB_1078398, HPA077243: "	"unprognostic (1.74e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.88e-3)"	"prognostic favourable (1.00e-4)"	"unprognostic (4.58e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.42e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.47e-3)"	"unprognostic (8.58e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.06e-1)"	56.1	6.6	3.8	5.4	7.0	1.1	37.2	1.2	4.9	6.5	12.9	13.2	0.9	1.6	10.7	6.1	4.1	6.4	6.5	2.9	5.3	3.0	22.1	11.6	24.1	13.0	10.9	4.3	7.5	7.8	3.2	1.0	27.9	5.5	6.2	10.8	2.7	3.2	1.7	8.2	13.0	3.7	2.5	6.7	11.4	5.9	5.8	9.3	1.1	5.1	3.5	4.5	4.4	4.4	2.8	11.9	1.3	15.5	0.3	1.3	4.7	0.0	1.5	0.0	0.0	28.8	20.5	0.3	3.8	0.4	0.6	0.9	1.2	1.6	0.2	3.8	0.5	0.0	0.5	1.0	1.6	0.0	1.0	0.0	6.2	0.1	0.1	0.4	0.7	37.0	0.2	0.4	0.8	0.0	0.0	0.0	2.9	0.6	0.0	0.2	0.6	2.0	1.1	0.2	0.0	2.9	2.2	0.1	0.0	27.1	4.2	3.2	0.4	10.1	0.1	0.5	3.1	0.2	0.0	0.1	0.1	4.9	1.7	5.1	2.3	0.3	15.5	0.1	0.1	10.2	0.0	1.4	1.2	0.0	11.9	2.8	0.7	0.1	1.3	0.3	4.7	0.8	1.3	4.7	3.8	7.0	1.2	4.9	5.3	3.0	10.9	4.3	5.5	9.3
CTSK	"CTSO, CTSO2, PKND, PYCD"	ENSG00000143387	"Cathepsin K"	P43235	1	150796208-150808323	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 104.1"	"Group enriched"	"Detected in some"	8	"ASC diff: 200.2;ASC TERT1: 73.3;BJ hTERT+: 161.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 6.7"	"Lineage enriched"	"Detected in many"	6	"monocytes: 6.7"	"Low region specificity"	"Detected in all"							HPA050346			Supported	Vesicles	"Intracellular and membrane"			Vesicles	Vesicles	"HPA050346: AB_2681101"	"unprognostic (1.48e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.61e-3)"	"unprognostic (5.08e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.60e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.54e-2)"	"prognostic unfavourable (7.12e-5)"	"unprognostic (6.07e-3)"	"unprognostic (2.98e-2)"	"unprognostic (5.93e-3)"	"unprognostic (6.41e-2)"	104.1	2.4	1.2	6.5	1.6	1.3	79.3	2.4	2.3	70.6	23.6	2.2	10.1	2.7	72.5	25.9	26.5	12.5	53.4	14.7	1.1	1.1	3.4	1.8	8.7	10.4	1.1	1.7	25.4	2.9	0.3	3.0	30.6	2.6	24.2	11.5	56.0	10.9	6.8	19.9	44.0	11.0	26.9	2.0	5.6	8.6	24.1	0.9	1.1	7.1	13.2	10.7	38.0	48.2	0.1	1.0	1.0	6.7	0.5	1.2	1.8	0.1	0.1	0.3	0.3	200.2	73.3	0.2	5.7	161.8	0.4	0.8	0.0	0.1	0.1	0.2	11.1	0.2	0.0	0.1	0.2	0.1	0.1	0.3	0.1	0.0	1.0	0.1	0.4	14.6	0.5	4.5	0.1	0.6	0.0	0.5	0.4	0.3	0.0	0.7	1.1	0.1	0.0	0.1	0.0	0.4	0.1	0.1	0.6	0.3	0.0	3.0	0.2	0.2	0.4	0.2	0.1	0.2	0.2	0.6	0.5	1.1	17.0	0.0	0.9	0.0	6.7	1.0	0.7	3.4	0.2	0.0	0.6	0.2	0.4	0.1	0.3	0.5	0.6	0.5	2.0	1.0	1.2	1.8	1.2	1.6	2.4	2.3	1.1	1.1	1.1	1.7	2.6	0.9
DEPP1	"C10orf10, DEPP, FIG, Fseg"	ENSG00000165507	"DEPP1, autophagy regulator"	Q9NTK1	10	44970981-44978810	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 204.9;breast: 227.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 34.4;HDLM-2: 23.9;HHSteC: 62.2;HSkMC: 48.4;HUVEC TERT2: 38.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB013687, HPA037818, HPA037819"	Uncertain		Supported	Vesicles,Mitochondria	"Intracellular and membrane"			Mitochondria	Mitochondria	"CAB013687: , HPA037818: , HPA037819: AB_2675685"	"unprognostic (3.99e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.57e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.88e-2)"	"unprognostic (5.66e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.25e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.89e-2)"	"prognostic unfavourable (2.29e-6)"	"unprognostic (2.30e-3)"	"unprognostic (2.13e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.74e-1)"	204.9	14.6	8.7	14.1	16.8	2.4	227.9	10.8	19.7	14.1	36.5	2.9	10.0	7.4	25.0	14.9	23.5	25.5	28.0	37.0	8.5	6.0	13.0	48.2	70.7	20.6	9.4	3.3	51.2	107.1	4.7	12.2	33.4	21.6	25.8	5.7	12.1	16.2	13.0	81.0	19.6	9.9	30.2	39.0	9.5	12.7	31.9	11.0	0.8	33.3	13.4	19.1	52.1	27.6	0.0	3.7	1.2	0.3	0.0	0.7	1.4	6.7	0.0	0.1	0.0	34.4	16.8	1.7	0.0	2.3	0.1	0.4	0.2	2.5	0.0	0.3	3.0	0.2	0.2	2.0	0.1	23.9	0.9	0.0	0.0	2.4	62.2	0.0	0.0	48.4	0.1	0.0	0.3	38.3	0.0	14.7	0.1	0.0	0.0	0.3	0.0	0.2	1.1	0.4	5.6	0.1	2.4	1.3	0.0	0.0	0.3	1.3	0.0	1.6	0.3	1.8	1.3	0.1	1.6	0.4	0.6	0.0	10.4	0.6	0.9	0.0	0.3	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.1	0.5	0.0	0.1	3.7	0.0	1.4	8.7	16.8	10.8	19.7	8.5	6.0	9.4	3.3	21.6	11.0
DGAT2		ENSG00000062282	"Diacylglycerol O-acyltransferase 2"	Q96PD7	11	75759512-75801535	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 104.3;blood: 68.9;liver: 81.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 33.6;HDLM-2: 24.3;Hep G2: 25.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 19.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	11	"eosinophil: 26.3;neutrophil: 68.9"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 68.9"	"Low region specificity"	"Detected in all"																		"unprognostic (2.28e-1)"	"unprognostic (3.69e-1)"	"unprognostic (9.38e-2)"	"prognostic unfavourable (2.84e-4)"	"unprognostic (3.63e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.10e-2)"	"unprognostic (7.59e-2)"	"unprognostic (4.46e-1)"	"unprognostic (4.12e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.49e-7)"	"unprognostic (2.03e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.60e-2)"	104.3	1.3	1.9	12.5	6.8	1.7	30.4	0.1	4.2	1.0	11.8	0.6	0.4	3.6	0.5	0.6	6.3	0.7	6.3	6.0	1.0	1.2	1.0	81.3	1.8	16.1	0.6	1.2	0.6	1.3	0.4	0.6	0.5	1.0	1.0	1.4	1.2	9.9	0.6	1.3	34.1	8.1	0.9	0.6	3.7	3.3	13.6	0.5	1.0	2.4	3.9	4.5	4.0	2.7	1.5	1.1	68.9	4.2	0.0	0.0	0.9	5.1	2.5	0.1	4.5	33.6	2.7	0.4	0.4	0.6	0.6	0.4	18.5	5.4	8.2	6.8	0.1	0.2	0.7	2.6	1.8	24.3	0.4	0.5	1.7	25.4	0.3	2.9	2.9	11.2	13.8	3.0	4.3	0.4	0.4	11.2	0.2	3.3	1.9	6.3	1.4	12.1	0.0	0.0	9.6	0.4	14.2	9.2	0.5	4.7	0.7	1.2	1.8	10.4	0.6	5.8	2.8	0.1	3.5	6.6	14.6	11.0	4.2	9.3	10.0	3.0	4.2	26.3	0.0	0.8	0.0	1.5	0.0	0.0	1.1	1.2	0.0	0.0	68.9	0.0	0.8	0.3	0.0	0.9	1.9	6.8	0.1	4.2	1.0	1.2	0.6	1.2	1.0	0.5
DHRS9	"3alpha-HSD, RDH15, RDHL, RETSDR8, SDR9C4"	ENSG00000073737	"Dehydrogenase/reductase 9"	Q9BPW9	2	169064789-169096167	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 40.0;blood: 53.1;heart muscle: 32.2;intestine: 30.9"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 8.8;NB-4: 14.4;THP-1: 42.2;TIME: 18.8;U-2197: 13.9"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 16.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 53.1;eosinophil: 23.9;neutrophil: 19.5"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 53.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA036491, HPA036667"	Approved				"Intracellular and membrane"					"HPA036491: AB_10673498, HPA036667: AB_10670237"	"unprognostic (1.15e-1)"	"unprognostic (3.82e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.80e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.62e-4)"	"prognostic unfavourable (2.73e-4)"	"unprognostic (2.72e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.41e-1)"	40.0	0.1	1.3	14.9	1.0	3.3	2.2	0.3	1.9	4.0	30.9	1.1	0.8	0.6	1.3	0.9	12.8	0.6	2.3	32.2	1.2	0.8	0.4	1.0	9.6	8.0	2.5	1.1	1.2	1.4	0.0	0.3	4.9	1.1	3.5	20.9	0.6	2.9	0.3	1.0	1.5	2.7	3.5	2.4	4.0	4.6	12.3	0.6	0.9	0.5	23.2	12.0	3.7	4.6	1.7	5.4	53.1	6.1	0.0	0.1	1.3	0.0	0.3	0.0	0.0	1.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.4	0.1	0.2	0.5	2.6	8.8	0.4	0.0	0.0	0.0	0.0	14.4	0.0	3.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	42.2	18.8	0.0	0.1	13.9	0.1	0.0	0.0	0.0	0.3	7.5	0.0	53.1	5.4	23.9	0.0	6.1	0.1	1.7	0.0	0.0	5.4	1.0	0.0	0.0	19.5	0.0	1.2	0.4	0.0	1.3	1.3	1.0	0.3	0.7	1.2	0.8	2.5	1.1	1.1	0.6
DPT		ENSG00000143196	Dermatopontin	Q07507	1	168695459-168729264	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 128.1"	"Group enriched"	"Detected in some"	13	"ASC diff: 54.0;fHDF/TERT166: 21.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA065548			Approved	Vesicles	"Secreted to extracellular matrix"	25000	25000	Vesicles	Vesicles	"HPA065548: AB_2685511"	"unprognostic (1.49e-1)"	"unprognostic (7.62e-2)"	"unprognostic (5.66e-2)"	"unprognostic (4.39e-2)"	"unprognostic (4.64e-2)"	"unprognostic (3.78e-3)"	"unprognostic (4.09e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.16e-2)"	"prognostic unfavourable (4.74e-5)"	"unprognostic (2.12e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.98e-3)"	128.1	6.1	0.8	22.6	0.8	0.0	99.3	0.8	2.4	51.0	81.7	0.9	19.8	2.4	20.4	38.8	33.1	23.0	52.3	48.8	0.8	0.3	2.4	6.0	9.6	7.7	0.8	0.8	12.8	13.4	0.0	0.9	7.8	0.9	24.0	9.4	1.8	14.4	10.2	13.0	8.6	23.1	76.1	0.8	1.0	23.6	8.7	0.8	2.3	16.3	55.7	22.8	48.7	39.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.0	0.2	0.0	0.0	2.4	2.6	2.7	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.8	2.4	0.8	0.3	0.8	0.8	0.9	0.8
DTX1	"hDx-1, RNF140"	ENSG00000135144	"Deltex E3 ubiquitin ligase 1"	Q86Y01	12	113056709-113098028	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 9.7;lymphoid tissue: 13.3"	"Group enriched"	"Detected in some"	12	"Daudi: 40.0;REH: 16.4;U-698: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051249, HPA055275"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA051249: , HPA055275: AB_2682769"	"unprognostic (2.13e-3)"	"unprognostic (3.20e-3)"	"unprognostic (4.24e-4)"	"unprognostic (2.01e-1)"	"unprognostic (7.48e-3)"	"unprognostic (1.59e-3)"	"unprognostic (2.49e-3)"	"unprognostic (1.81e-1)"	"unprognostic (9.55e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.58e-1)"	"prognostic unfavourable (3.02e-5)"	"unprognostic (2.41e-2)"	"unprognostic (4.70e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.78e-3)"	9.7	2.3	6.1	8.9	7.0	3.2	3.9	7.3	8.3	0.8	0.7	1.1	0.5	1.6	2.0	0.5	1.2	1.7	1.0	2.7	5.4	5.9	1.7	6.4	0.5	13.3	3.7	4.2	0.5	2.0	0.0	2.2	0.9	4.6	0.8	0.2	1.4	3.2	0.5	0.5	0.5	2.2	0.5	1.1	9.8	1.0	4.9	0.5	0.5	1.3	0.5	8.1	0.5	0.5	2.3	0.0	0.0	0.0	1.0	0.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	1.6	0.0	0.7	0.0	16.4	0.0	0.9	0.0	0.0	1.0	2.7	0.1	0.1	0.9	0.0	0.1	0.4	0.0	1.5	0.0	0.0	0.2	0.0	40.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.5	0.0	0.0	2.3	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.2	6.1	7.0	7.3	7.1	5.4	5.9	3.7	4.2	4.6	0.5
EBF2	"COE2, FLJ11500"	ENSG00000221818	"Early B cell factor 2"	Q9HAK2	8	25841730-26045397	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 25.8"	"Cell line enhanced"	"Detected in some"		"ASC diff: 12.3;ASC TERT1: 24.9;HSkMC: 25.3;hTEC/SVTERT24-B: 14.1;U-138 MG: 9.1;U-2197: 11.9;U-87 MG: 10.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"pons and medulla: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basal ganglia: 5.9;cerebellum: 3.4;hypothalamus: 2.4;midbrain: 5.3;pons and medulla: 2.9"	"Low region specificity"	"Detected in many"														"unprognostic (3.70e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.47e-3)"	"unprognostic (1.03e-1)"	"unprognostic (6.10e-2)"	"unprognostic (5.92e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.13e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (2.51e-6)"	"unprognostic (7.41e-4)"	"unprognostic (2.28e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.82e-2)"	25.8	1.1	0.2	3.2	0.9	0.1	14.5	0.2	0.2	3.0	4.2	0.0	2.9	0.2	3.0	14.1	5.2	5.1	3.8	16.4	0.2	0.5	0.9	0.2	1.3	4.4	0.9	0.0	3.9	4.0	3.1	0.6	0.8	2.8	3.7	0.7	0.1	1.7	0.8	11.1	1.8	1.0	5.4	10.1	0.2	1.2	4.2	0.0	0.4	7.4	11.6	0.5	6.2	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	12.3	24.9	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	25.3	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.1	11.9	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.2	0.2	0.2	0.5	0.9	0.0	2.8	0.0
EXOC1L		ENSG00000250821	"Exocyst complex component 1 like"		4	55819819-55837487	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"adipose tissue: 1.7;blood: 5.2;testis: 1.3"	"Group enriched"	"Detected in some"	6	"HEK 293: 5.7;HSkMC: 2.2"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	52	"NK-cell: 5.2"	"Lineage enriched"	"Detected in single"	52	"NK-cells: 5.2"	"Region enriched"	"Detected in single"	4	"pons and medulla: 3.0"	"Not detected"	"Not detected"																															1.7	0.0		0.0		0.0	0.0		0.5	0.0	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.3			0.0	0.4	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.2		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.7	1.3			0.0		0.1	0.0		0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	5.7	0.7	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0										
F2RL3	PAR4	ENSG00000127533	"F2R like thrombin or trypsin receptor 3"	Q96RI0	19	16888860-16892606	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 69.4;breast: 30.7;lung: 33.0"	"Group enriched"	"Detected in some"	7	"HEL: 24.3;HMC-1: 9.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031401, HPA042340"			Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane"	"Plasma membrane"	"HPA031401: , HPA042340: "	"unprognostic (6.17e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.64e-2)"	"unprognostic (3.83e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.31e-3)"	"unprognostic (2.97e-1)"	"unprognostic (3.28e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.30e-2)"	"unprognostic (3.00e-3)"	"prognostic favourable (6.25e-4)"	"unprognostic (2.37e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.11e-2)"	69.4	3.3	0.2	2.6	0.4	1.3	30.7	0.2	0.6	1.3	16.9	0.4	0.5	1.9	1.3	1.9	4.3	1.0	4.5	9.7	0.5	0.2	5.0	0.8	33.0	2.6	0.2	0.3	3.9	12.3	0.5	2.3	1.1	1.4	1.4	1.5	1.3	1.0	0.8	6.5	2.2	4.4	1.1	0.2	3.0	5.4	2.5	0.2	0.3	27.1	2.3	1.5	3.4	1.9	5.3	4.3	5.8	2.5	3.9	3.3	3.2	0.2	0.2	0.7	0.3	0.1	0.2	0.7	0.4	0.0	0.2	0.1	0.4	0.7	0.5	0.5	0.2	0.6	0.1	0.2	0.2	0.3	0.3	24.3	0.9	0.4	0.2	0.3	9.8	0.0	0.1	0.3	0.2	0.8	1.9	1.0	0.1	0.3	0.3	2.4	0.3	0.2	0.2	0.2	0.7	0.2	0.5	0.4	0.2	0.2	0.1	0.1	0.5	1.6	0.9	0.5	0.5	0.3	0.3	0.5	0.3	0.5	0.2	0.4	0.4	5.8	2.5	1.6	2.2	1.4	2.1	3.9	2.4	1.9	0.8	5.3	3.3	3.1	5.3	3.9	1.8	4.3	1.7	3.2	0.2	0.4	0.2	0.6	0.5	0.2	0.2	0.3	1.4	0.2
FADS3	"CYB5RP, LLCDL3"	ENSG00000221968	"Fatty acid desaturase 3"	Q9Y5Q0	11	61873519-61892051	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 63.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 62.2;HHSteC: 53.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 8.9;naive B-cell: 10.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045224	Approved		Approved	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"	"Nucleoli fibrillar center"	"HPA045224: AB_10967570"	"unprognostic (4.69e-3)"	"unprognostic (1.31e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.91e-2)"	"prognostic unfavourable (9.54e-5)"	"unprognostic (1.76e-3)"	"unprognostic (3.46e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.28e-3)"	"unprognostic (2.04e-1)"	"prognostic unfavourable (1.50e-9)"	"unprognostic (1.14e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.37e-1)"	63.1	25.9	15.7	17.5	17.9	4.1	23.5	8.7	16.5	9.3	8.3	13.8	5.9	4.3	9.8	25.4	7.4	9.0	9.9	22.7	14.4	11.6	16.6	8.5	16.3	15.4	16.9	10.0	12.7	12.1	12.4	5.0	48.2	15.1	7.1	4.4	16.8	5.5	11.3	15.7	4.2	9.0	14.9	13.3	9.7	8.3	6.0	15.6	1.1	6.1	7.3	15.7	10.4	9.9	10.6	0.7	5.7	1.2	0.6	2.4	0.7	7.6	2.4	0.7	4.8	62.2	12.6	15.5	15.5	37.8	16.6	16.1	3.4	2.8	5.7	10.1	30.8	4.2	2.9	42.1	8.8	1.6	1.6	4.7	10.1	6.7	53.9	0.4	0.9	13.8	18.3	19.9	38.1	19.1	4.5	10.8	28.2	8.8	1.7	2.3	2.2	6.3	9.6	30.7	15.8	18.5	2.7	1.2	1.5	17.7	2.4	15.7	3.4	1.0	12.9	16.2	11.2	4.7	6.7	3.3	1.6	6.8	13.5	2.3	11.7	0.0	0.7	5.7	1.8	1.2	1.6	8.9	1.6	2.4	0.7	10.6	0.1	0.6	0.3	0.6	0.8	0.0	0.4	0.7	15.7	17.9	8.7	15.4	14.4	11.6	16.9	10.0	15.1	15.6
FAM124B	FLJ22746	ENSG00000124019	"Family with sequence similarity 124 member B"	Q9H5Z6	2	224378698-224402085	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 28.8;blood: 18.0"	"Cell line enriched"	"Detected in some"	7	"HUVEC TERT2: 48.1"	"Cancer enriched"	"Detected in many"	10	"testis cancer: 7.3"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 18.0;eosinophil: 11.6"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA070240	Approved		Approved	Nucleoplasm,Mitochondria				Nucleoplasm	Nucleoplasm	"HPA070240: AB_2686238"	"unprognostic (2.01e-1)"	"unprognostic (1.83e-1)"	"unprognostic (6.87e-3)"	"unprognostic (2.49e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.28e-2)"	"unprognostic (5.78e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.36e-1)"	"unprognostic (7.61e-3)"	"unprognostic (1.36e-2)"	"unprognostic (4.30e-1)"	"unprognostic (2.25e-1)"	"unprognostic (5.80e-3)"	28.8	0.6	1.6	1.4	1.9	5.9	16.0	0.6	1.8	4.2	2.1	1.6	0.7	1.3	2.4	2.5	2.6	1.8	1.7	2.4	2.2	2.2	1.4	2.6	5.8	0.8	2.0	0.6	2.5	0.5	9.4	0.8	12.5	1.8	3.9	1.5	4.0	1.7	0.6	4.3	2.6	1.5	3.5	2.1	0.8	1.2	2.3	0.2	1.0	2.9	0.8	1.0	3.4	2.6	0.0	5.6	18.0	2.1	3.8	1.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	48.1	2.1	0.1	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	3.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	2.1	11.6	0.1	1.6	0.0	0.0	0.5	0.0	5.6	0.0	0.0	0.0	0.1	3.8	0.5	0.0	1.7	0.7	1.6	1.9	0.6	1.8	2.2	2.2	2.0	0.6	1.8	0.2
FAM180B	LOC399888	ENSG00000196666	"Family with sequence similarity 180 member B"		11	47586693-47589194	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"adipose tissue: 4.6;breast: 6.9;skin 1: 5.2;thyroid gland: 3.9"	"Cell line enhanced"	"Detected in some"		"HEL: 2.2;NB-4: 2.0;SK-MEL-30: 4.1;U-937: 3.1"	"Cancer enhanced"	"Detected in some"		"melanoma: 1.7"					"Cell type enriched"	"Detected in single"	5	"memory CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.2"					"Not detected"	"Not detected"			HPA029408	Uncertain									"HPA029408: AB_10601319"	"unprognostic (1.28e-2)"	"unprognostic (4.99e-3)"		"unprognostic (7.48e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.03e-5)"	"unprognostic (5.65e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.44e-1)"	4.6	0.4	0.2	0.0	1.4	0.3	6.9	0.7	1.2	0.5	0.4			0.1	0.1	0.3	0.0	0.7	0.8	0.6	0.2	0.9	0.0	0.0	0.1	0.1	1.4		0.1	0.0	0.0	0.0	0.0		0.0	0.4		0.8	0.0	1.1	5.2	0.0	0.1	1.2	0.0	0.3	0.7			3.9		0.2	0.5	0.1	0.0	0.0	0.0	0.2	0.1	1.2	0.0	0.0	0.0	1.8	0.0	1.2	1.3	0.3	0.2	0.1	0.0	0.0	0.2	0.1	0.5	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.3	2.2	0.4	0.7	0.0	0.4	0.6	0.5	0.2	0.0	0.0	0.0	0.5	0.2	0.2	2.0	0.1	2.0	0.3	0.2	0.6	0.4	0.0	0.0	0.1	0.0	0.3	0.2	0.0	4.1	0.2	0.6	1.1	0.5	0.3	0.2	0.0	0.3	0.2	0.1	0.0	3.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0										
FAM213A	"Adrx, C10orf58, MGC4248, PAMM"	ENSG00000122378	"Family with sequence similarity 213 member A"	Q9BRX8	10	80407829-80437115	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 120.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 138.2;HaCaT: 38.8;HUVEC TERT2: 61.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	10	"plasmacytoid DC: 48.5"	"Lineage enriched"	"Detected in all"	10	"dendritic cells: 48.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009025, HPA024565"	Approved				"Intracellular and membrane"					"HPA009025: AB_1078312, HPA024565: AB_1845519"	"unprognostic (1.73e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.96e-3)"	"unprognostic (2.15e-2)"	"unprognostic (3.02e-2)"	"unprognostic (4.31e-2)"	"unprognostic (3.14e-1)"	"unprognostic (6.68e-2)"	"unprognostic (2.58e-1)"	"unprognostic (7.01e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.83e-3)"	"unprognostic (3.32e-3)"	"unprognostic (3.55e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.80e-1)"	"prognostic favourable (6.11e-4)"	120.6	9.3	42.3	6.5	47.7	1.7	64.1	9.8	44.0	33.0	21.1	17.8	11.2	28.0	18.4	75.3	22.5	11.3	10.8	22.5	36.2	33.7	38.2	65.6	7.4	7.6	36.6	26.2	11.4	22.3	34.6	23.3	15.5	26.5	25.0	15.1	31.7	17.4	16.6	15.4	27.1	25.4	7.9	29.6	4.4	7.3	17.1	16.3	5.0	19.2	24.3	11.4	19.1	13.0	4.6	48.5	3.3	1.0	1.9	4.4	1.5	3.5	8.7	14.9	0.0	138.2	0.0	1.0	0.5	3.0	0.2	0.0	8.3	10.7	2.2	11.7	0.0	38.8	1.3	1.5	0.0	0.1	2.4	4.5	3.3	12.1	13.4	0.0	1.3	10.3	2.9	0.9	0.0	61.5	3.6	0.0	0.0	12.2	5.6	0.6	7.2	0.0	16.0	6.9	0.1	31.6	14.7	15.4	11.0	1.5	21.0	22.7	9.4	6.3	16.6	0.1	0.1	0.0	0.0	1.3	2.9	0.0	9.5	0.0	1.0	0.2	1.0	3.3	2.1	0.2	1.7	4.6	1.1	1.7	1.0	3.5	4.4	4.4	0.7	1.9	0.0	48.5	0.0	1.5	42.3	47.7	9.8	44.0	36.2	33.7	36.6	26.2	26.5	16.3
FAM89A	"C1orf153, MGC15887"	ENSG00000182118	"Family with sequence similarity 89 member A"	Q96GI7	1	231018958-231040246	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 39.6;placenta: 48.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 51.1;SK-MEL-30: 26.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 4.3"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA059052, HPA059578"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"	"Golgi apparatus, Vesicles"	"HPA059052: AB_2683890, HPA059578: AB_2684070"	"unprognostic (7.80e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.58e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.05e-3)"	"unprognostic (4.85e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.44e-2)"	"prognostic unfavourable (1.75e-5)"	"unprognostic (2.87e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.26e-2)"	39.6	12.9	8.0	3.7	8.5	3.9	32.8	3.9	5.4	5.1	3.6	4.9	2.0	1.6	5.7	2.1	3.4	2.7	4.6	4.7	7.9	11.2	8.7	5.7	10.5	6.7	14.0	2.3	4.7	15.0	4.0	4.2	48.3	13.1	4.7	2.4	12.0	3.5	3.9	4.2	14.1	1.8	3.5	10.9	9.6	3.1	2.8	8.3	0.8	3.9	5.0	3.6	4.3	9.7	1.2	0.0	4.3	0.7	0.3	3.0	0.8	0.3	4.7	2.2	4.6	5.4	1.1	51.1	2.6	2.0	1.0	1.8	7.1	4.2	0.0	0.6	1.7	2.8	4.1	0.6	0.8	14.2	10.0	2.2	0.1	0.3	20.7	1.6	12.4	18.0	9.3	0.0	4.7	2.5	17.6	3.0	0.9	1.6	1.0	2.9	3.3	1.5	5.5	7.1	5.3	3.5	5.0	2.0	5.6	0.9	0.4	26.7	0.2	9.9	0.3	8.0	0.0	0.1	4.9	6.4	7.7	3.9	2.3	3.3	15.8	4.3	0.7	0.0	0.6	0.1	1.1	1.2	0.8	1.5	0.0	0.6	1.3	3.0	0.0	0.3	0.2	0.0	0.0	0.8	8.0	8.5	3.9	5.4	7.9	11.2	14.0	2.3	13.1	8.3
FASN	"FAS, SDR27X1"	ENSG00000169710	"Fatty acid synthase"	P49327	17	82078333-82098332	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 147.6"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 152.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005192, HPA006461, CAB015417, HPA056108"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		1600000	1600000	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"CAB005192: AB_2101095, CAB015417: AB_2231427, HPA006461: AB_1848437, HPA056108: AB_2683039"	"unprognostic (3.35e-2)"	"prognostic unfavourable (1.42e-5)"	"unprognostic (9.69e-3)"	"unprognostic (4.09e-2)"	"unprognostic (3.46e-3)"	"unprognostic (1.55e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.74e-3)"	"unprognostic (3.15e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (7.16e-5)"	"unprognostic (4.50e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.35e-2)"	"unprognostic (7.03e-3)"	147.6	7.8	8.2	14.2	11.5	11.1	57.5	19.1	23.0	6.6	27.7	17.0	14.1	8.2	4.7	14.2	17.1	4.3	19.4	6.3	7.9	6.7	3.7	30.8	26.8	9.8	7.3	11.5	6.4	10.4	6.7	15.3	8.4	21.7	28.8	3.4	7.6	16.9	10.8	7.5	17.2	6.5	4.6	8.4	5.1	11.9	6.6	8.8	1.9	5.1	10.7	5.4	8.0	6.6	0.5	1.4	0.0	0.8	0.2	1.9	0.8	23.1	24.3	11.3	7.8	18.3	12.4	24.2	4.6	6.0	4.9	9.0	25.4	15.8	7.7	3.8	3.5	19.4	10.9	21.3	0.9	3.6	47.4	16.0	18.2	33.9	5.2	8.6	2.4	11.9	5.6	12.5	2.9	5.5	24.1	6.9	1.7	40.1	9.4	13.7	21.9	14.2	8.3	6.4	15.3	5.5	29.7	28.1	15.6	6.8	152.8	12.4	27.2	16.5	9.6	7.2	14.8	5.9	11.0	9.3	2.0	8.0	4.3	9.4	10.6	0.0	0.8	0.0	1.2	0.5	0.7	0.5	1.9	1.4	1.4	0.2	0.7	0.6	0.0	0.2	0.4	1.1	0.6	0.8	8.2	11.5	19.1	23.0	7.9	6.7	7.3	11.5	21.7	8.8
FFAR3	"FFA3R, GPR41"	ENSG00000185897	"Free fatty acid receptor 3"	O14843	19	35358460-35360485	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 6.5;blood: 5.6;lymphoid tissue: 6.1"	"Group enriched"	"Detected in some"	5	"ASC diff: 1.1;HHSteC: 3.8;HSkMC: 3.3;U-937: 1.4"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	5	"eosinophil: 4.7;neutrophil: 5.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 5.6"									HPA044681	Uncertain									"HPA044681: AB_2679043"	"unprognostic (1.15e-1)"		"unprognostic (5.16e-3)"		"unprognostic (1.45e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.21e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.92e-4)"	"unprognostic (3.80e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.04e-3)"	"unprognostic (2.18e-2)"	"unprognostic (3.41e-1)"	"unprognostic (3.22e-2)"	6.5	0.0	0.1	6.1	0.3	1.7	3.8	0.0	0.2	0.0	2.1			0.7	0.0	0.0	0.0	0.5	1.1	0.2	0.4	0.2	0.0	0.5	0.6	0.4	0.5		0.3	1.0	0.4	0.5	0.9		0.2	0.1		0.0	0.0	0.0	0.0	0.9	3.7	1.5	2.4	1.3	0.0			0.9		0.0	0.7	0.0	0.0	0.1	5.6	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.4	0.0	0.1	4.7	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.6	0.0	0.3	0.0	0.0	0.2										
FGF16	MF4	ENSG00000196468	"Fibroblast growth factor 16"	O43320	X	77447405-77457278	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 3.2;seminal vesicle: 4.2"	"Cell line enriched"	"Detected in some"	5	"U-2197: 22.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"cerebral cortex: 1.5;hypothalamus: 1.1;pons and medulla: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"basal ganglia: 3.7;hippocampal formation: 2.2;olfactory region: 8.3"	"Not detected"	"Not detected"								"Secreted in other tissues"						"unprognostic (4.01e-2)"					"unprognostic (5.30e-2)"		"unprognostic (1.12e-1)"		"unprognostic (1.10e-1)"	"unprognostic (1.28e-1)"			"unprognostic (2.31e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.49e-2)"		3.2	0.0	0.2	0.1	0.2	0.0	2.3	0.1	1.5	0.1	0.5	0.7	0.1	0.0	1.2	0.6	0.5	0.4	0.7	1.0	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.1	0.1	1.8	0.1	0.2	0.1	0.5	4.2	1.3	0.4	0.4	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.1	0.1	2.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	1.5	0.1	1.1	0.1	0.1	1.8	0.1
FMO2		ENSG00000094963	"Flavin containing monooxygenase 2"	Q99518	1	171185208-171211230	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 40.0;esophagus: 35.3;lung: 53.0"	"Group enriched"	"Detected in some"	57	"ASC diff: 24.0;ASC TERT1: 10.9;HSkMC: 28.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			HPA028261	Approved									"HPA028261: AB_10601012"	"unprognostic (1.85e-2)"	"unprognostic (3.14e-2)"	"unprognostic (7.44e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.00e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.28e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.26e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.83e-2)"	40.0	11.8	1.2	1.7	4.4	0.0	22.5	1.5	0.6	7.6	5.0	0.6	2.9	0.3	1.9	3.5	35.3	6.7	2.0	17.4	1.8	1.2	9.4	1.8	53.0	5.7	3.9	1.2	6.1	2.1	1.8	7.0	0.0	2.4	6.0	0.7	8.3	14.0	1.3	7.6	1.7	1.5	2.5	1.9	0.4	2.4	3.3	1.3	0.4	5.8	6.8	5.5	5.0	10.2	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	28.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.2	4.4	1.5	0.6	1.8	1.2	3.9	1.2	2.4	1.3
FPR3	"FMLPY, FPRH1, FPRL2, RMLP-R-I"	ENSG00000187474	"Formyl peptide receptor 3"	P25089	19	51795163-51826189	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 35.9"	"Cell line enriched"	"Detected in some"	7	"HEL: 14.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	20	"classical monocyte: 3.2;intermediate monocyte: 9.6;myeloid DC: 3.4"	"Group enriched"	"Detected in many"	43	"dendritic cells: 3.4;monocytes: 9.6"																				"unprognostic (3.77e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.37e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.17e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavourable (9.13e-4)"	"unprognostic (1.96e-1)"	"unprognostic (4.28e-2)"	35.9	10.0	1.5	12.9	2.1	0.0	6.2	0.6	1.8	3.2	6.6	1.8	0.5	5.9	3.1	7.0	3.4	3.0	10.7	6.3	1.7	1.2	6.8	13.0	25.9	15.1	2.8	0.9	5.4	3.2	0.7	2.2	5.2	2.4	5.0	10.3	4.9	5.1	1.3	4.6	2.3	10.9	4.6	5.2	10.8	3.4	3.3	1.1	8.0	2.7	6.4	10.1	9.3	2.6	0.0	3.4	0.1	9.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	14.6	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.1	0.0	0.7	0.0	0.1	0.0	2.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	3.2	0.0	0.0	9.6	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.6	1.5	2.1	0.6	1.8	1.7	1.2	2.8	0.9	2.4	1.1
FZD4	"CD344, EVR1"	ENSG00000174804	"Frizzled class receptor 4"	Q9ULV1	11	86945679-86955391	"CD markers, Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 75.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 25.4;Hep G2: 31.8;HSkMC: 18.3;HUVEC TERT2: 36.0;TIME: 17.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA042328, HPA074833"	Approved		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA042328: , HPA074833: AB_2686716"	"unprognostic (6.49e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.87e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.97e-2)"	"unprognostic (3.33e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.22e-1)"	"prognostic favourable (8.60e-5)"	"unprognostic (1.05e-2)"	"unprognostic (9.96e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.97e-1)"	75.7	5.3	3.4	6.0	4.8	0.5	57.8	1.5	4.3	11.5	9.0	1.4	32.6	2.0	13.1	13.5	6.3	9.6	8.7	12.5	3.1	2.2	17.0	8.9	19.0	4.7	2.9	3.2	12.8	6.0	4.4	10.1	7.3	5.5	9.3	4.3	20.0	7.1	56.0	17.9	3.7	5.4	8.6	2.8	8.6	8.2	5.5	1.6	0.5	11.4	11.1	3.0	8.3	20.7	0.4	0.2	0.8	0.4	1.4	0.3	0.0	0.5	0.4	1.0	2.0	25.4	6.6	1.4	3.2	2.9	1.2	1.3	2.7	0.3	0.0	0.7	1.0	1.0	1.2	0.5	1.0	0.1	0.8	1.0	0.8	31.8	7.5	0.0	0.0	18.3	0.2	1.1	0.2	36.0	1.4	0.1	0.8	0.8	0.0	0.0	1.5	7.2	0.0	1.9	0.0	3.5	5.2	0.2	0.3	1.3	0.3	0.5	4.6	0.0	17.6	3.0	2.0	3.6	0.6	0.1	0.5	0.0	0.4	0.0	0.8	0.7	0.3	0.1	0.3	0.2	0.1	0.2	0.3	0.2	0.1	0.4	0.2	0.3	0.8	1.4	0.4	0.2	0.0	0.0	3.4	4.8	1.5	4.3	3.1	2.2	2.9	3.2	5.5	1.6
GALNT15	"GALNT7, GALNTL2, pp-GalNAc-T15"	ENSG00000131386	"Polypeptide N-acetylgalactosaminyltransferase 15"	Q8N3T1	3	16174649-16231992	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 66.7;brain: 52.3"	"Group enriched"	"Detected in some"	5	"ASC diff: 43.8;ASC TERT1: 43.2;HSkMC: 32.9"	"Cancer enriched"	"Detected in many"	5	"glioma: 21.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"cerebellum: 10.7;pons and medulla: 6.7"	"Low region specificity"	"Detected in all"			HPA017076	Uncertain		Approved	"Golgi apparatus,Cytosol"	"Intracellular and membrane"	25000	25000	"Golgi apparatus"	"Golgi apparatus"	"HPA017076: AB_1849458"	"unprognostic (3.87e-1)"	"unprognostic (4.84e-4)"	"unprognostic (6.39e-2)"	"unprognostic (8.77e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.52e-1)"	"unprognostic (7.40e-4)"	"unprognostic (4.24e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.28e-6)"	"unprognostic (5.13e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.88e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.78e-3)"	66.7	5.3	7.6	2.6	17.4	1.1	22.8	2.3	31.5	3.9	8.6	28.1	1.1	2.8	3.5	3.3	11.4	5.3	5.2	7.3	14.8	6.6	8.3	2.8	3.1	3.4	38.9	8.4	8.4	3.2	1.6	1.0	35.5	24.8	4.9	3.8	1.3	8.0	4.1	17.3	11.6	5.3	10.5	52.3	12.8	4.6	8.1	19.9	0.0	6.3	1.6	1.5	16.6	23.5	0.6	0.9	0.9	0.3	0.3	0.4	0.3	0.0	0.0	0.0	0.0	43.8	43.2	0.0	0.9	0.7	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	32.9	0.0	0.4	0.5	0.6	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.1	7.7	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.5	0.2	0.3	0.2	0.2	0.1	0.4	0.2	0.3	0.0	0.6	0.4	0.2	0.9	0.3	0.3	0.9	0.3	0.3	7.6	17.4	2.3	13.6	14.8	6.6	38.9	8.4	24.8	19.9
GFPT2	GFAT2	ENSG00000131459	"Glutamine-fructose-6-phosphate transaminase 2"	O94808	5	180300690-180353387	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 65.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 24.0;ASC TERT1: 41.2;HSkMC: 26.4;hTEC/SVTERT24-B: 49.0;U-87 MG: 85.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 7.1"	"Lineage enriched"	"Detected in single"	49	"T-cells: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056892, HPA059910"	Uncertain		Supported	Vesicles				Vesicles	Vesicles	"HPA056892: AB_2683266, HPA059910: AB_2684157"	"unprognostic (3.48e-1)"	"prognostic unfavourable (9.09e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.28e-2)"	"unprognostic (3.39e-3)"	"unprognostic (3.05e-1)"	"prognostic unfavourable (2.95e-4)"	"unprognostic (7.65e-2)"	"unprognostic (2.73e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.94e-2)"	"prognostic unfavourable (2.58e-14)"	"unprognostic (3.67e-3)"	"unprognostic (1.23e-2)"	"prognostic unfavourable (3.47e-4)"	"unprognostic (1.52e-3)"	65.6	3.9	4.5	15.8	5.6	0.9	11.0	17.0	9.2	10.0	9.2	9.3	5.4	2.1	9.0	16.7	5.9	15.9	14.6	16.4	7.1	3.8	2.8	2.6	11.0	3.1	6.2	6.8	17.5	11.1	3.5	2.5	6.0	8.4	7.7	3.6	2.9	4.0	8.0	6.0	4.0	5.0	10.0	17.2	1.7	6.6	6.3	7.7	0.0	5.6	5.4	3.5	14.3	14.6	0.0	0.1	0.0	0.0	0.1	7.1	0.2	0.0	5.3	4.2	5.4	24.0	41.2	0.4	0.6	0.1	0.4	0.1	0.1	0.0	0.0	0.2	4.4	0.0	2.3	0.0	0.2	0.5	0.8	0.0	2.6	0.0	10.0	0.0	0.0	26.4	0.2	49.0	0.1	7.9	0.0	0.0	21.0	0.7	0.0	0.0	9.0	2.4	0.1	0.0	0.0	0.0	0.0	0.2	0.3	8.3	0.1	0.3	0.3	0.0	3.7	13.5	2.1	8.7	9.9	0.0	0.0	0.0	85.2	0.0	0.3	0.0	0.0	0.0	1.4	0.0	7.1	0.0	0.8	2.4	0.1	0.0	0.8	1.1	0.0	0.1	0.0	0.1	0.0	0.2	4.5	5.6	17.0	9.2	7.1	3.8	6.2	6.8	8.4	7.7
GFRAL	"bA360D14.1, C6orf144, GRAL, UNQ9356"	ENSG00000187871	"GDNF family receptor alpha like"	Q6UXV0	6	55327469-55402493	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 1.9;blood: 2.2;liver: 2.4"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.6;Karpas-707: 1.5"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"neutrophil: 2.2"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	10	"pons and medulla: 0.3"	"Low region specificity"	"Detected in many"			HPA047372	Uncertain									"HPA047372: AB_2680017"															"unprognostic (2.31e-1)"			1.9	0.0	0.1	0.3	0.1	0.4	0.6	0.2	0.2	0.0	0.0			0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.2	0.1		0.1	0.0	0.0	0.1	0.0		0.0	0.4		0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.9			0.0		0.1	0.0	0.0	1.2	0.7	2.2	0.6	0.6	0.3	0.0	0.0	0.4	0.1	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.3	0.0	0.0	0.1	0.8	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.5	0.3	0.1	0.8	0.6	0.2	0.2	0.1	0.1	0.8	0.2	0.1	0.0	1.2	0.3	0.3	2.2	0.6	0.2	0.7	0.0	0.0										
GPAM	"GPAT1, KIAA1560, MGC26846"	ENSG00000119927	"Glycerol-3-phosphate acyltransferase, mitochondrial"	Q9HCL2	10	112149864-112215377	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 107.3;liver: 56.6"	"Cell line enhanced"	"Detected in all"		"ASC diff: 75.2;Hep G2: 20.2"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 20.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046339, HPA060090"	Approved		Approved	Mitochondria				Mitochondria	Mitochondria	"HPA046339: AB_2679627, HPA060090: AB_2684202"	"unprognostic (1.82e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.80e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.16e-2)"	"unprognostic (4.59e-1)"	"unprognostic (4.80e-1)"	"unprognostic (2.37e-2)"	"unprognostic (5.44e-2)"	"prognostic favourable (4.54e-6)"	"unprognostic (2.84e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.37e-1)"	107.3	17.2	11.4	2.6	12.1	1.8	30.8	6.6	11.0	2.0	3.2	6.5	5.1	2.2	4.1	32.1	2.4	1.9	3.0	5.8	12.2	2.9	2.4	56.6	2.2	2.3	7.2	7.3	3.5	2.8	3.2	2.3	1.8	5.6	2.3	2.6	12.0	6.8	2.9	3.6	1.8	3.3	3.4	3.8	1.7	2.4	2.8	7.2	2.8	6.1	2.4	2.3	3.2	1.6	3.2	2.0	0.5	1.2	1.1	3.4	1.0	2.7	2.1	2.8	3.7	75.2	2.7	3.7	2.6	3.0	1.9	1.5	4.9	1.6	1.9	1.4	1.8	3.5	4.5	2.2	3.6	1.4	2.4	1.8	2.3	20.2	2.3	3.1	1.0	13.1	3.8	3.4	7.0	1.6	2.3	1.7	2.2	1.5	2.6	2.4	2.3	2.9	2.7	7.4	1.4	1.2	1.9	1.2	3.6	3.6	1.7	4.1	1.8	1.1	1.2	2.2	1.3	2.7	4.2	1.8	2.0	4.1	2.6	2.7	1.6	0.0	1.0	0.5	2.5	1.2	3.2	1.9	1.9	1.9	1.2	3.2	2.0	3.4	0.0	1.1	1.0	2.0	1.9	1.0	11.4	12.1	6.6	11.0	12.2	2.9	7.2	7.3	5.6	7.2
GPD1		ENSG00000167588	"Glycerol-3-phosphate dehydrogenase 1"	P21695	12	50103819-50111319	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 116.3;skeletal muscle: 106.9"	"Cell line enriched"	"Detected in some"	4	"ASC diff: 52.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044620	Enhanced					3800000	3800000			"HPA044620: AB_10796803"	"unprognostic (2.65e-2)"	"unprognostic (5.60e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.45e-3)"	"unprognostic (7.19e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.24e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.58e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-2)"	116.3	1.2	2.4	3.6	3.0	0.3	44.9	1.6	3.9	0.3	13.4	12.2	0.4	16.2	0.3	3.0	1.2	0.3	8.1	3.9	4.3	2.7	30.6	31.4	4.0	1.6	6.8	1.2	0.2	1.8	2.3	0.3	0.2	13.5	0.5	0.9	0.1	17.7	0.5	106.9	2.0	23.5	0.5	24.7	0.2	0.8	0.3	2.0	0.0	0.7	14.1	0.3	1.1	0.3	0.7	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	52.2	0.0	0.1	0.0	0.0	0.0	0.0	10.5	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	9.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.6	0.1	0.0	0.2	0.0	0.0	0.6	0.3	0.7	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.4	3.0	1.6	3.9	4.3	2.7	6.8	1.2	13.5	2.0
GPIHBP1	"GPI-HBP1, LOC338328"	ENSG00000277494	"Glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1"	Q8IV16	8	143213193-143217170	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 47.6;brain: 18.5"	"Cell line enriched"	"Detected in some"	5	"Karpas-707: 8.4"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA066302	Enhanced				"Intracellular and membrane"					"HPA066302: AB_2685654"	"unprognostic (2.05e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.43e-3)"	"unprognostic (1.58e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.75e-3)"	"unprognostic (8.01e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.31e-2)"	"unprognostic (8.69e-2)"	"unprognostic (5.06e-3)"	"unprognostic (9.65e-3)"	"unprognostic (1.41e-1)"	"unprognostic (5.96e-2)"	"unprognostic (2.85e-3)"	47.6	2.2	0.0	0.3	11.5	0.1	9.0	0.6	7.5	1.6	1.7	17.9	0.0	0.4	1.6	0.2	2.0	2.2	3.7	8.3	2.1		2.6	0.7	13.0	1.3	18.5	2.9	1.9	0.6	0.3	0.0	4.0	9.7	0.7	0.4	1.1	0.5	1.1	16.0	1.6	0.3	1.5	12.8	4.2	0.4	1.4	10.2	0.0	0.6	0.4	0.7	1.5	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.8	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GPNMB	"HGFIN, NMB"	ENSG00000136235	"Glycoprotein nmb"	Q14956	7	23235967-23275108	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 137.7"	"Cell line enriched"	"Detected in many"	5	"ASC diff: 322.8"	"Cancer enhanced"	"Detected in all"		"melanoma: 354.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 3.8;intermediate monocyte: 7.1"	"Lineage enriched"	"Detected in many"	6	"monocytes: 7.1"	"Region enhanced"	"Detected in some"		"olfactory region: 12.1"	"Low region specificity"	"Detected in some"								"Intracellular and membrane"	41000000	41000000				"unprognostic (3.37e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.16e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.89e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.83e-1)"	"unprognostic (6.40e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.82e-1)"	"unprognostic (6.95e-2)"	137.7	4.3	7.7	9.5	5.9	0.7	33.8	1.0	5.5	56.0	20.7	7.9	9.2	3.5	56.5	34.6	32.6	17.3	45.8	50.0	5.5	2.8	10.8	8.9	58.7	24.1	4.4	5.0	39.7	4.0	0.3	3.7	52.7	18.2	24.8	15.7	115.7	18.1	9.8	11.3	97.2	12.1	26.2	15.7	8.4	11.2	19.8	1.5	20.6	14.0	31.7	26.7	33.4	41.9	0.4	0.8	1.2	7.1	0.3	0.2	0.8	1.1	0.0	0.0	0.0	322.8	58.8	0.0	2.0	35.0	1.7	7.4	0.0	0.0	0.0	0.0	6.6	7.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	3.9	0.0	0.0	40.4	8.4	2.9	0.3	0.0	0.0	0.0	9.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.4	27.3	0.1	0.0	0.0	10.9	50.3	0.1	0.1	0.0	10.3	1.1	18.7	0.3	0.3	0.5	0.0	3.6	0.1	10.3	0.9	3.8	0.1	0.2	7.1	0.1	0.2	0.0	0.0	0.8	0.4	0.2	0.1	1.2	0.3	0.3	0.8	0.1	0.8	7.7	5.9	1.0	5.5	5.5	2.8	4.4	5.0	18.2	1.5
GPR42	"FFAR3L, GPR41L, GPR42P"	ENSG00000126251	"G protein-coupled receptor 42 (gene/pseudogene)"	O15529	19	35370929-35372962	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 2.3;blood: 2.1;intestine: 2.1"	"Cell line enhanced"	"Detected in single"		"RPMI-8226: 1.1"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	5	"eosinophil: 1.9;neutrophil: 2.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.1"									HPA044681	Uncertain									"HPA044681: AB_2679043"											"unprognostic (1.73e-3)"			"unprognostic (1.31e-4)"				2.3	0.0	0.0	1.5	0.1	0.1	1.2	0.0	0.2	0.0	1.7			0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1		0.0	0.1	1.3	0.1	0.4		0.1	0.3		0.0	0.0	0.0	0.0	2.1	0.2	0.4	0.8	1.3	0.0			0.5		0.0	0.3	0.0	0.0	0.1	2.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.9	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.3	0.0	0.0	0.0										
GRIFIN		ENSG00000275572	"Galectin-related inter-fiber protein"	A4D1Z8	7	2474844-2476894	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 1.6;skin 1: 3.4"	"Cell line enhanced"	"Detected in single"		"HMC-1: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																		"unprognostic (1.18e-2)"			"unprognostic (2.98e-2)"		"unprognostic (1.36e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.68e-2)"	"unprognostic (4.31e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.73e-1)"			1.6	0.7		0.0		0.8	0.0		0.1	0.5	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.4			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.2	3.4	0.0	0.0		0.1	0.0	0.2			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GRK3	"ADRBK2, BARK2"	ENSG00000100077	"G protein-coupled receptor kinase 3"	P35626	22	25564849-25729294	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 28.0"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 22.6;SH-SY5Y: 20.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"classical monocyte: 4.8;eosinophil: 5.6;intermediate monocyte: 8.0;memory B-cell: 4.9;myeloid DC: 3.7;naive B-cell: 6.2;non-classical monocyte: 7.4;plasmacytoid DC: 3.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000804	Uncertain		Approved	"Nucleoplasm,Plasma membrane"				Nucleoplasm	Nucleoplasm	"HPA000804: AB_1078281"	"unprognostic (1.02e-1)"	"unprognostic (4.38e-2)"	"unprognostic (5.68e-3)"	"unprognostic (4.33e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.95e-3)"	"unprognostic (5.79e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.89e-2)"	"prognostic favourable (1.29e-4)"	28.0	6.0	11.9	12.4	10.8	7.0	11.3	7.9	18.9	4.7	4.0	3.1	0.7	3.0	5.7	3.1	2.7	9.1	5.0	4.6	15.7	8.3	3.0	3.4	9.4	14.1	9.7	9.8	4.1	8.4	4.4	8.2	4.5	9.6	8.2	4.3	4.8	3.7	1.9	1.4	4.1	6.1	6.2	4.9	23.2	4.0	14.8	2.7	11.6	4.5	1.3	15.2	6.7	2.5	6.2	3.7	5.6	8.0	0.0	0.4	1.6	0.0	2.1	6.5	2.1	4.5	0.6	9.4	0.7	2.0	2.0	3.5	3.4	3.7	11.8	0.2	0.1	0.1	6.4	4.8	6.1	22.6	4.2	5.4	0.7	7.4	0.2	17.5	9.2	1.1	3.3	1.4	2.5	0.3	0.5	0.0	2.4	2.9	12.5	1.2	4.6	0.0	5.6	10.3	2.0	0.0	3.5	15.1	20.5	1.1	0.0	4.9	1.8	7.0	0.2	0.0	13.3	0.1	2.5	1.4	4.6	9.2	8.7	6.2	2.0	0.6	4.8	5.6	0.0	8.0	0.3	4.9	0.0	0.3	3.7	6.2	0.1	0.2	0.3	0.0	7.4	3.2	0.4	1.6	11.9	10.8	7.9	18.9	15.7	8.3	9.7	9.8	9.6	2.7
HAS1	HAS	ENSG00000105509	"Hyaluronan synthase 1"	Q92839	19	51713112-51723994	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 23.7;lymphoid tissue: 13.7;ovary: 23.6"	"Cell line enriched"	"Detected in some"	4	"U-87 MG: 49.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"eosinophil: 5.9;neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 5.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA067602	Approved		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA067602: AB_2685871"	"unprognostic (3.56e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.26e-4)"	"unprognostic (7.17e-3)"	"unprognostic (7.05e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.49e-4)"	"unprognostic (4.80e-2)"	"unprognostic (1.99e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.30e-11)"	"unprognostic (9.12e-4)"	"unprognostic (8.99e-2)"	"unprognostic (3.73e-4)"	"unprognostic (2.43e-2)"	23.7	0.5	0.6	13.7	1.3	2.8	1.0	1.5	1.9	0.6	1.2	0.4	1.1	0.1	0.8	2.5	1.3	5.8	5.5	5.9	1.4	2.0	0.3	0.6	4.5	0.3	0.6	0.3	23.6	2.2	0.0	0.3	0.3	0.6	0.4	0.5	1.0	0.3	1.2	2.1	2.7	4.0	3.6	0.9	0.7	0.7	0.9	0.3	0.3	0.3	0.8	0.3	1.8	0.3	0.1	0.1	5.9	0.1	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.0	11.7	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	49.8	0.0	0.1	0.0	0.1	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	1.6	0.0	0.0	0.1	0.0	0.1	0.6	1.3	1.5	1.7	1.4	2.0	0.6	0.3	0.6	0.3
HAS2		ENSG00000170961	"Hyaluronan synthase 2"	Q92819	8	121612116-121641390	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 22.8"	"Group enriched"	"Detected in some"	4	"HBF TERT88: 33.9;hTEC/SVTERT24-B: 32.6;LHCN-M2: 43.3;U-138 MG: 85.2;U-251 MG: 25.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA052060			Approved	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA052060: AB_2681712"	"unprognostic (7.01e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.91e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.57e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.19e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.66e-7)"	"unprognostic (1.47e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.54e-3)"	22.8	0.9	1.6	9.1	2.4	0.0	5.5	0.8	1.7	4.0	8.5	2.0	0.0	2.6	1.5	2.5	4.8	3.9	7.7	8.3	1.7	1.7	1.2	2.7	6.5	4.5	1.8	0.6	1.2	1.8	0.3	0.7	2.1	5.7	4.3	5.6	2.7	1.9	0.1	2.7	3.8	9.5	3.7	4.2	0.3	2.3	3.2	2.6	0.4	1.7	5.5	2.1	5.7	1.4	0.0	0.2	0.7	0.2	0.3	0.1	0.0	0.0	0.5	0.0	0.0	1.0	2.5	0.0	4.8	3.6	6.3	11.0	0.0	0.0	0.0	0.0	4.3	0.8	0.0	0.0	33.9	0.0	0.1	0.0	0.1	0.0	4.3	0.0	0.0	6.7	0.0	32.6	3.0	0.0	0.0	0.0	43.3	0.0	0.0	0.0	0.0	0.7	0.0	5.6	0.0	0.0	0.4	0.0	0.1	2.0	0.0	1.1	0.0	0.0	0.0	85.2	0.3	7.9	25.2	0.0	0.0	0.0	1.8	0.0	1.7	0.5	0.2	0.2	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.7	0.3	0.2	0.2	0.1	0.0	1.6	2.4	0.8	1.7	1.7	1.7	1.8	0.6	5.7	2.6
HOXC12	"HOC3F, HOX3, HOX3F"	ENSG00000123407	"Homeobox C12"	P31275	12	53954834-53958956	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 3.0;lymphoid tissue: 8.1;skin 1: 6.0"	"Cell line enhanced"	"Detected in some"		"HaCaT: 21.8;K-562: 6.0;SiHa: 4.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055632	Uncertain									"HPA055632: AB_2682867"	"unprognostic (6.95e-2)"	"unprognostic (2.34e-2)"				"unprognostic (1.10e-1)"		"unprognostic (4.37e-2)"	"unprognostic (5.98e-2)"			"unprognostic (1.45e-1)"	"unprognostic (1.17e-3)"	"unprognostic (3.84e-2)"	"unprognostic (2.55e-1)"			3.0	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.8	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.5	6.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	21.8	0.0	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	1.1	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HOXC9	"HOX3, HOX3B"	ENSG00000180806	"Homeobox C9"	P31274	12	53994895-54003337	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 18.9;skeletal muscle: 28.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 14.4;HDLM-2: 18.3;HEK 293: 22.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA063965, HPA072160"			Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA063965: AB_2685162, HPA072160: AB_2686491"	"unprognostic (2.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.19e-5)"	"unprognostic (1.23e-1)"	"unprognostic (4.09e-3)"	"unprognostic (7.12e-2)"	"unprognostic (6.92e-3)"	"unprognostic (1.06e-3)"	"unprognostic (4.32e-1)"	"unprognostic (1.58e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.08e-2)"	"unprognostic (9.85e-2)"	"unprognostic (8.33e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.53e-1)"	18.9	2.5	0.0	1.2	0.0	0.1	12.8	0.0	0.1	0.5	0.2	0.0	0.4	0.1	1.7	7.8	0.3	6.3	0.1	0.1	0.0	0.0	12.2	0.1	0.1	4.3	0.0	0.0	5.6	1.0	0.1	0.0	2.0	0.0	0.9	0.1	0.0	0.5	0.2	28.3	5.7	4.4	1.2	0.5	0.1	0.1	4.3	0.0	0.1	0.2	0.2	0.3	1.3	1.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	2.2	0.0	14.4	5.8	4.8	1.0	1.5	1.3	1.9	1.2	0.6	2.2	0.0	1.1	5.7	2.6	0.3	1.5	1.6	18.3	22.3	0.4	3.3	0.5	0.6	0.0	3.3	5.4	2.5	2.8	1.3	1.8	4.5	0.0	3.8	1.6	0.0	1.3	0.0	0.2	0.2	2.8	0.0	4.3	1.4	0.0	4.2	5.2	2.8	5.7	4.3	0.2	0.0	3.4	6.1	1.0	1.7	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HRCT1	"LGLL338, PRO537, UNQ338"	ENSG00000196196	"Histidine rich carboxyl terminus 1"	Q6UXD1	9	35906192-35907141	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 25.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 13.5;HBEC3-KT: 7.4;HeLa: 11.1;Hep G2: 8.3;U-2197: 20.0;U-251 MG: 9.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			HPA067038			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA067038: AB_2685767"	"unprognostic (2.48e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.49e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (3.62e-4)"	"unprognostic (6.63e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.00e-1)"	"unprognostic (9.41e-2)"	"unprognostic (2.80e-1)"	"unprognostic (9.43e-2)"	25.3	1.9	1.9	3.6	2.8	0.4	21.4	0.9	3.4	5.3	16.8	1.8	1.4	11.2	4.2	3.9	6.6	3.5	2.1	7.6	2.6	1.6	17.6	1.8	5.2	5.0	2.4	2.3	2.2	1.6	0.3	0.7	4.7	3.6	3.6	14.8	5.8	4.6	4.0	6.1	4.2	14.3	6.5	1.5	0.8	2.5	5.3	1.4	0.0	3.5	1.2	1.5	4.6	3.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.6	4.5	0.0	0.1	0.4	0.1	0.0	0.1	1.2	0.0	13.5	0.3	0.0	0.0	7.4	0.0	0.0	0.0	0.0	11.1	8.3	1.7	0.0	0.0	4.4	3.8	1.5	0.9	4.6	0.0	0.0	2.0	0.0	0.0	0.0	0.1	1.8	0.0	0.2	0.0	2.4	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	3.8	0.2	4.0	20.0	9.3	0.0	0.0	0.0	2.3	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.8	0.9	3.4	2.6	1.6	2.4	2.3	3.6	1.4
IL6	"BSF2, HGF, HSF, IFNB2, IL-6"	ENSG00000136244	"Interleukin 6"	P05231	7	22725884-22732002	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 60.1;lymphoid tissue: 48.0"	"Cell line enriched"	"Detected in some"	5	"BJ hTERT+: 221.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 10.0;cerebral cortex: 4.4;hippocampal formation: 3.9;pons and medulla: 12.8"	"Group enriched"	"Detected in some"	70	"memory B-cell: 6.1;naive B-cell: 7.7"	"Lineage enriched"	"Detected in single"	77	"B-cells: 7.7"					"Not detected"	"Not detected"			"CAB023406, CAB072821"	Supported		Approved	Vesicles	"Secreted to blood"			Vesicles	Vesicles	"CAB023406: AB_617317, CAB072821: "	"unprognostic (1.13e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.59e-2)"	"unprognostic (9.88e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.07e-3)"	"unprognostic (3.25e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.48e-2)"	"unprognostic (8.57e-2)"	"prognostic unfavourable (1.10e-11)"	"unprognostic (2.45e-3)"	"unprognostic (2.10e-1)"	"unprognostic (4.31e-2)"	"unprognostic (7.80e-2)"	60.1	5.6	1.4	48.0	10.0	15.3	11.5	0.7	4.4	2.9	8.1	1.2	0.4	0.7	2.1	4.6	14.3	7.8	16.1	21.6	3.9	1.5	1.3	5.2	34.9	3.0	1.8	0.2	5.3	8.3	5.7	14.2	4.5	12.8	6.5	7.5	3.3	3.1	0.8	6.9	2.8	4.5	8.2	7.0	3.5	6.5	3.2	1.2	0.1	4.5	12.7	3.5	34.9	8.4	7.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.8	221.9	4.2	14.2	0.0	0.0	0.0	7.3	1.4	0.1	0.0	0.0	5.6	8.7	0.0	0.0	0.3	0.0	4.7	0.0	0.0	0.5	0.0	42.4	6.1	1.5	0.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	14.4	0.0	0.0	0.0	0.0	1.3	1.4	0.1	2.6	0.4	0.0	2.5	0.0	10.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	10.0	0.7	4.4	3.9	1.5	1.8	0.2	12.8	1.2
INHBB		ENSG00000163083	"Inhibin beta B subunit"	P09529	2	120346143-120351808	"Cancer-related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 23.3"	"Cell line enhanced"	"Detected in some"		"A549: 15.1;ASC diff: 21.0;MCF7: 18.2;PC-3: 29.6;SK-BR-3: 52.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	14	"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"						"unprognostic (7.80e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavourable (1.44e-4)"	"unprognostic (1.26e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.61e-3)"	"unprognostic (2.13e-2)"	"unprognostic (5.52e-2)"	"unprognostic (6.99e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavourable (3.02e-4)"	"unprognostic (1.57e-3)"	"unprognostic (4.14e-1)"	"prognostic favourable (1.02e-4)"	"unprognostic (1.76e-2)"	23.3	3.6	6.0	1.2	3.5	0.2	19.2	0.9	3.8	7.0	0.8	3.1	2.6	1.3	3.9	2.6	1.5	3.3	2.4	3.5	4.7	1.4	1.2	19.2	2.7	1.0	2.2	3.1	1.6	3.5	4.5	3.8	1.2	4.7	7.7	0.3	0.5	7.8	0.9	4.9	7.6	0.9	2.1	1.9	0.4	1.8	14.4	2.2	0.4	19.1	1.6	1.3	4.4	7.8	0.0	0.0	1.3	0.0	0.0	0.0	0.0	7.6	15.1	0.0	0.0	21.0	1.6	0.0	1.0	1.2	6.8	12.7	0.3	0.0	0.0	2.7	0.3	0.0	1.2	0.0	9.5	0.0	0.2	0.0	0.0	0.3	0.3	0.0	0.0	0.8	1.1	0.2	0.0	0.1	0.0	0.0	0.0	18.2	0.0	0.0	0.0	29.6	0.0	0.0	0.3	1.8	0.0	1.7	0.0	0.0	52.9	0.0	12.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	6.0	3.5	0.9	3.7	4.7	1.4	2.2	3.1	4.7	2.2
IRX6	"IRX-3, IRX7"	ENSG00000159387	"Iroquois homeobox 6"	P78412	16	55323760-55330760	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 11.1;breast: 18.9;heart muscle: 11.1;skin 1: 9.3"	"Cell line enhanced"	"Detected in some"		"AF22: 2.4;HEK 293: 2.8;RPTEC TERT1: 10.4;SK-MEL-30: 6.6"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.9"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.1"	"Lineage enriched"	"Detected in single"	11	"B-cells: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA018332	Uncertain		Approved	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"	"Nucleoplasm, Mitochondria"	"HPA018332: AB_1851920"	"unprognostic (1.22e-1)"	"unprognostic (1.02e-1)"		"unprognostic (4.93e-4)"	"unprognostic (2.48e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.46e-1)"	"prognostic favourable (3.34e-4)"	"unprognostic (3.63e-2)"	"unprognostic (4.36e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.83e-2)"	"unprognostic (9.63e-3)"	"unprognostic (7.12e-3)"	"unprognostic (5.48e-2)"	"unprognostic (5.23e-3)"	11.1	0.0	0.2	0.2	1.4	0.0	18.9	0.2	0.5	3.3	0.2	0.2	0.2	0.0	0.6	0.2	0.5	0.0	0.2	11.1	0.2	0.4	1.5	0.2	2.3	0.2	0.2	0.2	0.5	0.2	0.1	0.2	0.2	0.2	0.2	0.0	2.0	2.5	0.2	2.7	9.3	0.2	0.2	0.2	1.6	0.0	0.6	0.2	3.5	0.7	0.2	2.3	0.2	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	0.0	10.4	0.0	0.2	0.1	0.1	1.7	6.6	0.6	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.2	0.5	0.2	0.4	0.2	0.2	0.2	0.2
ITGAX	CD11c	ENSG00000140678	"Integrin subunit alpha X"	P20702	16	31355134-31382997	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 47.9;blood: 31.7;lung: 33.2;lymphoid tissue: 46.3"	"Cell line enriched"	"Detected in some"	6	"HMC-1: 48.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 10.1;eosinophil: 9.2;intermediate monocyte: 18.1;myeloid DC: 12.4;neutrophil: 31.7;NK-cell: 14.9;non-classical monocyte: 20.3"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB004458, HPA004723, CAB072871"	Enhanced									"CAB004458: AB_626859, CAB072871: AB_2665723, HPA004723: AB_1846231"	"unprognostic (9.75e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.59e-2)"	"unprognostic (8.06e-3)"	"unprognostic (3.20e-1)"	"unprognostic (7.75e-2)"	"unprognostic (3.34e-1)"	"prognostic unfavourable (1.37e-4)"	"unprognostic (3.92e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.95e-2)"	47.9	1.9	4.4	28.1	5.7	28.6	2.9	1.4	4.4	1.8	2.1	17.1	0.6	1.7	2.1	2.5	1.9	4.3	7.7	2.5	5.3	4.6	2.3	4.6	33.2	24.4	13.6	3.8	3.0	2.1	0.8	2.4	3.3	8.1	2.5	3.2	2.5	4.3	1.3	1.1	1.6	3.8	3.3	15.6	46.3	3.3	0.9	7.5	3.8	2.2	0.9	9.7	5.1	1.9	0.8	12.4	31.7	20.3	14.9	1.8	3.2	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.1	0.0	0.0	0.0	0.1	0.0	8.1	0.0	0.0	0.1	0.1	0.0	0.4	48.1	0.0	0.0	0.7	0.1	0.4	0.0	0.1	0.0	0.0	0.0	3.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.4	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.2	0.7	0.1	3.9	10.1	9.2	1.8	18.1	0.1	0.8	0.0	0.3	12.4	0.4	0.0	0.2	31.7	14.9	20.3	0.2	0.0	3.2	4.4	5.7	1.4	4.4	5.3	4.6	13.6	3.8	8.1	7.5
KIF25	KNSL3	ENSG00000125337	"Kinesin family member 25"	Q9UIL4	6	167996241-168045089	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 6.2;brain: 9.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.1;HDLM-2: 5.1;HMC-1: 2.7;SiHa: 2.2;U-266/84: 3.1;U-937: 3.0;WM-115: 2.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.3"					"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in many"			HPA046153	Uncertain									"HPA046153: AB_10960550"	"unprognostic (1.11e-1)"	"unprognostic (9.32e-3)"	"unprognostic (1.39e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.66e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.45e-1)"	"unprognostic (7.08e-5)"	"unprognostic (1.55e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.77e-3)"	6.2	0.0	2.0	0.2	3.1	0.1	1.3	9.9	2.7	0.2	0.3			0.2	0.1	0.9	0.0	0.6	1.5	1.9	2.7	2.3	0.0	0.3	0.3	0.9	3.5		2.0	0.0	0.0	0.0	1.9		0.8	1.1		1.0	0.1	3.1	2.0	0.2	0.2	3.1	0.8	0.3	1.6			0.0		0.3	1.6	0.0	0.7	0.3	1.7	0.3	0.1	0.2	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.3	0.5	0.0	0.0	0.0	2.1	0.0	0.2	0.7	0.0	0.0	0.0	0.0	1.7	5.1	0.8	0.0	0.3	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.8	0.0	0.0	0.2	0.5	0.1	0.5	1.5	0.1	0.0	0.8	0.2	0.5	2.2	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.1	0.1	3.1	0.1	0.1	3.0	2.2	1.7	0.3	0.9	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.7	0.2	0.2	1.4	0.1	0.2	0.3	0.1	0.1										
KLF14	BTEB5	ENSG00000266265	"Kruppel like factor 14"		7	130731235-130734061	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"adipose tissue: 2.3;pancreas: 1.8;placenta: 2.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.9;BJ hTERT+: 3.9;RH-30: 4.3;SK-MEL-30: 1.7"	"Cancer enriched"	"Detected in single"	6	"melanoma: 1.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA044729	Uncertain									"HPA044729: AB_10960356"	"unprognostic (4.49e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.53e-1)"		"unprognostic (1.92e-1)"		"unprognostic (9.90e-3)"	"unprognostic (7.98e-2)"	"unprognostic (5.30e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.03e-3)"	"unprognostic (3.63e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.24e-2)"	2.3	1.7		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.4	0.0	0.0	0.2	0.0	0.0			0.0	0.0	0.0	0.0			0.2	1.8	0.0		2.9		0.0	0.0		0.0	0.0	1.6	0.3	0.0	0.5		0.5	0.0	1.1			0.0		0.0	0.0		0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.1	0.0	2.9	0.8	3.9	1.2	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	4.3	0.0	0.0	0.0	0.7	0.0	0.3	0.0	1.7	0.5	0.0	0.0	0.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRTAP13-4	KAP13.4	ENSG00000186971	"Keratin associated protein 13-4"	Q3LI77	21	30430230-30431026	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 2.3;adrenal gland: 1.5;parathyroid gland: 1.3"	"Cell line enriched"	"Detected in single"	31	"NTERA-2: 3.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																	200000	200000																					2.3	1.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0		0.0	0.0	1.3	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
LBHD2		ENSG00000283071	"LBH domain containing 2"		14	103084210-103090027	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"adipose tissue: 1.9;brain: 1.6;testis: 2.7"	"Cell line enhanced"	"Detected in some"		"EFO-21: 3.5;HeLa: 2.2;Hep G2: 1.1;K-562: 1.0;PC-3: 1.5;RT4: 1.2;SiHa: 1.0"									"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 134.1"																																	1.9	0.0		1.0		0.0	0.0		1.6	0.0	0.2			0.0	0.0	0.3	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.6			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.6	0.0	0.2		0.3	0.0	2.7			0.0		0.1	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.5	1.5	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
LIPA	"CESD, LAL"	ENSG00000107798	"Lipase A, lysosomal acid type"	P38571	10	89213569-89414557	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 139.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 60.3;ASC TERT1: 75.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 31.8;intermediate monocyte: 68.4;myeloid DC: 23.3;non-classical monocyte: 35.6"	"Group enriched"	"Detected in all"	5	"dendritic cells: 23.3;monocytes: 68.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034892, HPA057052"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	150000	150000	Vesicles	Vesicles	"CAB034892: AB_784329, HPA057052: AB_2683322"	"unprognostic (1.27e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.30e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.42e-2)"	"unprognostic (5.71e-2)"	139.0	16.3	15.8	14.4	22.7	7.8	19.9	8.8	21.4	13.4	28.1	61.3	3.4	37.4	10.2	5.2	9.5	9.0	19.4	8.7	22.5	13.8	10.8	49.3	38.5	45.7	41.6	13.4	10.4	9.5	17.5	6.3	17.8	28.4	7.4	16.7	5.7	11.0	8.8	4.1	6.8	65.8	11.3	55.1	87.3	7.9	3.1	37.2	7.0	8.3	4.7	10.0	15.1	8.6	7.0	23.3	3.2	68.4	5.5	8.3	25.5	53.8	8.3	5.5	60.3	56.9	75.6	1.6	28.6	33.5	11.9	21.5	3.2	29.1	9.9	5.6	44.8	54.1	2.4	15.5	8.9	14.0	5.6	4.1	3.5	12.8	15.0	8.0	8.2	33.6	11.1	12.7	6.9	2.3	0.0	18.6	9.3	4.5	6.9	5.4	3.6	9.4	4.5	6.5	9.2	11.0	8.5	1.8	3.8	6.9	9.0	21.0	10.3	10.3	4.3	10.2	2.7	21.8	6.9	9.7	10.2	4.1	12.2	17.6	12.7	0.8	31.8	3.2	8.2	68.4	8.2	6.5	7.3	7.8	23.3	7.0	7.7	8.3	1.4	5.5	35.6	4.7	7.1	25.5	15.8	22.7	8.8	21.4	22.5	13.8	41.6	13.4	28.4	37.2
LPL	LIPD	ENSG00000175445	"Lipoprotein lipase"	P06858	8	19901717-19967258	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 178.6;breast: 146.2;heart muscle: 121.4"	"Cell line enriched"	"Detected in some"	5	"AF22: 89.3"	"Cancer enhanced"	"Detected in all"		"glioma: 39.2"	"Region enhanced"	"Detected in many"		"basal ganglia: 16.3"	"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 7.1"	"Lineage enriched"	"Detected in many"	5	"monocytes: 7.1"	"Region enhanced"	"Detected in many"		"basal ganglia: 40.6"	"Region enriched"	"Detected in all"	4	"basal ganglia: 64.0"	HPA048749			Supported	Vesicles	"Secreted to blood"	880000	880000	Vesicles	Vesicles	"HPA048749: AB_2680511"	"unprognostic (5.52e-2)"	"unprognostic (3.16e-1)"	"unprognostic (6.41e-2)"	"unprognostic (3.03e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.88e-4)"	"unprognostic (1.05e-1)"	"unprognostic (6.78e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.28e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.20e-3)"	"unprognostic (4.16e-3)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (6.07e-4)"	178.6	4.3	2.0	11.4	16.3	0.6	146.2	3.9	8.0	1.0	16.9	0.3	27.3	0.8	1.3	1.1	1.1	0.7	8.2	121.4	2.8	2.3	4.8	0.6	20.7	7.0	4.5	0.7	2.7	1.8	32.6	0.9	7.1	1.7	0.9	1.8	8.4	9.2	85.1	53.8	1.8	3.1	1.3	2.8	0.8	1.8	0.7	3.4	0.0	2.7	9.7	1.0	3.2	6.1	0.0	0.7	1.3	7.1	0.0	0.1	0.4	0.0	0.0	89.3	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	17.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.0	14.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.8	0.0	0.7	0.0	0.0	0.0	0.0	0.0	7.2	0.0	1.6	1.3	0.0	2.8	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.4	2.0	16.3	3.9	2.3	2.8	2.3	4.5	0.7	1.7	3.4
MARC1	"FLJ22390, MOSC1"	ENSG00000186205	"Mitochondrial amidoxime reducing component 1"	Q5VT66	1	220786759-220819657	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 71.3;breast: 81.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 51.0;HeLa: 21.7;Hep G2: 25.0;NTERA-2: 21.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	11	"basophil: 12.0;classical monocyte: 20.6;eosinophil: 8.1;neutrophil: 28.5"	"Group enriched"	"Detected in many"	32	"granulocytes: 28.5;monocytes: 20.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA028702	Approved		Supported	Mitochondria				Mitochondria	Mitochondria	"HPA028702: AB_10601135"	"unprognostic (3.15e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.16e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.39e-1)"	"unprognostic (7.51e-2)"	"unprognostic (7.71e-3)"	"unprognostic (3.71e-1)"	"unprognostic (4.30e-1)"	"prognostic unfavourable (4.51e-4)"	"unprognostic (3.85e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.50e-1)"	71.3	3.0	4.6	7.5	6.1	7.3	81.3	3.1	4.0	3.4	7.8	2.1	18.7	3.3	1.4	5.5	3.4	2.8	6.4	6.7	3.7	4.6	3.4	33.6	4.3	4.3	4.0	3.3	2.5	4.0	4.0	3.3	9.7	4.3	14.9	6.8	4.4	27.8	10.5	4.2	1.4	3.8	2.6	2.6	4.3	3.2	0.6	1.4	0.1	22.0	2.7	1.4	3.9	7.5	0.2	0.7	28.5	20.6	0.0	0.1	4.9	5.6	3.1	2.0	0.0	0.4	0.1	51.0	0.5	0.4	0.3	0.5	16.8	0.3	0.0	2.1	0.5	0.0	10.6	1.0	0.7	0.0	10.7	0.0	21.7	25.0	1.3	0.1	0.1	2.0	0.6	0.0	0.0	0.3	1.6	0.1	0.3	5.5	0.0	10.7	21.5	9.4	0.0	0.0	0.1	2.4	6.3	6.0	14.0	3.0	3.7	0.0	14.2	12.8	0.1	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	12.0	20.6	8.1	0.1	1.5	0.0	0.2	0.0	0.0	0.7	0.1	0.0	0.0	28.5	0.0	0.4	0.2	0.0	4.9	4.6	6.1	3.1	4.0	3.7	4.6	4.0	3.3	4.3	1.4
MCTP1	FLJ22344	ENSG00000175471	"Multiple C2 and transmembrane domain containing 1"	Q6DN14	5	94703741-95284575	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 49.2;brain: 42.4"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 20.7;Karpas-707: 28.3;RPMI-8226: 28.0;RPTEC TERT1: 21.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	41	"basophil: 11.5;classical monocyte: 12.9;eosinophil: 5.8;intermediate monocyte: 19.2;myeloid DC: 10.1;neutrophil: 18.7;non-classical monocyte: 17.6;plasmacytoid DC: 5.3"	"Group enriched"	"Detected in many"	52	"dendritic cells: 10.1;granulocytes: 18.7;monocytes: 19.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019018			Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA019018: AB_1853665"	"unprognostic (1.20e-2)"	"unprognostic (6.70e-4)"	"unprognostic (1.77e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.16e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.99e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.91e-6)"	"unprognostic (5.38e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.89e-3)"	"unprognostic (4.43e-2)"	49.2	2.7	6.5	11.4	42.4	36.9	18.3	18.3	16.5	6.9	7.2	0.3	4.4	5.0	11.1	9.2	6.5	4.1	16.7	4.6	8.5	7.4	3.0	3.8	11.3	5.5	4.1	3.8	3.3	3.4	3.1	5.2	7.1	3.9	5.9	7.3	1.0	4.3	2.7	5.1	4.5	4.8	10.9	5.7	8.2	5.3	4.0	8.1	5.5	5.0	21.2	4.3	17.3	12.6	0.3	10.1	18.7	19.2	0.2	0.2	3.3	0.1	2.0	1.3	0.0	19.9	8.0	0.0	0.1	9.8	0.9	3.2	0.0	5.2	7.2	7.7	0.0	0.0	0.1	0.1	1.1	0.0	1.4	4.3	4.8	0.0	2.6	8.9	5.8	2.9	0.0	3.6	13.1	20.7	0.1	28.3	7.4	0.2	0.5	6.8	1.6	8.2	0.3	0.0	28.0	21.3	11.3	4.0	0.2	0.6	0.0	14.6	0.0	8.4	0.1	3.6	5.6	0.1	1.6	2.0	0.0	0.0	16.9	14.9	3.5	11.5	12.9	5.8	0.0	19.2	0.0	0.3	0.0	0.1	10.1	0.1	0.2	0.0	18.7	0.2	17.6	5.3	0.0	3.3	6.5	42.4	18.3	12.2	8.5	7.4	4.1	3.8	3.9	8.1
MEDAG	"AWMS3, C13orf33, FLJ14834, MEDA-4"	ENSG00000102802	"Mesenteric estrogen dependent adipogenesis"	Q5VYS4	13	30906191-30925572	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 63.0"	"Group enriched"	"Detected in some"	4	"ASC diff: 76.2;ASC TERT1: 21.4;U-2197: 41.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"pons and medulla: 2.6"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"														"unprognostic (2.28e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.44e-2)"	"unprognostic (3.42e-2)"	"unprognostic (6.06e-3)"	"unprognostic (8.80e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavourable (3.29e-5)"	"unprognostic (8.69e-3)"	"unprognostic (2.48e-1)"	"unprognostic (5.41e-3)"	"unprognostic (7.52e-2)"	63.0	1.9	0.1	7.4	0.3	0.2	43.8	0.1	0.4	9.0	10.0	0.3	7.5	1.2	10.2	24.8	13.3	14.5	7.2	18.6	0.4	0.4	2.0	0.4	5.3	7.3	0.4	0.5	17.9	6.8	0.5	2.2	6.4	2.6	3.6	3.2	4.6	6.0	1.7	27.1	8.0	3.5	10.8	2.4	0.4	5.2	9.5	0.1	0.0	15.3	12.7	3.6	21.5	10.5	0.0	0.0	1.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	76.2	21.4	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	9.0	0.0	10.9	0.0	10.0	0.0	0.0	0.9	0.0	0.0	0.0	0.9	0.0	0.0	9.3	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.3	0.4	0.4	0.4	0.5	2.6	0.1
MEOX2	"GAX, MOX2"	ENSG00000106511	"Mesenchyme homeobox 2"	P50222	7	15611212-15686812	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 45.3"	"Group enriched"	"Detected in some"	5	"AN3-CA: 70.6;U-138 MG: 18.2"	"Cancer enriched"	"Detected in many"	8	"glioma: 15.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"pons and medulla: 4.4"	HPA053793	Enhanced									"HPA053793: AB_2682264"	"unprognostic (1.10e-1)"	"unprognostic (4.72e-2)"	"unprognostic (9.82e-3)"	"unprognostic (4.22e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.47e-3)"	"unprognostic (4.44e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.65e-5)"	"unprognostic (3.67e-3)"	"unprognostic (1.13e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.46e-4)"	45.3	0.9	0.7	6.0	0.6	0.0	22.7	0.4	0.6	6.9	5.4	0.0	3.9	0.3	8.1	13.3	9.8	3.2	4.4	10.5	0.5	0.8	0.6	1.4	12.0	6.1	0.7	0.0	4.5	1.5	0.9	1.2	33.8	1.5	7.5	1.5	0.6	6.7	3.1	16.5	5.5	2.1	6.3	3.2	0.6	2.3	7.6	0.0	1.1	7.4	19.4	7.0	14.2	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.6	0.7	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.2	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.4	0.6	0.5	0.8	0.7	0.0	1.5	0.0
MESP1	"bHLHc5, MGC10676"	ENSG00000166823	"Mesoderm posterior bHLH transcription factor 1"	Q9BRJ9	15	89748661-89751310	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 14.1;prostate: 10.9"	"Cell line enhanced"	"Detected in some"		"A-431: 5.6;HDLM-2: 4.9;HEK 293: 4.9;PC-3: 9.3;SCLC-21H: 4.3"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 6.3;prostate cancer: 26.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA069981			Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoplasm	"HPA069981: AB_2686225"	"unprognostic (4.17e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.83e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.68e-2)"	"unprognostic (4.95e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.47e-1)"	"unprognostic (8.38e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.03e-2)"	14.1	1.6	6.8	1.4	4.3	1.1	3.8	7.3	8.8	2.5	1.9	1.1	0.1	1.3	1.0	1.0	0.9	1.0	2.9	3.9	4.9	5.0	1.3	1.2	1.1	1.1	3.3	4.3	1.0	1.2	1.1	1.1	0.8	2.4	10.9	1.0	1.3	3.0	1.2	7.0	0.9	1.1	0.9	1.4	0.9	1.0	1.4	1.9	0.0	1.0	2.2	0.9	0.9	0.4	0.0	0.1	0.0	0.1	0.0	0.8	0.1	5.6	2.1	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.3	0.1	0.0	0.3	0.0	2.2	0.0	0.0	0.4	0.0	0.0	4.9	4.9	0.2	0.9	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.8	1.4	0.0	9.3	0.2	0.0	1.3	0.1	0.0	4.3	0.1	1.1	1.8	1.1	0.1	0.7	0.0	0.0	0.3	3.4	1.1	2.2	0.7	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.1	6.8	4.3	7.3	8.8	4.9	5.0	3.3	4.3	2.4	1.9
MMD	"MMA, PAQR11"	ENSG00000108960	"Monocyte to macrophage differentiation associated"	Q15546	17	55392613-55421992	"Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 61.1;brain: 40.5;breast: 46.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 32.1;HSkMC: 58.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026978			Approved	Vesicles				Vesicles	Vesicles	"HPA026978: AB_2672068"	"unprognostic (1.33e-1)"	"unprognostic (2.92e-2)"	"prognostic favourable (3.52e-5)"	"prognostic unfavourable (3.88e-4)"	"unprognostic (2.48e-1)"	"unprognostic (4.16e-2)"	"prognostic unfavourable (6.39e-5)"	"unprognostic (8.07e-3)"	"unprognostic (6.67e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.06e-3)"	"prognostic unfavourable (2.85e-4)"	"unprognostic (3.71e-3)"	"unprognostic (7.93e-2)"	"prognostic unfavourable (8.62e-4)"	"unprognostic (1.12e-2)"	61.1	6.6	33.4	7.1	40.5	5.3	46.0	2.0	23.7	2.6	5.6	4.1	1.7	5.0	3.2	4.9	3.6	1.8	4.7	5.0	26.9	7.5	3.2	6.0	4.7	9.0	11.2	5.1	1.5	1.6	0.9	2.1	13.4	4.6	3.2	6.5	3.2	2.2	4.1	2.5	2.5	4.7	5.4	6.5	8.7	2.4	7.8	5.0	1.4	3.3	1.2	5.6	5.7	4.1	4.1	3.6	9.6	1.6	2.2	4.2	15.9	5.0	12.9	19.1	3.7	32.1	25.4	9.4	3.1	1.4	2.0	2.9	2.0	15.0	7.2	9.3	1.1	0.3	5.2	4.0	4.2	9.5	1.9	2.7	0.7	23.4	8.6	2.5	0.7	58.1	1.3	2.9	3.2	2.5	0.9	5.8	4.2	0.7	7.1	1.9	5.2	3.3	2.9	12.4	2.7	5.5	1.4	1.7	18.2	1.1	2.0	2.9	4.3	4.6	2.3	5.3	6.4	4.2	3.5	2.6	1.2	10.2	7.6	2.1	4.2	9.6	1.3	1.5	1.4	1.6	4.2	3.6	1.6	2.9	3.6	4.1	2.7	2.9	3.8	2.2	1.5	1.1	1.7	15.9	33.4	40.5	2.0	16.9	26.9	7.5	11.2	5.1	4.6	5.0
MMP19	"MMP18, RASI-1"	ENSG00000123342	"Matrix metallopeptidase 19"	Q99542	12	55835433-55842966	"Disease related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 60.7"	"Cell line enriched"	"Detected in many"	6	"BEWO: 55.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	16	"classical monocyte: 3.2;myeloid DC: 1.0"	"Group enriched"	"Detected in many"	16	"dendritic cells: 1.0;monocytes: 3.2"	"Region enriched"	"Detected in single"	6	"olfactory region: 8.8"	"Low region specificity"	"Detected in all"			HPA070804			Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	800000	800000	"Endoplasmic reticulum, Vesicles"	"Endoplasmic reticulum, Vesicles"	"HPA070804: AB_2686315"	"unprognostic (2.61e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.77e-3)"	"unprognostic (2.01e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.30e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.09e-1)"	"prognostic unfavourable (8.56e-9)"	"unprognostic (5.06e-3)"	"unprognostic (1.28e-3)"	"unprognostic (2.73e-2)"	"unprognostic (4.00e-2)"	60.7	1.9	0.2	10.9	0.7	0.0	9.9	0.2	0.5	7.6	3.9	0.4	1.4	0.8	12.7	6.0	3.6	11.8	30.3	4.7	0.6	0.1	4.1	3.0	14.0	15.5	0.5	0.2	7.4	8.1	0.0	0.5	24.5	1.0	2.9	2.8	3.1	2.0	3.5	2.1	2.7	4.1	7.7	0.8	27.4	5.0	2.9	0.2	2.7	3.3	1.8	7.1	5.9	3.5	0.0	1.0	0.1	3.2	0.0	0.0	0.6	0.8	0.0	0.0	0.0	6.2	7.9	55.9	5.9	6.9	2.4	2.8	0.3	0.2	0.0	0.0	8.2	0.0	0.0	1.8	3.3	0.3	0.0	0.0	0.0	0.1	5.1	0.0	0.2	8.2	0.2	1.5	1.5	0.4	0.1	0.0	8.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	1.0	2.8	0.0	0.0	0.1	0.0	0.0	0.0	0.1	9.5	1.5	3.3	0.0	0.2	0.0	0.0	0.0	4.3	0.0	0.0	0.0	3.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.2	0.7	0.2	0.5	0.6	0.1	0.5	0.2	1.0	0.2
MS4A4A	"CD20L1, MS4A4, MS4A7"	ENSG00000110079	"Membrane spanning 4-domains A4A"	Q96JQ5	11	60280541-60308972	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"adipose tissue: 47.2"	"Cell line enriched"	"Detected in some"	18	"K-562: 53.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 26.4;myeloid DC: 11.9;non-classical monocyte: 31.6;plasmacytoid DC: 11.7"	"Group enriched"	"Detected in many"	27	"dendritic cells: 11.9;monocytes: 31.6"									HPA029323	Approved									"HPA029323: AB_10601866"	"unprognostic (7.93e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.31e-1)"	"unprognostic (9.66e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.56e-1)"	"unprognostic (6.65e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.02e-3)"	"unprognostic (3.32e-2)"	"unprognostic (4.66e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.21e-2)"	47.2	13.9	3.8	10.2	5.3	1.3	18.8	1.4	3.1	8.5	9.8	2.8	2.5	2.6	4.4	18.9	6.2	10.6	14.8	13.7	4.1	3.0	12.6	9.9	20.4	28.2	4.9	1.5	4.4	3.1	1.6	5.0	32.7	6.7	8.3	9.5	8.7	7.7	2.7	3.9	2.6	9.9	12.1	7.4	30.7	5.7	5.6	3.6	2.8	5.0	3.4	4.0	13.1	3.1	0.2	11.9	0.3	31.6	0.8	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	53.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.2	0.0	0.0	26.4	0.0	0.2	0.0	0.0	11.9	0.0	0.0	0.0	0.3	0.8	31.6	11.7	0.0	2.3	3.8	5.3	1.4	3.1	4.1	3.0	4.9	1.5	6.7	3.6
MT1A	"MT1, MT1S"	ENSG00000205362	"Metallothionein 1A"	P04731	16	56638666-56640087	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 108.5;liver: 146.5;skeletal muscle: 111.3"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 13.7;HHSteC: 9.5;HMC-1: 14.1;hTEC/SVTERT24-B: 38.1;NTERA-2: 18.9"	"Cancer enhanced"	"Detected in all"		"liver cancer: 33.3"	"Group enriched"	"Detected in many"	7	"basal ganglia: 35.4;cerebral cortex: 14.5;hippocampal formation: 15.3;pons and medulla: 37.2"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"											"CAB002161, CAB013056"	Approved									"CAB002161: AB_563878, CAB013056: "	"unprognostic (1.36e-1)"	"unprognostic (4.91e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.26e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.47e-2)"	"unprognostic (6.67e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.86e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.35e-2)"	108.5	14.2	2.7	8.0	35.4	1.0	35.2	0.6	14.5	11.3	10.2	0.7	0.2	4.8	1.8	4.1	17.4	11.0	16.1	16.2	15.3	1.8	20.7	146.5	16.1	14.2	3.6	0.0	7.1	46.1	1.2	11.0	1.4	37.2	4.4	7.8	3.8	3.0	2.6	111.3	4.4	12.4	9.2	16.9	4.6	6.1	2.0	2.1	0.0	18.6	4.1	1.7	10.7	7.1	0.4	0.6	0.0	0.1	0.3	1.1	0.2	0.0	2.9	0.0	0.0	8.9	13.7	0.1	0.9	3.7	0.6	0.7	1.0	2.2	0.0	1.1	0.5	0.2	0.0	0.1	1.4	0.0	0.0	0.0	1.3	4.5	9.5	0.1	14.1	4.0	0.0	38.1	0.0	3.6	0.3	0.0	2.6	0.0	0.0	0.0	18.9	0.0	0.0	0.0	1.7	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	2.9	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.6	0.0	0.6	0.4	0.8	1.1	0.6	0.0	0.5	0.9	0.0	0.3	0.0	0.3	1.0	0.2	2.7	35.4	0.6	14.5	15.3	1.8	3.6	0.0	37.2	2.1
MT1M	"MT1, MT1K"	ENSG00000205364	"Metallothionein 1M"	Q8N339	16	56632233-56633986	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 78.0;brain: 80.1;liver: 85.1"	"Cell line enriched"	"Detected in some"	4	"RPTEC TERT1: 32.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.3"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.3"																				"unprognostic (1.83e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.10e-2)"	"unprognostic (4.19e-3)"	"unprognostic (7.73e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavourable (2.13e-4)"	"unprognostic (4.67e-2)"	"unprognostic (3.10e-1)"	"unprognostic (3.55e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.71e-2)"	78.0	10.3	16.5	12.7	80.1	1.6	25.5	4.7	31.0	5.1	33.7	6.1	0.4	8.1	2.8	4.9	20.5	16.9	12.4	9.5	39.3	13.6	38.9	85.1	17.5	15.7	28.7	9.6	4.4	40.8	2.5	1.4	2.2	54.5	11.6	35.3	3.5	5.0	3.7	16.6	7.4	35.6	12.6	37.1	3.5	13.1	2.0	13.1	0.0	12.2	3.2	2.2	5.4	5.1	0.1	0.0	2.3	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	7.5	4.8	0.1	0.3	1.7	0.4	0.4	0.0	0.2	0.0	1.9	1.2	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.6	0.0	4.5	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	3.3	0.2	0.0	0.0	0.0	32.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	1.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.7	0.2	0.0	0.4	0.3	0.1	0.0	0.3	0.5	0.0	0.1	0.0	0.2	2.3	0.0	0.1	0.0	0.4	0.0	16.5	80.1	4.7	31.0	39.3	13.6	28.7	9.6	54.5	13.1
MYEOV	OCIM	ENSG00000172927	"Myeloma overexpressed"	Q96EZ4	11	69294138-69367726	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 29.4;breast: 16.9;esophagus: 17.3"	"Cell line enhanced"	"Detected in some"		"A-431: 57.8;A549: 27.8;CAPAN-2: 8.5;U-2 OS: 12.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.0"	"Low lineage specificity"	"Detected in single"											HPA012949	Uncertain		Approved	Nucleoplasm,Vesicles				Nucleoplasm	Nucleoplasm	"HPA012949: AB_1854241"	"unprognostic (1.42e-2)"	"unprognostic (8.56e-2)"	"unprognostic (7.07e-2)"	"unprognostic (3.36e-1)"	"unprognostic (5.60e-2)"	"unprognostic (7.28e-3)"	"unprognostic (7.58e-3)"	"prognostic unfavourable (2.00e-4)"	"unprognostic (3.49e-1)"	"unprognostic (6.33e-2)"	"prognostic unfavourable (1.54e-7)"	"unprognostic (2.83e-1)"	"prognostic unfavourable (1.48e-5)"	"unprognostic (2.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.69e-2)"	29.4	0.2	0.0	2.4	0.0	0.2	16.9	0.1	0.0	2.6	1.1	0.0	0.4	0.4	0.5	8.1	17.3	0.0	1.3	0.1	0.0	0.2	0.2	8.6	0.1	0.2	0.0	0.1	0.1	2.1	0.0	0.1	0.0	0.0	0.1	0.6	0.9	2.0	0.0	0.6	4.9	0.8	0.1	0.0	0.3	10.7	0.4	0.0	0.1	0.1	5.3	13.6	0.2	4.7	0.5	0.0	0.0	0.1	1.0	0.3	2.1	57.8	27.8	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.2	8.5	0.2	2.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0	2.7	0.8	0.0	0.0	1.2	0.0	0.0	0.0	2.2	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.8	0.1	1.0	0.1	0.8	0.0	12.8	0.0	0.6	0.1	0.6	0.1	0.0	0.2	1.1	0.0	0.1	0.0	0.2	0.0	0.3	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0
NEDD9	"CAS-L, CASS2, HEF1"	ENSG00000111859	"Neural precursor cell expressed, developmentally down-regulated 9"	Q14511	6	11183298-11382348	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 72.8"	"Cell line enhanced"	"Detected in many"		"EFO-21: 49.0;HSkMC: 24.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB009720, HPA038768, HPA039270"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Cytosol	Cytosol	"CAB009720: , HPA038768: AB_2676196, HPA039270: "	"unprognostic (2.83e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.54e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.59e-3)"	"unprognostic (2.25e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.05e-1)"	72.8	4.7	4.5	14.9	5.6	3.3	35.7	2.2	5.9	14.0	16.6	5.1	14.2	7.1	17.3	21.7	10.3	11.5	15.3	17.3	4.6	4.1	34.6	9.5	58.4	15.0	4.9	3.9	11.1	7.9	4.2	6.1	32.6	6.6	13.4	14.7	12.8	15.4	15.4	22.4	12.3	17.9	12.4	5.3	25.7	10.9	12.2	4.3	18.8	15.8	6.8	18.6	17.6	9.9	5.8	6.0	34.8	19.8	5.1	8.3	6.3	1.5	10.0	9.3	0.1	6.4	0.8	9.8	2.3	2.8	4.3	8.0	3.2	0.6	3.1	49.0	5.0	4.3	12.5	4.7	5.6	1.4	0.3	0.3	1.5	21.1	3.0	3.3	0.1	24.5	1.4	2.8	0.4	7.3	0.0	2.6	9.7	0.4	1.9	1.3	1.4	1.0	0.5	0.2	1.8	2.1	13.7	0.2	1.7	0.4	11.0	19.0	0.8	2.6	18.6	2.9	5.2	0.3	5.6	2.8	11.3	3.9	0.0	2.7	12.7	9.1	5.5	15.4	8.3	12.2	6.8	5.0	5.6	8.0	6.0	5.8	3.0	4.7	34.8	5.1	19.8	3.7	5.0	6.3	4.5	5.6	2.2	5.9	4.6	4.1	4.9	3.9	6.6	4.3
NOTCH4	INT3	ENSG00000204301	"Notch 4"	Q99466	6	32194843-32224067	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 31.3;lung: 26.2"	"Cell line enriched"	"Detected in single"	6	"EFO-21: 2.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									820000	820000				"unprognostic (2.27e-1)"	"unprognostic (2.27e-1)"	"unprognostic (6.80e-3)"	"unprognostic (9.50e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.00e-1)"	"prognostic unfavourable (3.84e-4)"	"unprognostic (1.31e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.13e-1)"	31.3	3.5	3.6	2.9	6.3	1.5	16.7	2.5	8.2	3.4	5.9	1.3	3.3	3.2	5.8	12.1	3.7	4.0	2.7	10.5	4.2	2.1	6.1	5.0	26.2	2.6	4.9	1.1	2.5	3.4	1.5	2.9	6.0	5.5	4.6	2.0	3.7	1.9	4.3	8.5	4.1	2.7	1.5	4.8	3.4	3.6	2.0	5.1	0.0	9.3	4.3	2.0	3.3	12.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	3.6	6.3	2.5	8.2	4.2	2.1	4.9	1.1	5.5	5.1
NR1H3	"LXR-a, RLD-1"	ENSG00000025434	"Nuclear receptor subfamily 1 group H member 3"	Q13133	11	47248300-47269032	"Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 74.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 22.5;HSkMC: 29.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 14.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036443, CAB037109"	Approved									"CAB037109: AB_1840991, HPA036443: AB_10966142"	"unprognostic (2.95e-3)"	"unprognostic (5.31e-3)"	"unprognostic (5.19e-2)"	"prognostic favourable (5.05e-4)"	"unprognostic (1.19e-1)"	"unprognostic (2.65e-2)"	"prognostic unfavourable (5.60e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.73e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (1.40e-5)"	"unprognostic (3.56e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.84e-1)"	"prognostic favourable (3.40e-4)"	74.2	9.4	4.8	12.7	6.9	1.2	22.8	7.0	5.5	10.2	17.9	4.4	7.2	23.1	6.7	10.0	6.6	8.1	9.2	8.5	4.0	2.9	10.3	35.7	13.7	29.4	6.8	5.6	7.5	7.8	4.3	3.5	16.1	4.3	10.1	5.9	6.4	7.1	9.0	6.1	5.1	19.0	7.1	3.4	40.2	7.6	13.7	4.1	6.3	9.7	2.6	10.7	10.8	12.9	1.1	4.5	6.5	14.6	6.1	3.8	2.1	1.5	6.6	3.0	2.9	20.5	22.5	14.4	1.7	8.4	2.7	4.3	8.2	21.0	2.9	3.2	1.3	4.4	3.6	2.9	1.9	2.7	2.9	3.8	8.9	12.2	8.4	1.4	0.5	29.3	1.8	4.3	2.5	2.4	4.7	1.2	1.9	6.9	2.6	7.7	3.3	2.2	3.9	4.1	1.9	2.5	15.0	3.0	1.0	5.9	3.9	5.0	9.5	3.7	0.6	2.2	3.0	4.4	0.9	5.8	8.5	3.5	4.1	1.8	1.0	6.5	2.9	2.4	1.5	14.6	2.1	1.1	1.7	1.4	4.5	0.9	1.8	1.5	1.5	6.1	4.5	0.8	3.8	2.1	4.8	6.9	7.0	5.5	4.0	2.9	6.8	5.6	4.3	4.1
NRN1	NRN	ENSG00000124785	"Neuritin 1"	Q9NPD7	6	5997999-6007605	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 32.1;brain: 59.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 37.7;ASC TERT1: 29.3;fHDF/TERT166: 37.9;REH: 49.8"	"Cancer enhanced"	"Detected in all"		"glioma: 38.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"MAIT T-cell: 5.7;neutrophil: 5.6"	"Group enriched"	"Detected in many"	8	"granulocytes: 5.6;T-cells: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (6.24e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.26e-2)"	"unprognostic (5.57e-2)"	"unprognostic (4.70e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.35e-1)"	"prognostic unfavourable (4.79e-5)"	"unprognostic (1.26e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.37e-3)"	32.1	3.7	38.8	4.0	21.5	0.7	16.8	53.3	59.3	6.1	5.8	3.5	1.1	2.6	5.9	2.9	5.4	6.2	6.9	9.9	40.2	9.8	3.2	3.1	9.3	5.3	10.0	22.1	2.5	1.9	1.9	3.5	25.5	23.4	3.2	3.4	4.1	3.7	5.2	10.0	7.8	3.4	6.8	5.6	9.3	3.2	0.8	1.8	0.0	3.0	2.8	2.5	7.8	5.7	0.7	0.5	5.6	0.4	0.0	5.7	0.2	4.2	0.2	0.4	0.1	37.7	29.3	5.8	0.7	0.0	3.1	4.3	0.0	0.0	0.0	0.6	37.9	0.1	11.2	0.0	3.1	7.0	5.7	3.6	0.2	0.0	0.0	14.7	11.7	4.6	0.0	2.8	0.0	15.1	0.1	0.2	11.1	1.0	22.4	0.7	0.1	0.0	49.8	12.7	0.1	0.0	0.1	6.7	2.4	0.0	0.2	3.6	0.1	4.4	3.1	15.2	0.5	5.8	9.4	0.0	0.5	0.3	23.0	0.3	2.3	1.0	0.3	0.0	0.3	0.4	5.7	0.7	0.4	0.7	0.0	0.0	0.0	0.1	5.6	0.0	0.3	0.5	0.2	0.2	38.8	21.5	53.3	58.3	40.2	9.8	10.0	22.1	23.4	1.8
OCSTAMP	"C20orf123, dJ257E24.3"	ENSG00000149635	"Osteoclast stimulatory transmembrane protein"	Q9BR26	20	46540946-46550574	"Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 6.9;blood: 2.6"	"Cell line enhanced"	"Detected in some"		"AF22: 2.6;HMC-1: 5.1;Karpas-707: 2.9;NB-4: 5.5;RPMI-8226: 2.4;U-266/70: 1.8;U-266/84: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	26	"plasmacytoid DC: 2.6"	"Lineage enriched"	"Detected in single"	26	"dendritic cells: 2.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA031116	Uncertain									"HPA031116: AB_10600758"	"unprognostic (2.77e-1)"		"unprognostic (3.04e-1)"		"unprognostic (8.80e-2)"	"unprognostic (5.02e-2)"		"unprognostic (2.42e-1)"	"unprognostic (2.71e-1)"					"unprognostic (2.65e-1)"	"unprognostic (9.59e-2)"	"unprognostic (2.08e-1)"		6.9	0.0	0.1	0.1	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.6	0.0	0.0	0.1	0.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.2	0.1	0.2	0.6	0.0	0.2	1.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	5.5	0.4	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	1.8	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.1	0.4	0.0	0.1	0.3	0.2	0.5	0.0	0.0	0.0
OR52N1		ENSG00000181001	"Olfactory receptor family 52 subfamily N member 1"	Q8NH53	11	5786471-5791265	"Cancer-related genes, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 1.8;bone marrow: 1.4"	"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.7"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA054028	Uncertain									"HPA054028: AB_2682348"																		1.8	0.0	0.0	0.3	0.0	1.4	0.3	0.0	0.2	0.0	0.1			0.0	0.4	0.1	0.1	0.2	0.9	0.2	0.0	0.0	0.1	0.1	0.2	0.2	0.1		0.1	0.1	0.0	0.1	0.1		0.3	0.0		0.1	0.0	0.3	0.1	0.6	0.0	0.0	0.2	0.1	0.4			0.0		0.0	0.1	0.0	0.5	0.7	1.2	0.6	1.0	0.7	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.4	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.3	0.0	0.1	0.7	0.5	0.0	0.2	0.3	0.0	0.1	0.0	0.7	0.8	0.7	0.2	0.1	0.2	0.0	0.1	0.4	0.6	1.2	0.6	0.2	0.5	0.4	0.6	0.5	0.7	0.6	0.0	0.5	0.7	0.7	0.5	1.0	0.5	0.7	0.1	0.0										
OR52N5	OR52N5Q	ENSG00000181009	"Olfactory receptor family 52 subfamily N member 5"	Q8NH56	11	5776165-5783355	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"adipose tissue: 1.8"	"Cell line enhanced"	"Detected in single"		"T-47d: 2.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																															1.8	0.2	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.1	0.1			0.0	0.2	0.3	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0		0.1	0.1	0.0	0.0	0.2		0.2	0.0		0.1	0.0	0.1	0.8	0.3	0.1	0.0	0.1	0.1	0.6			0.0		0.0	0.2	0.0	0.4	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.2	0.8	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	2.1	0.0	0.0	0.1	0.2	0.2	0.1	0.2	0.6	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0										
OR8G5	"OR8G5P, OR8G6"	ENSG00000255298	"Olfactory receptor family 8 subfamily G member 5"	Q8NG78	11	124256376-124266218	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 5.2;lung: 4.0;testis: 7.8"	"Group enriched"	"Detected in some"	4	"K-562: 5.0;PC-3: 3.1;T-47d: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																																				"unprognostic (1.48e-1)"			5.2	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.6	0.1	0.5	0.0	2.5	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.9	0.1	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.5	0.0	0.0	0.1	3.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PALM	KIAA0270	ENSG00000099864	Paralemmin	O75781	19	708939-748329	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 47.6;brain: 56.5"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 16.2;EFO-21: 15.0;REH: 26.6;SH-SY5Y: 17.1;U-2197: 14.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"non-classical monocyte: 4.7"	"Lineage enriched"	"Detected in single"	35	"monocytes: 4.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041713, HPA049578"	Approved		Enhanced	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"	"Nucleoplasm, Plasma membrane"	"HPA041713: AB_10794305, HPA049578: AB_2680822"	"unprognostic (9.08e-3)"	"unprognostic (2.97e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.53e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.39e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.36e-2)"	"prognostic favourable (9.81e-4)"	"unprognostic (2.74e-2)"	"prognostic favourable (5.44e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.55e-2)"	"unprognostic (6.00e-2)"	47.6	11.8	49.1	5.1	39.9	2.2	11.3	13.3	56.5	22.7	8.2	12.4	4.2	9.2	10.7	6.7	5.8	17.7	7.2	9.6	37.7	18.9	21.9	3.5	9.0	2.2	19.2	28.1	21.2	2.1	1.2	10.2	17.6	11.9	12.2	2.7	6.1	5.9	18.6	7.0	6.9	7.5	9.0	14.7	10.5	3.6	8.2	12.5	0.0	3.3	3.3	1.9	5.0	8.4	0.0	0.1	0.0	4.7	0.0	0.0	0.0	0.0	4.3	8.4	16.2	1.3	0.1	1.2	1.1	0.0	1.1	0.3	1.0	0.0	0.0	15.0	0.1	1.5	4.2	0.0	0.2	0.0	8.3	0.0	3.4	5.3	5.9	0.0	0.1	3.8	0.0	0.7	0.0	0.6	2.9	0.0	1.1	8.5	0.6	5.0	3.4	2.4	26.6	0.0	0.1	0.4	0.0	0.9	17.1	4.3	0.0	0.1	1.5	4.0	0.0	0.0	8.8	14.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	49.1	39.9	13.3	44.4	37.7	18.9	19.2	28.1	11.9	12.5
PALM2-AKAP2		ENSG00000157654	"PALM2-AKAP2 readthrough"		9	109780309-110172512	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"adipose tissue: 41.0;heart muscle: 26.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 15.4;hTEC/SVTERT24-B: 14.8;RH-30: 29.1;U-251 MG: 13.0;WM-115: 17.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA058905, HPA074153, HPA076866"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA058905: AB_2683851, HPA074153: AB_2686669, HPA076866: "	"unprognostic (7.12e-2)"	"unprognostic (1.64e-6)"	"unprognostic (7.90e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.19e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.40e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.05e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.98e-4)"	"unprognostic (3.36e-5)"	41.0	2.8	1.6	3.3	1.6	0.1	19.6	0.7	4.7	4.8	2.3	1.5	2.1	1.1	15.2	4.7	2.1	2.5	5.0	26.8	1.8	2.4	2.4	24.8	9.7	1.2	1.9	0.5	5.9	1.1	1.6	1.1	9.2	3.0	3.2	0.6	1.1	2.0	3.6	4.5	1.8	1.0	7.8	1.4	0.5	1.1	1.4	0.9	0.0	3.8	2.5	0.3	5.2	8.9	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.0	0.0	3.3	0.0	15.4	5.5	1.3	5.4	5.3	1.6	3.6	0.0	0.1	0.0	0.5	5.6	2.0	0.0	1.2	4.5	0.2	1.6	0.0	5.0	0.1	0.1	0.0	0.0	7.0	0.1	14.8	2.4	0.1	0.0	0.0	5.7	0.0	0.0	0.0	4.3	1.4	0.0	29.1	0.0	4.0	0.0	1.7	0.0	2.1	0.2	7.4	0.6	0.0	0.1	3.4	8.5	0.3	13.0	0.0	0.2	0.0	4.2	0.0	17.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	1.6	1.6	0.7	3.0	1.8	2.4	1.9	0.5	3.0	0.9
PALMD	"C1orf11, FLJ20271, PALML"	ENSG00000099260	Palmdelphin	Q9NP74	1	99645943-99694541	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 84.9;skeletal muscle: 106.9"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 42.5;LHCN-M2: 13.7;TIME: 59.6;U-87 MG: 26.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017959, HPA030549"	Supported		Supported	"Plasma membrane,Actin filaments,Focal adhesion sites"				"Actin filaments"	"Actin filaments"	"HPA017959: AB_1854949, HPA030549: AB_2673518"	"unprognostic (1.48e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.05e-2)"	"prognostic favourable (9.42e-4)"	"unprognostic (7.67e-2)"	"prognostic favourable (5.90e-5)"	"unprognostic (1.54e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.32e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.70e-1)"	"unprognostic (8.08e-2)"	84.9	18.6	8.3	6.2	4.3	0.0	46.4	1.1	3.7	17.1	6.5	3.9	4.0	1.3	18.6	10.1	16.2	8.7	5.3	59.0	5.6	3.4	5.1	20.9	10.6	3.4	3.9	3.8	17.4	2.2	4.4	4.7	16.8	19.0	8.1	2.6	7.9	34.0	4.4	106.9	18.0	3.5	12.2	4.1	2.3	2.8	7.5	2.2	2.1	3.4	48.2	6.2	6.9	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.7	2.9	0.0	0.1	0.0	0.0	0.0	0.0	5.5	7.1	0.0	0.0	0.0	1.1	0.5	0.0	0.0	42.5	6.0	0.0	13.7	0.1	0.0	0.0	0.0	1.8	0.0	10.6	0.0	0.0	2.2	0.2	0.1	0.0	2.7	0.0	0.6	0.0	59.6	0.0	0.1	4.6	0.0	0.0	0.0	0.0	26.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	4.3	1.1	3.7	5.6	3.4	3.9	3.8	19.0	2.2
PC	PCB	ENSG00000173599	"Pyruvate carboxylase"	P11498	11	66848233-66958376	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 41.1;liver: 76.0"	"Cell line enhanced"	"Detected in many"		"HeLa: 27.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 2.6;monocytes: 3.8;T-cells: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033742, HPA043922, HPA058765"	Enhanced		Enhanced	Mitochondria		96000	96000	Mitochondria	Mitochondria	"CAB033742: AB_2283532, HPA043922: AB_2678732, HPA058765: AB_2683812"	"unprognostic (2.10e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.36e-2)"	"unprognostic (8.24e-3)"	"unprognostic (3.67e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.63e-1)"	"prognostic unfavourable (7.86e-5)"	"unprognostic (1.54e-1)"	"unprognostic (1.17e-1)"	"prognostic favourable (8.22e-5)"	"unprognostic (8.58e-3)"	"unprognostic (5.67e-2)"	"unprognostic (9.15e-3)"	"unprognostic (1.05e-1)"	41.1	10.7	11.1	2.8	14.6	3.1	12.9	13.1	14.9	2.4	3.8	10.7	21.4	5.6	2.1	2.4	5.0	2.7	2.9	4.0	11.3	8.9	18.7	76.0	2.1	1.6	15.5	11.5	4.4	4.3	19.4	4.0	4.1	10.9	5.4	3.1	3.4	24.2	24.4	5.7	2.8	6.7	1.8	9.4	1.5	3.3	6.1	13.1	0.6	4.2	2.5	2.5	2.2	2.1	0.6	2.6	0.0	3.8	0.3	2.9	2.0	2.9	8.9	3.3	8.1	13.7	5.4	3.5	1.8	7.8	3.5	3.4	4.4	3.2	0.0	3.7	2.9	3.8	3.7	20.6	1.0	1.7	5.2	4.4	27.7	17.0	10.7	0.0	5.7	20.6	5.3	2.8	6.4	2.9	8.4	0.0	1.2	19.0	5.0	2.4	6.3	7.4	3.7	6.9	1.8	3.2	0.9	7.2	10.2	17.3	9.2	7.0	7.5	1.2	3.2	3.9	3.6	4.6	2.0	1.9	2.2	0.0	4.0	2.8	3.3	0.0	3.8	0.0	1.2	0.9	1.4	0.2	0.5	1.9	2.6	0.6	2.9	1.6	0.0	0.3	0.5	1.0	1.5	2.0	11.1	14.6	13.1	13.6	11.3	8.9	15.5	11.5	10.9	13.1
PDE3B	HcGIP1	ENSG00000152270	"Phosphodiesterase 3B"	Q13370	11	14643723-14872044	"Enzymes, FDA approved drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 42.6"	"Cell line enhanced"	"Detected in many"		"HL-60: 13.3;Karpas-707: 15.4;THP-1: 16.3;U-266/70: 17.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"cerebellum: 19.2"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"granulocytes: 5.0;T-cells: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056111			Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA056111: AB_2683041"	"unprognostic (1.05e-1)"	"unprognostic (2.86e-2)"	"unprognostic (4.12e-2)"	"unprognostic (2.76e-3)"	"unprognostic (4.25e-1)"	"unprognostic (1.84e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.20e-1)"	"prognostic favourable (7.91e-4)"	"unprognostic (1.77e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.47e-1)"	"unprognostic (9.03e-3)"	42.6	1.0	2.3	12.6	2.2	6.7	17.0	19.2	3.0	2.9	21.8	0.9	0.8	2.2	0.9	1.4	2.6	1.0	6.9	4.7	2.2	2.1	2.4	18.2	10.2	14.1	1.6	1.6	0.9	7.3	0.3	5.1	5.5	1.5	10.7	8.1	1.9	16.5	1.3	0.8	0.9	6.3	9.7	2.1	8.7	3.0	12.5	0.8	7.8	1.2	2.3	7.1	10.5	4.5	0.3	0.4	5.0	1.2	0.1	8.7	1.8	0.0	1.5	3.3	5.4	6.6	0.0	1.3	0.4	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.1	11.1	0.1	8.1	10.0	2.3	13.3	0.0	0.5	0.0	0.0	0.3	0.0	11.7	15.4	0.0	0.1	2.6	6.5	4.5	2.4	6.4	1.5	10.0	0.0	1.1	5.1	9.5	1.3	8.6	2.9	0.0	16.3	0.0	0.0	0.8	0.0	0.0	17.4	5.3	0.4	0.1	2.3	1.0	0.0	0.7	2.9	1.4	0.7	2.9	0.3	4.2	3.2	0.4	0.2	8.7	7.5	5.0	0.1	1.2	0.1	4.2	1.8	2.3	2.2	19.2	3.0	2.2	2.1	1.6	1.6	1.5	0.8
PECAM1	CD31	ENSG00000261371	"Platelet and endothelial cell adhesion molecule 1"		17	64319415-64413776	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"adipose tissue: 77.7;blood: 88.4;placenta: 65.7"	"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 118.2;TIME: 81.3"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 88.4"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004690	Enhanced									"HPA004690: AB_1078462"	"unprognostic (2.79e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.42e-3)"	"unprognostic (2.84e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.25e-2)"	"unprognostic (4.53e-2)"	"unprognostic (9.68e-2)"	"prognostic unfavourable (8.98e-5)"	"unprognostic (9.72e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.16e-2)"	77.7	2.5	2.2	10.2	3.3	3.8	26.5	1.2	3.6	14.2	9.2	1.6	3.7	3.5	15.2	7.6	12.3	4.7	12.2	13.8	2.2		13.4	3.5	50.2	10.7	3.0	0.3	7.4	2.3	2.7	1.2	65.7	3.7	10.2	4.9	4.6	2.9	3.0	21.2	2.0	4.8	11.6	2.8	13.9	3.4	6.4	2.0	7.8	15.7	10.0	7.8	15.2	16.2	5.0	21.0	53.3	88.4	5.2	10.0	24.2	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	18.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.2	0.3	0.5	0.0	0.0	0.0	0.0	0.1	0.0	118.2	0.3	8.9	0.0	0.0	4.8	1.2	0.0	1.2	0.2	2.3	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	7.2	81.3	0.1	0.0	0.1	0.0	0.5	0.9	1.0	0.2	1.0	0.0	6.2	34.8	28.9	2.8	57.2	2.7	3.6	0.3	6.7	21.0	5.0	5.4	10.0	53.3	5.2	88.4	12.0	0.2	24.2										
PFKFB1	PFRX	ENSG00000158571	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1"	P16118	X	54932961-54998534	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 24.2;liver: 24.4;skeletal muscle: 48.3"	"Group enriched"	"Detected in some"	4	"ASC diff: 13.6;Hep G2: 5.4"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 7.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (2.51e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.64e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.33e-1)"	"unprognostic (3.26e-3)"	"unprognostic (2.88e-1)"	"unprognostic (5.36e-3)"	"unprognostic (5.06e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.16e-4)"	"unprognostic (1.96e-3)"	24.2	0.2	0.1	1.6	0.1	0.1	13.1	0.1	0.2	0.1	1.7	0.1	0.1	0.0	0.1	0.2	0.5	0.0	0.1	0.1	0.1	0.1	0.4	24.4	0.1	1.6	0.1	0.1	0.1	0.6	0.2	0.2	0.1	0.1	0.3	0.2	0.1	1.3	0.1	48.3	0.3	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.5	8.3	0.6	0.2	2.0	1.5	0.1	0.0	0.7	1.3	2.1	0.3	0.3	0.2	0.4	0.6	13.6	0.3	1.0	0.0	0.1	0.2	0.0	0.8	0.2	0.6	0.2	0.1	0.5	0.1	0.3	0.4	0.4	1.1	0.4	0.1	5.4	0.0	0.1	0.5	0.2	0.6	0.1	0.4	0.0	0.1	2.1	0.2	0.7	0.6	0.3	0.3	0.3	0.5	0.2	0.1	0.0	0.4	0.4	0.2	0.5	1.5	0.2	0.4	0.0	0.1	0.1	0.5	0.4	0.2	1.1	1.7	0.4	0.2	0.4	0.1	0.0	0.0	0.0	0.2	0.7	2.1	1.5	0.2	0.0	0.0	0.8	0.0	0.8	0.0	1.3	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1
PFKFB3		ENSG00000170525	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3"	Q16875	10	6144934-6254644	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 105.6;skeletal muscle: 135.7"	"Cell line enhanced"	"Detected in many"		"A549: 71.1;RPTEC TERT1: 44.9;T-47d: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 20.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008266, CAB020795, HPA043889"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB020795: , HPA008266: AB_1855239, HPA043889: AB_2678717"	"unprognostic (1.61e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.89e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.11e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.30e-2)"	"unprognostic (7.34e-2)"	"prognostic unfavourable (1.87e-7)"	"unprognostic (1.89e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.74e-1)"	105.6	9.0	16.4	25.7	17.9	77.0	43.4	8.5	29.4	6.6	8.8	29.1	10.6	7.4	9.4	6.3	13.0	14.4	22.4	5.7	16.6	13.2	22.1	11.2	15.1	12.1	19.2	12.9	8.0	8.1	4.0	10.2	7.5	20.7	5.4	3.8	19.3	9.1	20.0	135.7	11.8	6.9	6.5	36.0	12.4	6.7	4.6	16.8	3.3	2.9	4.7	10.3	10.3	10.1	1.5	3.6	20.5	7.1	0.8	4.7	2.9	5.1	71.1	5.6	4.5	21.4	2.7	3.0	7.6	5.4	5.6	8.8	3.3	18.8	8.8	5.0	3.3	16.6	6.0	12.0	6.5	10.4	4.2	5.2	3.6	1.2	1.8	5.0	7.9	1.9	4.0	9.7	2.3	10.9	3.8	3.3	4.5	8.4	3.5	4.7	5.5	5.0	8.0	2.7	3.4	44.9	2.6	5.4	2.2	5.5	6.0	10.8	46.8	6.0	13.7	5.9	5.4	0.7	9.1	6.8	2.3	8.0	16.3	5.9	9.0	2.2	5.6	5.5	1.8	7.1	4.7	1.5	3.4	2.3	3.6	1.4	2.5	2.4	20.5	0.8	4.1	2.2	3.2	2.9	16.4	17.9	8.5	16.9	16.6	13.2	19.2	12.9	20.7	16.8
PLA2G16	"AdPLA, H-REV107-1, HRASLS3, HREV107, HREV107-3, MGC118754."	ENSG00000176485	"Phospholipase A2 group XVI"	P53816	11	63573195-63616883	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 113.6"	"Cell line enhanced"	"Detected in many"		"A549: 32.3;ASC diff: 36.7;CAPAN-2: 59.1;HAP1: 30.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 52.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 52.4;T-cells: 16.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058997	Uncertain		Uncertain	Mitochondria				Mitochondria	Mitochondria	"HPA058997: AB_2683874"	"unprognostic (5.18e-2)"	"unprognostic (3.67e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.06e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavourable (5.58e-6)"	"unprognostic (6.38e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.75e-1)"	"prognostic favourable (2.54e-5)"	"unprognostic (2.35e-1)"	113.6	15.2	32.0	4.4	39.4	1.6	33.9	4.8	30.2	6.1	7.2	46.6	6.1	4.0	5.0	11.5	5.9	13.9	12.9	39.0	37.6	25.2	24.7	28.9	13.5	4.5	58.4	22.2	30.9	13.2	15.1	8.1	16.2	30.5	5.9	3.7	8.8	10.1	13.2	37.8	2.4	7.5	8.0	70.4	6.4	10.2	17.8	48.9	0.1	17.1	11.1	2.3	8.0	4.7	2.1	52.4	0.4	6.2	5.3	16.0	6.4	20.4	32.3	0.9	0.0	36.7	6.3	5.9	0.7	6.5	5.4	2.7	7.3	59.1	0.0	13.6	1.6	1.0	30.6	1.6	4.1	25.2	1.2	0.3	7.8	1.2	21.9	0.0	0.3	3.8	0.1	13.5	0.5	8.5	0.3	2.3	5.7	3.5	0.0	0.1	2.6	10.4	0.0	0.0	2.0	17.1	2.9	0.4	2.4	4.4	12.4	6.7	26.9	1.0	12.5	2.4	0.1	8.2	1.8	9.7	6.3	0.0	9.8	0.0	0.2	0.0	6.2	0.0	16.0	2.4	8.8	2.1	3.7	11.6	1.7	0.3	1.2	9.4	0.4	5.3	0.1	52.4	2.4	6.4	32.0	39.4	4.8	21.9	37.6	25.2	58.4	22.2	30.5	48.9
PLA2G7	"LDL-PLA2, PAFAH"	ENSG00000146070	"Phospholipase A2 group VII"	Q13093	6	46704201-46735693	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 57.0;lymphoid tissue: 32.9"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 3.8;PC-3: 7.7;RT4: 3.5;U-2 OS: 3.7"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 37.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 24.2"	"Group enriched"	"Detected in many"	56	"dendritic cells: 7.9;monocytes: 24.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	170000000	170000000				"unprognostic (3.63e-3)"	"unprognostic (2.82e-3)"	"unprognostic (8.69e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.26e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.06e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.47e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.08e-2)"	57.0	2.1	2.8	14.0	5.8	1.1	2.9	2.0	2.7	1.5	4.4	2.0	0.4	2.3	2.9	1.6	0.8	1.4	3.6	2.0	2.1	1.7	1.0	4.3	19.0	22.2	3.2	1.8	4.0	0.9	0.1	3.1	15.8	2.3	8.5	6.6	2.8	2.5	1.6	0.9	2.3	3.7	1.5	7.1	32.9	1.4	0.7	2.0	6.4	13.1	0.6	6.0	7.2	0.8	0.1	7.9	0.2	24.2	0.0	0.2	6.1	0.0	0.5	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	1.5	0.0	0.1	0.0	0.2	1.9	0.0	1.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.3	3.8	7.7	0.0	0.0	0.1	0.0	3.5	0.1	0.5	0.0	0.0	0.0	1.0	1.0	0.0	0.0	3.7	0.1	0.8	0.1	0.0	0.0	0.0	0.2	1.3	0.0	24.2	0.1	0.0	5.0	0.2	0.1	0.0	0.0	7.9	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	6.1	2.8	5.8	2.0	2.7	2.1	1.7	3.2	1.8	2.3	2.0
PLIN2	"ADFP, ADRP"	ENSG00000147872	"Perilipin 2"	Q99541	9	19108375-19149290	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 233.1;liver: 139.9"	"Group enriched"	"Detected in many"	5	"ASC diff: 197.8;HHSteC: 171.3"	"Group enriched"	"Detected in all"	5	"liver cancer: 63.0;renal cancer: 136.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 83.5;eosinophil: 76.1"	"Group enriched"	"Detected in all"	5	"granulocytes: 83.5;monocytes: 21.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016607, CAB037331"	Supported		Supported	"Lipid droplets"				"Lipid droplets"	"Lipid droplets"	"CAB037331: , HPA016607: AB_2669403"	"unprognostic (2.02e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.02e-2)"	"unprognostic (3.28e-3)"	"unprognostic (4.92e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavourable (3.32e-4)"	"unprognostic (3.14e-3)"	"unprognostic (7.89e-2)"	"prognostic favourable (2.16e-4)"	"unprognostic (1.77e-1)"	233.1	17.4	1.8	6.5	2.8	14.9	98.9	1.1	3.2	11.2	47.4	2.0	5.4	28.4	7.7	7.8	6.2	6.1	10.9	37.0	1.7	1.6	36.0	139.9	18.3	9.6	2.2	1.2	37.5	4.5	2.0	4.7	46.4	3.0	17.1	3.5	5.9	8.5	4.5	75.7	13.5	61.6	6.8	3.1	9.8	5.5	16.5	2.4	4.4	8.8	4.0	4.6	63.2	102.9	3.2	8.6	83.5	21.1	2.0	11.5	11.8	0.0	2.8	3.2	2.3	197.8	27.0	35.9	9.1	7.1	5.5	6.3	4.3	0.6	0.0	0.1	18.6	0.3	3.1	0.0	9.6	11.5	0.0	15.1	0.4	16.1	171.3	1.8	27.8	28.5	3.2	13.6	0.0	6.8	2.7	3.3	21.6	0.7	4.1	6.2	4.3	5.6	10.0	1.5	0.1	0.0	10.6	0.2	5.3	4.2	1.0	9.0	2.2	4.0	10.7	0.0	1.7	8.6	0.0	2.0	2.0	6.1	0.0	3.1	0.8	83.5	14.9	76.1	11.5	19.7	10.0	3.2	10.1	8.2	8.6	2.9	9.9	8.4	0.9	2.0	21.1	1.0	9.6	11.8	1.8	2.8	1.1	3.2	1.7	1.6	2.2	1.2	3.0	2.4
PLVAP	"FELS, gp68, PV-1, PV1"	ENSG00000130300	"Plasmalemma vesicle associated protein"	Q9BX97	19	17351448-17377350	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 128.3"	"Cell line enriched"	"Detected in some"	28	"EFO-21: 109.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	6	"plasmacytoid DC: 22.1"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 22.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA002279	Supported		Approved	"Plasma membrane,Centrosome,Cytosol"		53000	53000	Cytosol	Cytosol	"HPA002279: AB_1079636"	"unprognostic (3.19e-1)"	"unprognostic (8.22e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.49e-3)"	"unprognostic (4.17e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.53e-2)"	"unprognostic (8.96e-2)"	"unprognostic (4.24e-3)"	"unprognostic (4.70e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.58e-1)"	"unprognostic (8.17e-2)"	128.3	9.8	0.8	16.4	0.9	0.0	56.3	0.4	1.5	28.7	29.8	3.2	12.8	20.2	32.0	19.8	27.4	16.6	43.1	18.9	1.1	0.4	33.7	4.6	13.1	34.6	0.9	0.5	14.3	22.9	13.8	16.1	12.6	2.7	26.1	5.2	26.3	16.0	10.4	20.7	11.5	23.7	13.5	1.2	77.8	22.1	9.5	0.7	3.8	88.3	13.9	15.2	30.1	87.7	0.0	22.1	0.0	3.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	109.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.9	0.0	0.4	0.0	0.0	0.1	0.4	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	22.1	0.0	0.3	0.8	0.9	0.4	1.5	1.1	0.4	0.9	0.5	2.7	0.7
PLXNA4	"DKFZp434G0625PRO34003, FAYV2820, KIAA1550, PLXNA4A, PLXNA4B"	ENSG00000221866	"Plexin A4"	Q9HCM2	7	132123332-132648688	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 23.2;breast: 34.7"	"Cell line enhanced"	"Detected in some"		"ASC diff: 14.9;HMC-1: 9.9;RH-30: 10.7;TIME: 32.6"	"Cancer enhanced"	"Detected in many"		"glioma: 3.3"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"plasmacytoid DC: 6.1"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 6.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029919, HPA052141, HPA075592"	Approved		Approved	"Plasma membrane"	"Intracellular and membrane"			"Plasma membrane"	"Plasma membrane"	"HPA029919: AB_10671093, HPA052141: AB_2681745, HPA075592: "	"unprognostic (2.05e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.08e-2)"	"prognostic unfavourable (1.61e-6)"	"unprognostic (5.76e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.99e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.69e-5)"	"unprognostic (1.67e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.90e-2)"	"unprognostic (1.42e-3)"	23.2	5.1	8.7	3.5	9.0	1.1	34.7	3.9	15.1	16.2	2.0	1.0	0.8	1.5	2.3	1.0	7.7	3.0	4.2	6.9	9.7	7.2	2.0	1.3	1.8	2.5	4.0	6.6	6.2	1.0	1.0	1.6	6.7	6.6	1.4	2.1	0.7	1.2	2.4	1.7	4.1	1.4	5.1	1.5	2.4	2.8	2.4	1.8	0.0	3.3	0.0	1.3	2.1	9.4	0.0	6.1	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.1	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	9.9	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	10.7	1.1	0.0	0.0	0.2	5.6	0.0	0.0	0.0	0.0	0.0	32.6	3.3	0.1	0.7	0.2	0.0	0.0	0.0	3.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	1.1	0.0	6.1	0.0	0.0	8.7	9.0	3.9	15.1	9.7	7.2	4.0	6.6	6.6	1.8
PNLIPRP3		ENSG00000203837	"Pancreatic lipase related protein 3"	Q17RR3	10	116427867-116477957	"Enzymes, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 8.5;breast: 15.9;esophagus: 12.0;skin 1: 15.5"	"Cell line enriched"	"Detected in some"	18	"hTCEpi: 84.8"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"HPA046202, HPA052009"	Uncertain				"Secreted - unknown location"					"HPA046202: AB_10959739, HPA052009: AB_2681692"					"unprognostic (2.62e-4)"	"unprognostic (1.60e-1)"			"unprognostic (6.97e-2)"									8.5	0.1	0.0	0.0	0.2	0.0	15.9	0.0	0.0	1.6	0.2	0.0	0.0	0.1	0.0	0.4	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	15.5	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.3	0.0	8.1	1.9	0.7	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	84.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
PPARG	"NR1C3, PPARG1, PPARG2, PPARgamma"	ENSG00000132170	"Peroxisome proliferator activated receptor gamma"	P37231	3	12287368-12434356	"Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 97.6;breast: 102.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 47.4;ASC TERT1: 27.0;BEWO: 55.9;CAPAN-2: 25.0;HSkMC: 27.8;PC-3: 24.9;RT4: 34.1"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 33.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.8;intermediate monocyte: 2.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB004282, HPA051239, HPA063663"	Approved		Enhanced	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"CAB004282: AB_628115, HPA051239: AB_2681400, HPA063663: "	"unprognostic (7.35e-3)"	"unprognostic (3.27e-2)"	"unprognostic (4.05e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.27e-3)"	"prognostic unfavourable (3.41e-5)"	"unprognostic (9.13e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.77e-1)"	"prognostic favourable (1.59e-8)"	"unprognostic (1.51e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.68e-3)"	"prognostic favourable (5.52e-5)"	97.6	1.6	1.9	17.1	1.2	0.7	102.1	1.5	1.3	3.1	24.9	0.8	2.1	7.5	3.5	2.2	2.8	2.4	8.7	12.5	1.4	0.9	6.7	5.9	24.8	11.4	1.1	0.9	6.7	1.2	2.8	0.3	26.8	0.9	10.4	13.9	1.1	5.8	1.5	5.0	2.7	9.6	7.4	1.2	7.0	11.9	3.5	0.6	0.9	6.2	4.3	2.1	30.2	14.1	0.0	0.4	0.0	2.3	0.0	0.7	0.3	9.6	8.6	0.0	0.0	47.4	27.0	55.9	0.9	10.4	1.3	0.5	1.8	25.0	0.0	0.0	0.9	3.9	3.4	0.1	0.2	23.2	4.8	0.0	1.9	2.3	12.6	0.0	0.0	27.8	2.3	2.3	9.0	0.1	0.0	0.0	2.0	2.4	0.0	0.1	0.1	24.9	0.0	0.0	0.0	7.1	34.1	0.0	0.2	4.0	1.5	0.5	0.0	7.7	7.8	1.8	2.6	1.0	0.0	0.0	0.0	0.0	0.8	0.1	0.2	0.0	1.8	0.0	0.0	2.3	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.3	1.9	1.2	1.5	1.3	1.4	0.9	1.1	0.9	0.9	0.6
PPP1R1A		ENSG00000135447	"Protein phosphatase 1 regulatory inhibitor subunit 1A"	Q13522	12	54575387-54588659	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 67.0;skeletal muscle: 227.2"	"Group enriched"	"Detected in some"	4	"ASC diff: 6.4;NTERA-2: 20.8;RPTEC TERT1: 22.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 17.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"memory B-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"B-cells: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB007811, HPA041542"	Approved									"CAB007811: AB_598171, HPA041542: AB_2677542"	"unprognostic (6.39e-3)"	"unprognostic (2.61e-1)"	"unprognostic (4.61e-3)"	"prognostic unfavourable (2.36e-5)"	"unprognostic (1.55e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.19e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.04e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.76e-3)"	"unprognostic (2.88e-3)"	"unprognostic (7.68e-3)"	"unprognostic (2.17e-1)"	"unprognostic (8.49e-3)"	"unprognostic (7.49e-2)"	67.0	2.1	9.9	1.6	33.2	1.3	51.8	2.2	8.2	1.6	4.0	2.9	0.5	2.2	1.7	1.8	4.3	1.6	1.9	34.6	6.6	3.7	35.4	27.5	1.3	1.4	6.4	4.8	3.3	5.6	3.9	0.1	1.2	4.8	2.9	1.8	0.1	3.1	2.3	227.2	1.3	2.4	2.3	2.7	1.3	4.7	1.7	7.8	0.0	1.4	16.6	1.4	1.4	4.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	3.8	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	20.8	0.0	0.0	0.0	0.1	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	33.2	2.2	8.2	6.6	3.7	6.4	4.8	4.8	7.8
PQLC2L	C3orf55	ENSG00000174899	"PQ loop repeat containing 2 like"	A1A4F0	3	157543246-157677749	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 29.8;breast: 36.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 33.6;ASC TERT1: 18.6;EFO-21: 12.7;HSkMC: 12.1;LHCN-M2: 16.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA054395	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"	"Nucleoplasm, Nuclear bodies"	"HPA054395: AB_2682473"	"unprognostic (1.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.65e-3)"	"unprognostic (1.83e-5)"	"unprognostic (2.29e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.56e-2)"	"unprognostic (3.34e-2)"	"unprognostic (4.59e-3)"	"unprognostic (7.47e-7)"	"unprognostic (1.17e-3)"	"unprognostic (2.75e-1)"	"unprognostic (4.81e-2)"	"unprognostic (7.56e-3)"	29.8	1.6	0.2	1.8	1.3	0.1	36.0	0.0	0.8	5.3	4.1	0.0	0.0	0.1	1.3	2.0	3.1	1.8	4.3	5.6	0.3	1.2	4.5	0.1	8.4	1.6	0.5	0.1	0.4	1.4	0.1	5.9	2.6	1.3	3.9	1.4	4.6	4.5	1.0	4.8	2.2	1.6	3.4	0.3	0.1	3.8	2.7	0.0	0.0	11.8	3.0	0.5	4.2	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.7	0.0	0.0	33.6	18.6	0.0	1.7	3.5	0.7	1.0	0.0	2.4	0.0	12.7	5.3	0.0	0.0	0.0	2.3	0.0	0.0	0.5	0.0	0.0	2.6	0.0	0.0	12.1	0.6	5.2	0.3	5.3	0.3	0.0	16.9	0.1	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.1	2.1	0.0	0.1	0.1	1.1	0.0	4.8	0.0	4.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	1.3	0.0	0.8	0.3	1.2	0.5	0.1	1.3	0.0
PRG4	"bG174L6.2, CACP, FLJ32635, HAPO, JCAP, MSF, SZP"	ENSG00000116690	"Proteoglycan 4"	Q92954	1	186296279-186314562	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 20.9;liver: 76.0"	"Cell line enriched"	"Detected in some"	7	"ASC diff: 79.8"	"Cancer enriched"	"Detected in many"	10	"liver cancer: 28.4"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"T-reg: 4.0"	"Lineage enriched"	"Detected in single"	33	"T-cells: 4.0"	"Low region specificity"	"Detected in many"							HPA028523	Uncertain				"Secreted to extracellular matrix"	4300000000	4300000000			"HPA028523: AB_10669642"	"unprognostic (8.67e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.87e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.91e-13)"	"unprognostic (1.40e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.60e-3)"	"unprognostic (7.05e-3)"	20.9	0.7	0.1	1.0	0.1	0.2	5.1	0.2	0.3	0.2	2.8	0.4	0.1	0.1	0.2	1.7	0.9	6.8	0.3	11.0	0.1	0.3	0.2	76.0	7.2	0.3	0.3	0.1	0.7	1.1	0.1	0.3	0.1	0.3	0.3	0.2	2.6	1.0	0.2	13.8	1.6	0.2	0.7	0.1	0.3	0.2	1.1	0.1	0.2	0.7	1.9	0.3	0.7	0.1	0.1	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.0	0.0	79.8	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	7.3	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.6	0.2	0.0	0.0	0.0	0.0	4.0	0.1	0.1	0.1	0.2	0.3	0.1	0.3	0.3	0.1	0.3	0.1
PROKR1	"GPR73, GPR73a, PKR1, ZAQ"	ENSG00000169618	"Prokineticin receptor 1"	Q8TCW9	2	68643589-68658247	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 3.3;epididymis: 8.9"	"Cell line enhanced"	"Detected in some"		"HMC-1: 2.2;NTERA-2: 6.5;SCLC-21H: 1.5"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.5"	"Lineage enhanced"	"Detected in single"		"monocytes: 1.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA029396	Uncertain									"HPA029396: AB_10610285"	"unprognostic (5.46e-2)"	"unprognostic (1.60e-2)"	"unprognostic (8.75e-2)"	"unprognostic (4.99e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.72e-2)"	"unprognostic (8.96e-7)"	"unprognostic (4.07e-2)"	"unprognostic (2.53e-1)"	"unprognostic (4.19e-1)"	"unprognostic (7.22e-2)"	3.3	2.6	0.0	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.2			0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	1.3	0.0		0.0	0.1		0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0										
PRR25	gs64	ENSG00000167945	"Proline rich 25"	Q96S07	16	805443-813861	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 1.5;blood: 1.2"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.2;HEK 293: 4.5;PC-3: 1.6"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"neutrophil: 1.2"	"Low lineage specificity"	"Detected in single"											HPA042974	Uncertain									"HPA042974: AB_2678247"	"unprognostic (2.49e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.31e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.10e-1)"		"unprognostic (2.23e-1)"	"unprognostic (1.60e-1)"	"unprognostic (8.69e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.56e-3)"	"unprognostic (3.15e-2)"	"unprognostic (2.28e-1)"	"unprognostic (8.10e-4)"	"unprognostic (4.04e-4)"	1.5	0.0	0.6	1.0	0.6	0.4	0.0	0.8	0.9	0.2	0.3			0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.6	0.1	0.0	0.1	0.2	0.4		0.1	0.0	0.0	0.3	0.0		0.1	0.0		0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.6	0.4	0.5			0.0		0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.6	0.5	0.0	0.7	0.0	0.1	0.5	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.1	0.9	0.2	0.0	1.2	0.0	0.0	0.0	0.5	4.5	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.1	0.2	0.1	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.1	0.0	0.5	0.5	0.5	0.1	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.0	1.2	0.6	0.0	0.0	0.0	0.0										
PTX3	"TNFAIP5, TSG-14"	ENSG00000163661	"Pentraxin 3"	P26022	3	157436789-157443628	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 61.7;skeletal muscle: 67.7;urinary bladder: 77.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 84.6;ASC TERT1: 122.6;BJ hTERT+: 80.5;HHSteC: 157.4;HSkMC: 163.9;hTEC/SVTERT24-B: 86.6;TIME: 116.7;U-2197: 108.8"	"Cancer enhanced"	"Detected in many"		"glioma: 22.5"	"Group enriched"	"Detected in some"	6	"hippocampal formation: 1.1;pons and medulla: 3.6"	"Cell type enhanced"	"Detected in some"		"eosinophil: 3.2"	"Group enriched"	"Detected in many"	20	"dendritic cells: 1.3;granulocytes: 3.2;monocytes: 1.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA069320	Approved		Approved	"Plasma membrane"	"Secreted to blood"	310000	310000	"Plasma membrane"	"Plasma membrane"	"HPA069320: AB_2686118"	"unprognostic (1.93e-2)"	"unprognostic (4.96e-3)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (8.35e-9)"	"unprognostic (5.79e-3)"	"prognostic unfavourable (6.36e-4)"	"unprognostic (6.03e-3)"	"prognostic unfavourable (8.75e-6)"	"unprognostic (2.45e-1)"	"unprognostic (6.69e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.76e-9)"	"unprognostic (6.03e-3)"	"unprognostic (5.98e-2)"	"unprognostic (2.15e-4)"	"unprognostic (1.92e-3)"	61.7	3.4	0.3	16.7	0.2	31.6	35.3	0.2	0.7	0.8	13.2	0.3	0.6	0.5	0.5	0.8	2.0	6.5	3.5	14.7	1.1	0.0	3.0	0.6	22.5	7.0	0.3	0.1	6.8	18.0	0.3	1.0	4.9	3.6	2.5	1.2	5.2	1.8	0.4	67.7	6.0	1.9	6.4	0.9	9.6	4.9	0.9	0.2	0.3	2.7	0.4	0.4	77.0	2.5	0.0	1.3	3.2	1.2	0.0	0.0	0.1	0.0	0.0	51.0	0.0	84.6	122.6	0.0	8.8	80.5	3.8	4.1	0.0	0.5	0.0	31.4	10.3	0.0	0.0	0.0	7.5	0.0	0.0	0.1	0.0	0.0	157.4	0.1	0.0	163.9	0.0	86.6	29.5	17.8	0.0	0.0	25.4	0.0	0.0	0.1	0.7	0.3	0.0	0.0	0.0	0.3	3.5	0.4	0.0	0.5	0.0	0.0	0.0	0.1	116.7	17.3	0.8	108.8	1.5	0.0	0.0	0.0	3.6	0.4	4.9	0.0	1.2	3.2	0.0	1.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.3	0.2	0.2	0.2	1.1	0.0	0.3	0.1	3.6	0.2
PVALEF	AATK-AS1	ENSG00000225180	"Parvalbumin like EF-hand containing"		17	81165507-81183164	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"			"Tissue enhanced"	"Detected in some"		"adipose tissue: 1.2;brain: 1.1"	"Cell line enhanced"	"Detected in some"		"MCF7: 2.3;REH: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (1.35e-2)"				"unprognostic (2.55e-1)"					"unprognostic (4.40e-1)"				"unprognostic (2.30e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.09e-1)"		1.2	0.1		0.0		0.0	0.1		1.1	0.0	0.0			0.7	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.1	0.0		0.2	0.0	0.1	0.0	0.2	0.0		0.0	0.0	0.2			0.1		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.9	0.0	1.0	0.0	0.0	0.0	0.2	0.7	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
RAB7B	"MGC16212, MGC9726"	ENSG00000276600	"RAB7B, member RAS oncogene family"	Q96AH8	1	205976740-206003461	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 21.3;skin 1: 23.7"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 11.4;HBEC3-KT: 14.9;HMC-1: 40.6;hTCEpi: 17.4"	"Low cancer specificity"	"Detected in all"							"Cell type enriched"	"Detected in some"	6	"myeloid DC: 8.4"	"Lineage enriched"	"Detected in many"	8	"dendritic cells: 8.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (4.18e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavourable (4.87e-4)"	"unprognostic (6.99e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.79e-2)"	"unprognostic (7.88e-2)"	"unprognostic (9.14e-2)"	"unprognostic (2.23e-3)"	"unprognostic (5.97e-2)"	"unprognostic (8.57e-2)"	"unprognostic (3.89e-3)"	"unprognostic (3.13e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.63e-2)"	"unprognostic (8.82e-3)"	21.3	0.0	0.5	1.9	1.3	0.0	4.5	0.0	2.0	6.6	0.6	4.0	3.6	0.6	3.3	4.7	7.7	0.9	6.5	1.7	0.5		0.0	0.5	6.1	2.6	0.5	0.0	1.7	0.0	0.0	0.0	5.8	3.0	2.5	0.9	1.5	1.9	3.2	0.6	23.7	0.5	4.2	1.3	1.0	2.5	1.6	0.8	3.4	3.0	13.3	4.4	3.3	0.3	0.0	8.4	0.0	1.0	0.0	0.0	0.4	0.6	0.0	0.3	0.3	0.9	6.8	1.6	2.9	3.6	1.3	1.1	0.4	1.0	0.0	1.0	11.4	2.9	0.0	14.9	0.4	0.1	0.0	0.0	0.0	0.3	0.0	9.4	40.6	2.3	17.4	2.4	0.0	0.0	0.1	0.0	0.8	0.1	0.0	5.8	0.1	0.0	0.0	0.8	0.3	0.3	0.1	0.0	0.0	0.4	0.0	1.9	1.0	3.3	0.0	0.8	2.0	0.8	0.2	0.0	0.0	0.0	5.5	4.0	1.4	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.4										
RBP7	CRBPIV	ENSG00000162444	"Retinol binding protein 7"	Q96R05	1	9997206-10016020	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 68.1;breast: 210.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 10.3;SK-MEL-30: 6.9;T-47d: 26.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 54.1;intermediate monocyte: 23.4;neutrophil: 60.6"	"Group enriched"	"Detected in many"	30	"granulocytes: 60.6;monocytes: 54.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA034749	Enhanced		Uncertain	"Nuclear speckles,Cytosol"				"Nuclear speckles, Cytosol"	"Nuclear speckles, Cytosol"	"HPA034749: AB_10602084"	"unprognostic (1.93e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavourable (2.49e-4)"	"unprognostic (9.59e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.05e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.46e-2)"	"unprognostic (7.90e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.61e-2)"	68.1	3.7	3.8	3.0	11.4	7.5	210.2	2.1	5.5	4.3	10.9	8.7	2.7	0.5	6.4	4.5	7.2	2.4	14.7	29.7	5.3	2.8	7.6	2.5	2.5	4.5	7.6	3.0	2.6	3.7	14.7	3.5	4.4	6.2	4.7	1.2	3.5	4.8	2.7	5.9	6.6	2.0	4.4	8.9	21.5	3.0	2.6	5.2	1.2	11.3	1.8	1.4	4.5	17.5	0.0	1.8	60.6	54.1	0.0	0.1	15.0	0.0	0.6	0.2	0.0	0.0	0.3	0.0	0.0	0.0	1.9	0.8	1.8	2.3	0.0	10.3	1.0	0.0	0.0	0.7	3.3	0.0	2.5	0.0	0.1	0.9	1.2	0.0	0.0	0.0	1.6	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	4.3	0.0	0.0	0.0	0.5	0.0	0.1	0.3	1.9	0.1	6.9	26.2	1.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	54.1	0.4	0.0	23.4	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	60.6	0.0	11.1	0.3	0.1	15.0	3.8	11.4	2.1	5.5	5.3	2.8	7.6	3.0	6.2	5.2
RDH5	"HSD17B9, RDH1, SDR9C5"	ENSG00000135437	"Retinol dehydrogenase 5"	Q92781	12	55720367-55724705	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 39.4;retina: 127.9"	"Cell line enhanced"	"Detected in some"		"ASC diff: 19.5;ASC TERT1: 16.8;hTEC/SVTERT24-B: 10.2;LHCN-M2: 10.1;U-87 MG: 18.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063345			Approved	Vesicles	"Intracellular and membrane"			Vesicles	Vesicles	"HPA063345: AB_2684992"	"unprognostic (1.04e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.26e-3)"	"unprognostic (7.63e-2)"	"unprognostic (8.79e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.12e-3)"	"unprognostic (3.27e-2)"	39.4	0.7	0.6	2.8	0.8	0.2	14.9	0.5	0.8	1.0	7.6	1.0	1.5	8.6	1.9	4.5	2.4	2.2	4.8	3.9	1.0	0.5	3.7	27.2	0.7	1.6	0.8	0.8	1.4	1.5	0.0	0.6	0.4	1.5	1.8	1.9	127.9	3.2	1.0	3.1	1.0	9.4	8.8	1.1	0.9	2.7	0.9	1.0	0.3	1.1	2.6	0.7	2.0	2.5	0.4	2.3	2.1	0.9	1.5	2.6	0.4	0.4	0.9	0.5	0.3	19.5	16.8	0.4	2.5	2.8	0.5	1.0	0.3	5.2	0.6	0.4	1.4	0.2	0.2	0.0	0.4	0.6	0.8	0.1	1.1	1.3	0.5	0.0	0.2	7.2	0.6	10.2	0.0	0.2	0.1	0.9	10.1	0.4	0.2	0.1	0.2	1.5	0.3	0.3	0.3	0.1	0.5	0.2	0.7	0.1	0.3	2.3	0.4	0.4	0.3	1.0	1.0	0.7	0.6	0.8	0.3	0.1	18.1	0.2	0.2	0.3	0.6	2.1	0.4	0.9	0.2	0.4	1.2	2.6	1.2	0.3	1.0	0.4	0.9	1.5	0.9	2.3	0.2	0.4	0.6	0.8	0.5	0.8	1.0	0.5	0.8	0.8	1.5	1.0
RSAD2	"cig5, vig1, viperin"	ENSG00000134321	"Radical S-adenosyl methionine domain containing 2"	Q8WXG1	2	6865806-6898239	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 31.8"	"Group enriched"	"Detected in some"	5	"BJ hTERT+ SV40 Large T+: 30.4;BJ hTERT+ SV40 Large T+ RasG12V: 46.9;HMC-1: 21.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 24.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 24.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA041160, HPA049409"	Approved		Supported	"Nucleoli fibrillar center,Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA041160: AB_10795489, HPA049409: AB_2680751"	"unprognostic (8.91e-2)"	"unprognostic (3.85e-2)"	"unprognostic (7.89e-2)"	"prognostic unfavourable (4.60e-4)"	"unprognostic (3.27e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.66e-3)"	"unprognostic (9.47e-3)"	"unprognostic (4.06e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.54e-3)"	"unprognostic (4.47e-2)"	"unprognostic (1.79e-1)"	31.8	3.1	4.8	10.1	8.7	12.5	4.1	1.1	7.8	7.2	5.6	4.7	2.1	3.4	4.8	7.8	2.9	5.5	6.2	5.3	5.3	5.8	6.1	3.6	15.3	7.7	4.8	5.6	3.5	2.1	1.2	6.2	10.1	12.5	3.7	3.1	7.5	20.2	2.5	5.5	1.0	4.9	5.2	6.1	10.8	7.2	2.3	2.0	11.5	10.2	3.5	2.8	4.0	2.0	0.4	2.7	24.3	5.1	1.6	3.2	2.2	0.0	0.0	0.0	0.2	0.0	0.2	0.5	0.0	0.4	30.4	46.9	0.0	0.9	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	21.9	0.0	0.0	2.0	0.0	0.0	0.5	0.4	0.0	0.0	2.8	0.6	0.1	0.2	0.3	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.5	0.1	14.6	3.6	24.3	1.8	5.1	2.2	0.2	1.9	1.7	2.7	0.4	3.2	2.4	14.4	1.6	4.5	0.2	0.9	2.2	4.8	8.7	1.1	7.8	5.3	5.8	4.8	5.6	12.5	2.0
SAA2-SAA4		ENSG00000255071	"SAA2-SAA4 readthrough"		11	18231423-18248635	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"adipose tissue: 15.9;cervix, uterine: 10.6;liver: 44.4"	"Cell line enhanced"	"Detected in some"		"A-431: 6.7;CAPAN-2: 1.5;EFO-21: 3.9;HaCaT: 2.7;RPTEC TERT1: 1.5;SiHa: 1.5"	"Cancer enriched"	"Detected in many"	13	"liver cancer: 39.9"					"Cell type enriched"	"Detected in single"	10	"memory B-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"B-cells: 1.0"									HPA060139	Uncertain									"HPA060139: AB_2684210"	"prognostic favourable (4.56e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.23e-3)"	"unprognostic (9.41e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.96e-1)"		"unprognostic (8.27e-3)"	"unprognostic (3.17e-2)"	"unprognostic (7.30e-2)"	"prognostic unfavourable (2.92e-8)"	"unprognostic (1.92e-1)"			"unprognostic (2.72e-1)"	15.9	0.6	0.0	0.7	0.0	0.0	2.7	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0		0.0	44.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.1	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	1.5	0.0	3.9	0.0	2.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.5	0.6	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SEMA3G	"FLJ00014, sem2"	ENSG00000010319	"Semaphorin 3G"	Q9NS98	3	52433053-52445085	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 46.2;breast: 89.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 23.4;Hep G2: 6.2;HUVEC TERT2: 6.6;THP-1: 5.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	14	"T-reg: 4.5"	"Lineage enriched"	"Detected in single"	18	"T-cells: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001761	Uncertain				"Secreted to blood"	4400000	4400000			"HPA001761: AB_1079902"	"unprognostic (2.10e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.79e-4)"	"unprognostic (5.20e-3)"	"unprognostic (9.14e-2)"	"unprognostic (5.54e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.14e-1)"	"prognostic favourable (8.86e-5)"	"unprognostic (5.63e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.14e-1)"	46.2	1.6	3.1	2.4	5.0	0.2	89.1	11.5	5.3	3.5	5.4	2.8	1.5	2.1	3.3	3.0	3.5	3.2	4.5	8.0	3.8	3.3	8.8	0.7	30.4	1.2	5.5	2.5	2.0	2.2	1.1	1.1	19.3	3.1	2.9	2.8	6.8	13.6	2.1	8.0	5.2	6.7	3.2	3.6	7.2	2.7	2.0	1.1	0.4	3.5	4.7	1.4	3.7	5.3	0.2	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.1	0.1	0.2	23.4	0.2	2.6	0.0	0.0	0.0	0.0	0.7	0.4	3.0	1.3	0.0	0.0	0.1	0.0	0.0	0.2	1.2	3.4	0.2	6.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	6.6	0.0	0.3	0.0	0.2	0.2	4.0	1.2	0.1	0.0	0.0	3.7	0.0	0.2	0.6	0.6	0.0	0.3	0.4	2.0	5.8	2.5	0.0	2.5	0.0	0.0	0.4	1.7	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	3.1	5.0	11.5	5.3	3.8	3.3	5.5	2.5	3.1	1.1
SLC10A6	SOAT	ENSG00000145283	"Solute carrier family 10 member 6"	Q3KNW5	4	86823468-86849263	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 20.3;breast: 15.2;skin 1: 17.7"	"Cell line enhanced"	"Detected in some"		"ASC diff: 1.9;BJ: 4.8;BJ hTERT+: 3.9;HaCaT: 3.6;HBEC3-KT: 1.6;U-266/84: 2.0"	"Group enriched"	"Detected in many"	5	"cervical cancer: 3.5;head and neck cancer: 6.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA016662	Enhanced									"HPA016662: AB_1669899"	"unprognostic (2.79e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.31e-3)"	"unprognostic (5.88e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.84e-4)"	"unprognostic (1.54e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.22e-2)"	"unprognostic (5.89e-4)"	20.3	0.5	0.6	0.9	0.7	0.0	15.2	0.1	0.6	3.7	1.6	0.0	2.1	0.1	2.0	0.8	12.5	0.8	1.4	1.2	0.4	0.2	0.2	0.2	1.2	0.1	2.7	0.0	0.4	1.1	0.9	3.7	0.3	0.9	0.9	0.4	0.0	2.0	0.5	2.3	17.7	0.4	2.4	1.6	0.3	0.5	4.9	1.1	0.0	1.4	11.2	2.9	4.6	5.3	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	1.9	0.1	0.2	4.8	3.9	0.0	0.0	0.0	0.2	0.0	0.2	0.1	3.6	0.2	1.6	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	2.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.7	0.1	0.6	0.4	0.2	2.7	0.0	0.9	1.1
SLC19A3	THTR2	ENSG00000135917	"Solute carrier family 19 member 3"	Q9BZV2	2	227683763-227718031	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 48.2;breast: 78.2;placenta: 27.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 14.1;BEWO: 7.2;CACO-2: 18.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 8.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038898	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA038898: AB_10673481"	"unprognostic (3.37e-2)"	"unprognostic (3.59e-5)"	"unprognostic (1.95e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.67e-2)"	"unprognostic (3.12e-3)"	"unprognostic (7.28e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.71e-2)"	"unprognostic (7.01e-3)"	48.2	0.6	2.2	1.8	2.4	1.2	78.2	1.5	1.9	0.5	6.1	1.0	0.5	7.7	0.6	0.4	0.6	0.6	8.9	1.9	2.3	2.4	2.1	16.0	5.6	1.3	3.0	0.7	0.9	1.3	0.2	0.3	27.5	2.6	0.5	1.6	0.7	0.9	0.2	0.7	1.6	4.5	0.5	2.6	0.5	0.5	0.6	1.5	0.0	0.5	0.4	0.4	1.0	2.3	2.6	1.8	8.6	1.8	4.3	1.1	0.4	0.3	1.6	0.3	1.0	14.1	0.4	7.2	0.1	0.2	0.3	0.6	18.4	0.5	0.4	0.2	0.1	0.5	0.5	0.5	0.8	0.1	1.2	0.1	0.9	0.7	1.7	0.2	0.2	3.2	0.4	0.1	0.9	0.0	0.2	0.8	0.0	1.8	0.1	0.6	3.2	0.3	0.3	0.2	0.2	0.2	0.3	1.0	0.1	0.5	2.0	0.5	0.3	0.2	0.5	0.5	0.5	4.1	0.3	0.2	0.1	0.6	1.4	0.3	0.4	8.6	1.8	1.7	1.0	1.2	0.6	1.6	0.8	0.9	0.4	2.6	1.0	1.1	6.1	4.3	1.1	1.8	0.4	0.4	2.2	2.4	1.5	1.9	2.3	2.4	3.0	0.7	2.6	1.5
SLC29A4	"ENT4, FLJ34923"	ENSG00000164638	"Solute carrier family 29 member 4"	Q7RTT9	7	5274369-5306870	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 35.7"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 24.0;SH-SY5Y: 34.8;U-2 OS: 12.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA052829			Approved	"Microtubules,Cytokinetic bridge"				"Microtubules, Cytokinetic bridge"	"Microtubules, Cytokinetic bridge"	"HPA052829: AB_2681967"	"unprognostic (6.04e-2)"	"unprognostic (1.22e-2)"	"unprognostic (8.49e-5)"	"unprognostic (2.53e-1)"	"unprognostic (1.47e-3)"	"unprognostic (4.24e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.05e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.73e-2)"	"prognostic favourable (4.52e-4)"	"unprognostic (2.06e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.29e-3)"	"unprognostic (6.60e-2)"	35.7	8.3	7.6	2.5	6.4	0.8	6.5	4.2	9.7	2.0	2.5	2.0	0.3	4.5	2.4	5.3	1.3	4.2	1.8	1.7	9.4	15.7	3.4	3.8	1.2	1.8	12.2	5.4	3.2	13.0	0.5	1.6	0.8	7.0	3.0	2.0	11.5	1.1	1.0	2.1	1.4	5.4	2.0	3.1	1.1	7.1	1.3	1.1	0.3	4.3	0.3	0.7	2.3	0.5	1.3	1.1	4.3	1.1	4.3	1.3	0.3	0.0	10.4	6.2	24.0	0.3	0.1	1.1	0.9	0.0	0.8	0.4	5.8	0.2	0.0	1.2	0.9	0.1	2.3	0.2	0.2	0.0	1.3	0.1	0.3	8.5	1.9	0.1	1.4	0.7	8.0	0.1	0.4	0.7	1.6	0.1	0.6	5.0	0.9	0.4	7.8	0.6	3.9	1.0	0.9	1.6	0.2	4.1	34.8	0.6	2.1	0.4	2.6	2.8	0.3	8.6	12.0	0.8	0.2	0.5	0.0	0.0	1.1	0.3	3.8	2.0	1.1	0.6	0.8	0.5	1.3	0.7	0.5	0.7	0.4	1.3	0.7	0.9	4.3	4.3	0.5	1.1	0.3	0.3	7.6	6.4	4.2	9.7	9.4	15.7	12.2	5.4	7.0	1.1
SLC7A10	asc-1	ENSG00000130876	"Solute carrier family 7 member 10"	Q9NS82	19	33208664-33225850	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 40.9;brain: 13.6;breast: 15.6"	"Group enriched"	"Detected in some"	5	"BEWO: 4.2;HHSteC: 2.5;HSkMC: 3.6;THP-1: 8.2;U-2 OS: 2.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041884, HPA057036"	Uncertain		Uncertain	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA041884: AB_10794494, HPA057036: AB_2683317"	"unprognostic (1.85e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.79e-6)"	"unprognostic (1.16e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.98e-3)"	"unprognostic (4.64e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.28e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.34e-3)"	"unprognostic (8.91e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.18e-2)"	40.9	1.0	9.8	1.9	13.6	1.0	15.6	2.4	12.1	1.0	2.2	0.8	0.0	1.0	1.0	1.0	1.0	1.0	1.0	1.1	4.7	6.2	1.3	1.0	1.0	1.2	7.6	5.0	1.0	1.2	1.0	0.0	1.2	9.0	1.0	1.0	8.4	2.3	1.0	1.0	1.1	1.0	1.1	0.8	1.0	1.0	1.4	1.8	0.0	1.4	0.0	1.4	1.0	1.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.2	8.2	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	9.8	13.6	2.4	12.1	4.7	6.2	7.6	5.0	9.0	1.8
SNCG	"BCSG1, persyn, SR"	ENSG00000173267	"Synuclein gamma"	O76070	10	86958618-86963260	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 74.1;adrenal gland: 78.3;brain: 100.1;urinary bladder: 76.6"	"Group enriched"	"Detected in some"	4	"CAPAN-2: 93.7;RT4: 77.2"	"Group enriched"	"Detected in all"	8	"ovarian cancer: 84.1;urothelial cancer: 301.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.4;naive CD4 T-cell: 1.8"	"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 292.8"	"Low region specificity"	"Detected in many"			"CAB001452, HPA014404, CAB040581"	Enhanced	Supported	Supported	"Nuclear bodies,Centrosome"				Centrosome	Centrosome	"CAB001452: AB_564020, CAB040581: , HPA014404: AB_1857715"	"unprognostic (2.06e-1)"	"unprognostic (2.58e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.76e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.85e-3)"	"unprognostic (3.75e-1)"	"prognostic unfavourable (2.29e-8)"	"prognostic unfavourable (7.15e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.77e-3)"	74.1	78.3	82.3	5.3	20.8	1.0	28.9	12.3	44.5	9.5	5.8	4.6	6.4	4.8	6.1	12.0	11.0	26.5	6.2	9.0	40.0	92.9	4.1	1.9	4.6	4.9	72.9	35.1	15.0	3.5	1.6	1.7	4.9	100.1	11.9	2.7	10.8	10.9	44.4	6.6	8.5	5.4	5.8	35.2	20.2	2.6	2.9	5.3	0.2	3.4	3.3	9.6	76.6	18.3	0.0	0.7	0.0	2.4	0.0	1.8	0.6	0.2	1.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	93.7	0.0	1.9	0.1	7.8	0.0	0.3	0.0	0.0	0.0	0.5	18.2	0.3	0.1	0.0	0.1	0.4	7.3	0.0	0.0	6.6	0.6	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	77.2	0.0	0.0	0.6	1.0	0.1	20.3	0.0	17.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	2.4	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.7	0.0	1.8	0.0	0.0	0.0	0.9	0.0	0.0	0.6	82.3	20.8	12.3	44.5	40.0	92.9	72.9	35.1	100.1	5.3
SOX18		ENSG00000203883	"SRY-box 18"	P35713	20	64047582-64049641	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 53.3"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 15.2;NB-4: 25.0;REH: 5.9;TIME: 6.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073703			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA073703: AB_2686628"	"unprognostic (2.51e-1)"	"unprognostic (3.23e-1)"	"unprognostic (9.98e-3)"	"unprognostic (6.30e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.71e-2)"	"unprognostic (4.35e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.13e-3)"	"unprognostic (9.63e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.46e-1)"	"unprognostic (5.40e-2)"	53.3	6.2	3.1	9.9	5.0	1.8	27.5	2.5	5.2	18.3	9.4	3.1	4.3	7.4	26.0	10.0	16.4	15.0	15.8	29.7	3.2	3.1	10.1	6.8	29.3	17.7	4.8	2.3	11.2	3.6	4.6	3.2	12.4	6.1	12.3	2.7	13.1	8.1	5.8	20.3	7.9	7.2	7.0	3.4	13.7	7.2	6.9	1.2	2.9	13.8	20.5	5.8	8.4	18.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	3.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.7	0.0	0.1	0.2	0.0	0.0	0.3	0.7	0.0	2.0	3.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	15.2	2.6	0.0	0.0	0.5	0.0	25.0	0.1	0.2	5.9	0.0	0.4	0.0	1.0	0.4	0.4	0.2	0.0	0.3	0.4	1.2	6.9	0.1	1.9	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	5.0	2.5	5.2	3.2	3.1	4.8	2.3	6.1	1.2
SPAAR	"LINC00961, SPAR"	ENSG00000235387	"Small regulatory polypeptide of amino acid response"	A0A1B0GVQ0	9	35909483-35937153	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 12.2;breast: 13.7;testis: 16.5"	"Group enriched"	"Detected in some"	13	"HUVEC TERT2: 22.1;TIME: 25.7"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 1.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (3.17e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.91e-2)"	"unprognostic (7.00e-3)"	"unprognostic (4.23e-2)"	"unprognostic (2.61e-3)"	"unprognostic (6.95e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.40e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.72e-2)"	"unprognostic (7.12e-3)"	"unprognostic (1.67e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.22e-1)"	12.2	0.6	1.4	0.7	2.4	0.0	13.7	0.3	1.2	0.2	0.9	0.3	0.8	0.3	0.5	0.3	0.6	0.4	0.8	5.6	1.4		3.5	1.3	4.6	0.4	1.4	0.1	0.2	0.5	0.1	0.4	6.9	1.9	0.3	0.4	0.9	0.8	0.5	6.2	0.0	0.6	0.8	1.3	0.4	0.3	16.5	1.4	0.0	1.1	1.2	0.0	0.3	2.8	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.3	0.1	0.1	0.0	22.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.7	0.0	0.5	1.8	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0										
SPOCD1	"FLJ25348, PPP1R146"	ENSG00000134668	"SPOC domain containing 1"	Q6ZMY3	1	31790422-31816051	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 28.9;urinary bladder: 13.7"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 18.6;hTEC/SVTERT24-B: 19.3;RT4: 32.6;TIME: 16.9;U-87 MG: 32.1"	"Group enriched"	"Detected in many"	7	"glioma: 13.9;urothelial cancer: 5.6"	"Region enhanced"	"Detected in many"		"pons and medulla: 8.2"	"Cell type enriched"	"Detected in single"	15	"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 1.9"					"Low region specificity"	"Detected in some"			"HPA031713, HPA031714, HPA031715"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol				Cytosol	Cytosol	"HPA031713: AB_10604099, HPA031714: AB_2674007, HPA031715: "	"unprognostic (7.78e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.60e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.01e-2)"	"unprognostic (3.00e-1)"	"unprognostic (0.00e+0)"	"unprognostic (1.97e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.54e-2)"	"prognostic favourable (4.05e-5)"	28.9	0.5	1.8	5.1	1.6	0.3	1.6	0.4	3.9	2.0	0.7	1.5	0.1	1.6	2.4	2.8	0.3	2.1	1.6	0.4	1.2	1.6	0.5	0.2	12.9	0.9	2.6	0.3	1.8	0.1	0.1	1.6	3.5	8.2	1.8	0.9	1.8	0.1	0.3	0.4	0.1	0.9	2.4	3.1	1.9	1.1	11.9	0.6	0.1	0.4	0.8	0.2	13.7	2.1	0.0	0.0	1.9	0.1	0.0	0.0	7.3	10.6	0.3	0.0	0.0	0.2	1.5	0.5	13.9	18.6	13.5	9.0	0.2	0.6	0.1	1.9	15.6	1.4	0.0	0.2	4.3	0.0	0.0	0.0	1.9	0.0	0.6	0.0	0.2	6.8	0.2	19.3	0.6	9.1	0.2	0.2	7.9	0.0	0.1	0.0	0.2	0.3	0.0	1.4	0.0	0.0	32.6	0.0	0.0	0.3	0.0	0.9	8.0	0.0	16.9	14.2	1.4	9.2	5.2	0.0	0.1	0.0	32.1	0.0	2.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	7.3	1.8	1.6	0.4	0.6	1.2	1.6	2.6	0.3	8.2	0.6
SPRY1	hSPRY1	ENSG00000164056	"Sprouty RTK signaling antagonist 1"	O43609	4	123396795-123403760	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 139.1"	"Cell line enhanced"	"Detected in many"		"AF22: 29.6;AN3-CA: 59.8;ASC diff: 24.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 29.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013538, HPA051369, HPA070554"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"	"Golgi apparatus, Cytosol"	"CAB013538: AB_2533452, HPA051369: AB_2681457, HPA070554: "	"unprognostic (1.27e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.06e-1)"	"unprognostic (7.15e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.43e-2)"	"unprognostic (6.99e-2)"	"unprognostic (4.32e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.11e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.21e-3)"	"unprognostic (4.48e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.27e-1)"	139.1	12.6	3.3	14.7	4.3	5.8	69.0	4.9	3.5	28.5	24.8	1.9	18.0	4.5	18.6	28.0	38.1	19.1	27.1	34.1	2.6	1.7	10.2	6.4	23.1	9.1	3.3	2.8	32.2	9.8	17.0	9.5	15.6	2.9	25.0	8.8	11.8	14.6	16.5	48.1	25.5	8.1	20.7	2.8	7.1	11.6	28.4	1.5	13.0	29.6	16.3	8.6	60.8	39.9	29.9	0.7	2.8	0.1	6.1	15.5	0.9	1.8	0.5	29.6	59.8	24.3	16.5	1.9	0.1	1.5	0.1	0.6	1.8	3.1	0.0	13.3	0.8	0.3	0.7	1.4	0.2	0.0	3.0	0.6	0.0	9.2	6.9	4.1	0.0	6.7	0.7	0.2	0.6	2.5	0.5	0.5	1.4	0.2	4.8	10.3	7.1	9.8	2.1	3.2	0.0	4.0	4.3	4.5	3.8	0.0	6.0	5.7	0.6	0.0	6.1	0.3	0.0	0.1	0.8	0.3	0.0	0.0	0.4	0.8	0.9	0.0	0.1	2.8	0.5	0.0	15.5	9.6	1.8	4.2	0.0	29.9	2.7	2.9	0.1	6.1	0.0	0.7	0.0	0.9	3.3	4.3	4.9	3.5	2.6	1.7	3.3	2.8	2.9	1.5
SPX	"C12orf39, MGC10946, NPQ, spexin"	ENSG00000134548	"Spexin hormone"	Q9BT56	12	21526307-21537377	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 34.3;brain: 14.4;breast: 23.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 14.7;HBEC3-KT: 7.5;hTERT-HME1: 10.2;U-2 OS: 4.8"	"Cancer enhanced"	"Detected in many"		"renal cancer: 13.5"	"Region enriched"	"Detected in some"	9	"pons and medulla: 14.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"cerebral cortex: 65.0;hippocampal formation: 70.8;olfactory region: 47.5;pons and medulla: 40.3"						"Secreted to blood"						"unprognostic (2.78e-2)"	"unprognostic (9.34e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.11e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.95e-1)"	"prognostic favourable (1.31e-6)"	"unprognostic (2.37e-3)"	"unprognostic (9.78e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.01e-2)"	34.3	0.0	0.2	0.0	0.3	0.0	23.1	0.1	1.4	0.0	2.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.4	1.5	0.4	0.7	7.1	0.7	0.2	0.5	1.5	0.0	0.0	7.8	0.0	0.0	12.7	14.4	0.0	0.0	0.0	6.4	0.0	1.3	0.1	0.0	0.0	0.4	0.3	0.0	0.0	0.2	1.3	2.7	0.4	0.0	0.1	0.0	0.1	0.6	0.5	0.0	0.0	0.2	1.5	0.0	0.5	0.3	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.8	14.7	0.0	0.6	0.2	0.0	0.0	0.0	7.5	0.8	0.0	0.0	2.8	0.0	0.0	0.7	0.0	0.0	3.1	0.4	0.1	10.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.7	0.0	0.5	0.1	0.4	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	4.8	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.6	0.0	1.5	0.2	0.3	0.1	0.3	0.4	0.7	1.5	0.0	14.4	0.2
SRPX2	SRPUL	ENSG00000102359	"Sushi repeat containing protein, X-linked 2"	O60687	X	100644166-100675788	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 60.2;breast: 57.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 73.9;ASC TERT1: 31.6;HSkMC: 28.4;HUVEC TERT2: 20.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA038786	Approved				"Secreted to blood"					"HPA038786: AB_10672724"	"unprognostic (4.10e-2)"	"unprognostic (4.55e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.21e-3)"	"unprognostic (3.59e-3)"	"unprognostic (5.41e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.29e-1)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.84e-3)"	"unprognostic (1.69e-1)"	"unprognostic (8.67e-2)"	"unprognostic (3.85e-1)"	60.2	5.2	0.4	8.0	2.4	0.3	57.3	0.9	1.1	10.2	5.7	0.9	3.8	1.6	5.6	8.4	15.4	5.0	4.3	10.9	0.9	0.4	5.0	3.5	10.3	2.2	4.3	1.0	9.9	2.9	0.4	1.3	11.6	2.2	7.7	3.0	2.7	3.9	5.5	6.0	2.6	3.4	6.2	5.0	10.1	3.4	5.6	1.2	0.1	7.1	9.1	5.8	17.4	17.8	0.5	0.5	1.2	0.8	0.3	0.3	0.5	2.9	0.5	0.7	0.0	73.9	31.6	0.0	6.6	4.9	2.0	6.6	0.4	4.6	0.0	0.2	4.0	0.1	0.0	3.8	2.1	0.0	0.0	0.0	0.2	0.7	7.5	0.0	0.2	28.4	0.0	7.1	0.2	20.0	0.0	0.0	7.0	0.0	0.0	0.0	0.8	0.1	0.0	0.6	0.0	2.9	11.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	10.6	4.4	3.1	2.8	0.2	0.0	0.0	0.0	5.1	0.0	2.3	1.1	0.7	0.2	0.3	0.8	0.1	0.4	0.2	0.2	0.1	0.5	0.2	0.3	1.2	0.3	0.6	0.5	0.1	0.5	0.4	2.4	0.9	1.1	0.9	0.4	4.3	1.0	2.2	1.2
STBD1	"FLJ41801, GENX-3414"	ENSG00000118804	"Starch binding domain 1"	O95210	4	76306026-76311599	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 16.1;liver: 14.3;skeletal muscle: 34.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 14.7;Karpas-707: 30.9;U-266/70: 19.9"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA011952, HPA012849"	Enhanced		Supported	Cytosol				Cytosol	Cytosol	"HPA011952: AB_1847461, HPA012849: AB_1847460"	"unprognostic (1.46e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.84e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.96e-3)"	"unprognostic (4.42e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.84e-1)"	"unprognostic (5.74e-2)"	16.1	1.2	0.1	0.7	0.0	1.9	3.7	0.0	0.5	1.2	2.7			1.2	2.3	0.0	1.6	1.2	1.0	7.1	0.0	0.5	0.7	14.3	2.6	0.0	0.3		1.3	1.9	0.4	0.2	1.2		2.1	1.6		1.2	1.1	34.5	0.0	3.9	2.4	0.6	0.0	2.3	0.5			0.1		0.0	3.4	1.4	0.2	3.2	5.9	3.6	3.7	3.6	1.4	3.7	1.8	0.2	2.4	5.2	1.4	3.3	4.1	2.5	1.6	1.9	1.7	4.4	0.0	3.3	2.7	2.3	0.7	0.9	0.6	14.7	1.0	0.2	2.2	2.2	0.7	2.1	2.7	0.8	2.6	1.3	0.6	0.0	0.1	30.9	2.8	2.4	0.2	1.7	0.4	2.0	0.0	0.8	2.5	0.9	1.8	0.8	4.3	3.2	4.1	0.0	1.1	0.7	0.7	3.1	2.0	7.3	2.3	19.9	3.6	0.0	4.3	1.3	1.0	0.3	3.6	5.9	2.7	3.3	1.7	0.2	3.6	3.4	3.2	0.0	0.6	1.1	0.7	3.7	1.6	0.2	0.6	1.4										
STC1	STC	ENSG00000159167	"Stanniocalcin 1"	P52823	8	23841915-23854807	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 62.3"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 59.1;hTEC/SVTERT24-B: 34.8;U-251 MG: 24.0;U-87 MG: 108.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"neutrophil: 1.0"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB018625, HPA023918"	Approved				"Secreted in other tissues"	120000	120000			"CAB018625: AB_2197536, HPA023918: AB_1857566"	"unprognostic (1.18e-1)"	"prognostic unfavourable (8.45e-4)"	"unprognostic (3.58e-2)"	"unprognostic (2.13e-1)"	"prognostic unfavourable (6.44e-5)"	"prognostic unfavourable (6.32e-4)"	"unprognostic (2.84e-2)"	"prognostic unfavourable (1.53e-4)"	"unprognostic (4.82e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavourable (1.23e-6)"	"prognostic unfavourable (5.55e-4)"	"unprognostic (2.79e-1)"	"unprognostic (1.19e-3)"	"unprognostic (8.95e-3)"	62.3	2.0	3.5	1.9	8.3	0.3	27.4	2.9	15.9	37.8	6.6	0.7	2.5	1.3	22.8	8.3	7.0	4.2	10.6	23.3	1.6	3.4	9.5	2.9	5.8	0.6	3.5	0.0	7.1	9.5	7.7	19.6	19.3	11.0	8.8	1.5	10.9	6.8	6.0	12.7	2.2	2.0	5.3	8.2	0.6	6.2	4.6	3.2	0.0	38.2	8.8	2.7	20.9	22.4	0.0	0.1	1.0	0.0	0.0	0.1	0.0	0.2	0.2	0.3	0.0	2.2	2.5	0.0	3.4	59.1	1.1	5.5	0.0	0.0	0.0	5.2	1.1	0.1	0.1	0.8	10.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	11.4	0.0	34.8	0.0	0.4	0.1	0.1	4.9	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	2.0	0.0	0.1	0.0	5.3	0.3	0.3	3.6	0.0	4.5	14.3	0.5	0.2	24.0	0.0	0.0	0.0	108.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	3.5	8.3	2.9	15.9	1.6	3.4	3.5	0.0	11.0	3.2
STEAP4	"FLJ23153, SchLAH, STAMP2, TIARP, TNFAIP9"	ENSG00000127954	"STEAP4 metalloreductase"	Q687X5	7	88270892-88306891	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 122.8"	"Group enriched"	"Detected in some"	6	"HSkMC: 38.4;SiHa: 36.0;U-2197: 51.1"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 45.9"	"Group enriched"	"Detected in some"	5	"midbrain: 1.7;pons and medulla: 6.4"	"Cell type enriched"	"Detected in some"	13	"neutrophil: 48.9"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 48.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA065201			Approved	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"	"Nucleoplasm, Plasma membrane"	"HPA065201: "	"unprognostic (3.76e-2)"	"unprognostic (2.16e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.96e-2)"	"prognostic favourable (2.97e-4)"	"unprognostic (7.40e-2)"	"unprognostic (3.12e-1)"	"unprognostic (4.66e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.51e-3)"	"prognostic unfavourable (5.77e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.53e-2)"	122.8	29.3	0.3	12.7	0.8	2.4	55.6	0.6	0.7	15.9	14.0	1.1	5.3	1.4	10.7	22.3	23.7	17.1	9.3	18.7	0.5	0.3	10.8	71.7	27.5	49.4	1.7	0.2	17.8	13.3	12.0	35.1	45.0	6.4	25.8	3.9	4.9	14.6	4.6	22.1	10.5	5.2	13.9	1.8	5.3	5.7	27.3	0.4	0.4	40.9	8.4	5.2	28.4	26.3	0.0	0.3	48.9	3.8	0.0	0.0	0.7	1.4	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	38.4	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	36.0	3.0	0.0	0.2	0.0	0.0	0.1	0.1	51.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.8	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	48.9	0.0	0.0	0.0	0.0	0.7	0.3	0.8	0.6	0.7	0.5	0.3	1.7	0.2	6.4	0.4
SYNE3	"C14orf139, C14orf49, FLJ25605, LINC00341, NCRNA00341, Nesp3, Nesprin-3, NET53"	ENSG00000176438	"Spectrin repeat containing nuclear envelope family member 3"	Q6ZMZ3	14	95407266-95475836	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 12.2;bone marrow: 10.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 24.8;ASC TERT1: 19.4;Karpas-707: 21.9;REH: 17.3"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA055227, HPA077140"	Approved		Supported	"Nuclear membrane"				"Nuclear membrane"	"Nuclear membrane"	"HPA055227: AB_2682747, HPA077140: AB_2686826"	"unprognostic (4.63e-2)"	"unprognostic (6.99e-3)"	"unprognostic (3.79e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.15e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.45e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.92e-1)"	"unprognostic (2.87e-1)"	"unprognostic (8.50e-2)"	"unprognostic (3.32e-1)"	"unprognostic (7.41e-6)"	"unprognostic (1.31e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.95e-2)"	"unprognostic (7.19e-2)"	12.2	2.4	1.2	2.7	1.3	10.0	6.5	0.3	1.2	2.1	1.0			0.6	1.2	0.6	1.1	2.0	1.2	2.8	1.6	1.1	0.4	1.0	2.7	4.0	1.6		3.0	0.1	0.0	0.5	2.1		0.6	1.6		1.9	0.4	1.1	2.8	1.5	1.2	2.6	2.7	0.9	1.6			1.7		4.3	1.6	2.8	3.4	2.6	5.4	5.1	0.9	3.7	2.2	0.6	0.0	0.3	0.5	24.8	19.4	7.4	2.7	4.8	2.6	2.1	3.9	0.6	3.1	0.4	1.3	0.1	0.6	2.0	1.2	10.4	0.4	2.1	0.5	1.0	3.2	3.3	5.5	5.4	0.7	3.3	1.9	4.6	0.1	21.9	2.0	0.7	1.9	3.6	0.1	1.3	17.3	12.1	6.7	0.3	0.3	0.5	2.7	0.1	0.0	1.3	1.0	4.8	4.2	1.9	1.2	2.6	0.3	2.6	5.3	3.0	3.9	7.4	14.5	5.4	5.1	0.4	2.2	4.0	2.8	3.4	2.9	2.3	2.1	3.3	3.7	3.0	2.4	0.9	4.1	2.6	2.3	2.2										
TACR1	"NK1R, NKIR, SPR, TAC1R"	ENSG00000115353	"Tachykinin receptor 1"	P25103	2	75046463-75199700	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 23.9"	"Cell line enhanced"	"Detected in some"		"BJ: 1.3;EFO-21: 3.1;fHDF/TERT166: 2.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	40	"basophil: 4.4"	"Lineage enriched"	"Detected in single"	40	"granulocytes: 4.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA074573	Enhanced									"HPA074573: AB_2686701"	"unprognostic (5.74e-4)"	"unprognostic (2.41e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.62e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.33e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.63e-2)"	"unprognostic (5.91e-4)"	"unprognostic (1.03e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.76e-2)"	23.9	1.0	2.0	1.8	8.5	0.3	8.2	0.3	4.8	15.2	1.9	0.1	1.5	0.8	17.7	3.6	4.8	6.9	2.5	0.9	1.5	2.5	1.5	0.4	2.1	2.9	0.9	1.0	4.2	0.7	1.3	1.1	1.6	2.3	6.1	1.4	0.3	2.6	2.5	2.6	8.7	1.4	6.5	0.9	0.4	1.2	2.0	1.5	0.2	1.1	4.3	3.4	4.8	14.3	0.1	0.0	4.4	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	1.1	0.0	0.5	3.1	2.7	0.1	0.0	0.0	0.0	0.0	0.3	0.3	0.5	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.8	0.3	0.3	0.6	0.3	0.0	0.0	0.2	0.1	0.0	0.1	0.2	0.0	1.0	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.5	0.1	0.0	0.0	1.2	0.1	0.1	4.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	8.5	0.3	3.6	1.5	2.5	0.9	1.0	2.3	1.5
THBS4		ENSG00000113296	"Thrombospondin 4"	P35443	5	79991311-80083287	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 69.8;heart muscle: 59.0;skeletal muscle: 61.7;smooth muscle: 94.0"	"Cell line enhanced"	"Detected in some"		"AF22: 5.0;THP-1: 10.7;U-2 OS: 4.6;U-266/70: 4.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	51	"eosinophil: 8.0"	"Lineage enriched"	"Detected in single"	51	"granulocytes: 8.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB004597, HPA042426"	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	420000000	420000000	Vesicles	Vesicles	"CAB004597: AB_628352, HPA042426: AB_2677992"	"unprognostic (1.41e-1)"	"unprognostic (5.33e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.64e-2)"	"unprognostic (9.94e-2)"	"unprognostic (8.10e-2)"	"unprognostic (5.64e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.96e-3)"	"unprognostic (2.74e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.76e-3)"	"prognostic unfavourable (3.33e-4)"	69.8	1.0	7.6	2.1	8.3	3.7	9.7	0.8	4.6	1.1	21.4	2.6	1.2	1.3	12.2	13.6	6.5	1.4	4.1	59.0	6.4	6.4	0.8	0.6	1.0	0.9	8.5	1.9	2.1	23.0	5.5	7.8	0.6	10.7	3.7	3.7	4.9	19.8	2.6	61.7	1.5	1.4	94.0	11.5	0.6	4.0	5.5	2.6	2.0	9.9	39.3	4.1	3.4	2.7	0.1	0.0	8.0	0.0	0.0	0.1	0.0	0.2	0.0	5.0	0.3	0.4	2.2	0.5	0.1	0.2	1.5	0.5	0.1	0.6	0.2	0.2	0.4	0.2	0.2	0.6	1.3	0.2	0.7	0.5	0.0	0.3	2.7	0.0	0.1	1.5	0.3	0.1	0.3	0.0	0.0	0.3	0.3	0.7	0.1	0.0	3.9	0.1	0.0	1.5	0.0	0.3	0.1	4.0	1.2	0.1	0.0	0.4	0.0	10.7	0.0	0.1	4.6	0.3	0.3	4.1	0.1	0.7	1.8	3.4	0.9	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.6	8.3	0.8	4.6	6.4	6.4	8.5	1.9	10.7	2.6
THRSP	"Lpgp, LPGP1, S14, SPOT14, THRP"	ENSG00000151365	"Thyroid hormone responsive"	Q92748	11	78063861-78068351	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 62.0;liver: 92.5;salivary gland: 45.6"	"Cell line enriched"	"Detected in some"	13	"ASC diff: 41.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 44.1"	"Region enriched"	"Detected in single"	10	"cerebellum: 1.0"	"Cell type enhanced"	"Detected in some"		"NK-cell: 1.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA040642	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA040642: AB_10794878"	"unprognostic (1.19e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.07e-1)"	"unprognostic (9.91e-3)"	"unprognostic (1.59e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.07e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.58e-1)"	"prognostic unfavourable (1.16e-4)"	"unprognostic (9.64e-2)"	"unprognostic (1.57e-1)"	"prognostic favourable (3.28e-4)"	"unprognostic (1.69e-3)"	62.0	1.6	0.0	18.3	0.0	0.0	22.7	1.0	0.0	0.0	12.2	0.0	2.8	0.0	0.1	1.2	0.1	0.3	16.5	11.7	0.0	0.0	2.1	92.5	0.0	2.9	0.1	0.0	0.0	1.1	0.3	0.0	0.0	0.1	0.0	0.1	0.2	45.6	2.0	9.3	7.2	1.3	0.2	0.1	0.0	0.1	0.0	0.0	0.0	1.6	4.3	0.3	5.7	0.3	0.5	0.1	0.0	0.2	1.5	1.0	0.0	0.0	0.0	0.0	0.0	41.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.1	0.5	0.1	0.5	0.2	1.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0
TMEM132C	"DKFZp761O2018, PPP1R152"	ENSG00000181234	"Transmembrane protein 132C"	Q8N3T6	12	128267403-128707915	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 37.5"	"Group enriched"	"Detected in some"	6	"AF22: 5.9;ASC diff: 8.5;Daudi: 9.5"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 4.6;testis cancer: 4.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	25	"gdTCR: 5.4"	"Lineage enriched"	"Detected in single"	55	"T-cells: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015633, HPA015984"			Supported	Centrosome,Cytosol		110000000	110000000	"Centrosome, Cytosol"	"Centrosome, Cytosol"	"HPA015633: AB_1858089, HPA015984: AB_1858088"	"unprognostic (2.29e-2)"	"unprognostic (5.55e-3)"	"unprognostic (7.34e-2)"	"unprognostic (8.60e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.99e-3)"		"unprognostic (5.48e-2)"		"unprognostic (1.30e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.85e-2)"	"unprognostic (6.29e-2)"	"unprognostic (7.97e-3)"	"unprognostic (2.54e-1)"	"unprognostic (5.71e-2)"	"unprognostic (6.33e-3)"	37.5	4.2	9.6	1.1	7.0	0.8	23.3	5.0	6.6	22.0	2.5	4.2	8.9	1.2	5.9	5.7	4.7	13.4	5.1	3.5	5.0	3.8	1.3	0.8	1.6	2.0	4.9	3.1	7.9	4.1	0.9	0.6	5.1	4.6	3.7	1.3	5.3	2.9	9.1	1.9	2.2	1.4	2.1	3.9	1.1	1.5	2.1	5.4	0.0	1.1	0.9	1.3	3.8	10.5	0.0	0.0	0.0	0.0	0.0	5.4	0.1	0.0	0.0	5.9	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	9.6	7.0	5.0	6.6	5.0	3.8	4.9	3.1	4.6	5.4
TNFRSF4	"ACT35, CD134, OX40, TXGP1L"	ENSG00000186827	"TNF receptor superfamily member 4"	P43489	1	1211326-1214138	"Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 12.5;blood: 18.4;lymphoid tissue: 13.6"	"Group enriched"	"Detected in some"	9	"MOLT-4: 7.8;NB-4: 15.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"memory CD4 T-cell: 15.9;T-reg: 18.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			CAB016128	Enhanced									"CAB016128: AB_626897"	"unprognostic (2.24e-1)"	"unprognostic (8.69e-3)"	"unprognostic (1.36e-1)"	"unprognostic (8.55e-3)"	"unprognostic (1.02e-1)"	"prognostic favourable (3.50e-6)"	"prognostic unfavourable (6.03e-4)"	"unprognostic (3.30e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.04e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (4.52e-6)"	"unprognostic (1.61e-1)"	"unprognostic (5.46e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.91e-2)"	12.5	0.2	0.6	8.8	0.4	0.7	7.3	0.3	1.2	1.1	3.1	0.3	0.3	2.6	0.8	0.7	1.7	0.9	0.8	6.7	0.8	0.1	2.2	0.4	5.3	8.4	0.3	0.6	0.5	0.9	0.0	1.3	5.9	0.6	3.2	0.3	0.6	2.2	1.1	4.4	0.8	4.3	0.3	0.3	13.5	3.5	2.0	0.3	13.6	4.1	0.8	10.9	1.4	0.7	0.0	0.6	4.1	0.0	8.1	18.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	15.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.1	0.2	0.0	1.8	0.0	15.9	1.7	0.0	0.0	1.5	0.0	0.2	8.1	0.0	0.6	18.4	1.5	0.6	0.4	0.3	1.2	0.8	0.1	0.3	0.6	0.6	0.3
TNMD	"BRICD4, ChM1L, myodulin, TEM, tendin"	ENSG00000000005	Tenomodulin	Q9H2S6	X	100584802-100599885	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 18.4;seminal vesicle: 25.0"	"Group enriched"	"Detected in some"	13	"HAP1: 7.2;NTERA-2: 17.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA034961, HPA055634"	Uncertain									"HPA034961: AB_10670285, HPA055634: AB_2682868"	"unprognostic (3.60e-2)"		"unprognostic (9.84e-3)"	"unprognostic (3.19e-2)"	"unprognostic (7.77e-3)"		"unprognostic (2.42e-1)"			"unprognostic (2.15e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.40e-2)"	"unprognostic (9.60e-4)"	"unprognostic (6.82e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.48e-1)"	18.4	0.1	0.1	0.4	0.0	0.0	10.9	0.0	0.1	0.4	0.6	0.0	11.1	0.0	0.2	8.9	0.4	0.2	0.3	0.7	0.9	0.1	0.7	0.0	0.0	0.0	0.6	0.0	1.7	0.0	0.0	0.0	1.9	0.6	1.1	0.4	4.7	1.3	25.0	5.9	2.9	0.5	0.5	0.0	0.1	0.1	0.2	0.0	0.2	0.1	2.6	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.9	0.1	0.6	0.0	0.6	0.0
TNN		ENSG00000120332	"Tenascin N"	Q9UQP3	1	175067858-175148066	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 15.2;gallbladder: 14.2"	"Cell line enhanced"	"Detected in some"		"AF22: 7.5;NB-4: 4.6;THP-1: 14.0;U-266/70: 3.6;U-937: 2.6"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB010907, HPA026726, HPA026764"	Uncertain				"Secreted to extracellular matrix"	11000000	11000000			"CAB010907: AB_477565, HPA026726: AB_10601771, HPA026764: AB_10601859"	"unprognostic (1.16e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.55e-1)"	"unprognostic (5.25e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.69e-1)"	"unprognostic (5.07e-1)"	"unprognostic (1.08e-3)"	"unprognostic (1.76e-2)"	"unprognostic (9.38e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.02e-2)"	15.2	0.2	0.1	1.5	0.2	0.0	7.9	0.4	0.8	0.3	0.8	0.1	0.1	1.0	0.1	0.5	0.3	0.0	14.2	0.6	0.1	0.0	0.4	1.8	1.8	0.1	0.1	0.9	0.1	0.3	1.8	3.7	0.1	0.6	0.1	0.1	4.8	6.4	0.1	0.1	5.3	1.0	0.8	0.7	0.6	0.5	0.1	0.3	0.3	2.6	7.5	0.3	0.1	0.2	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	3.6	0.5	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.7	0.1	0.0	0.1	0.9	0.6	0.3
TREM2	"TREM-2, Trem2a, Trem2b, Trem2c"	ENSG00000095970	"Triggering receptor expressed on myeloid cells 2"	Q9NZC2	6	41158506-41163186	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 35.6;brain: 34.8;lung: 24.6"	"Group enriched"	"Detected in some"	4	"hTCEpi: 36.5;THP-1: 20.2"	"Cancer enhanced"	"Detected in all"		"glioma: 93.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.9"	"Group enriched"	"Detected in many"	6	"dendritic cells: 4.9;monocytes: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010917, HPA012571"	Approved				"Intracellular and membrane"	19000	19000			"HPA010917: , HPA012571: AB_1858260"	"unprognostic (3.89e-1)"	"unprognostic (4.44e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.53e-1)"	"prognostic unfavourable (4.24e-4)"	"unprognostic (4.83e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.57e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.58e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.85e-2)"	35.6	11.8	10.1	3.0	13.4	0.3	8.6	1.6	21.7	5.9	2.9	24.1	0.0	0.9	1.5	2.1	0.6	6.5	8.4	1.7	10.4	9.5	1.0	2.1	24.6	1.7	21.7	5.2	2.7	2.5	2.7	2.9	8.8	13.4	1.8	3.9	2.1	4.4	3.0	0.8	0.4	1.2	3.8	34.8	0.5	2.2	0.8	12.9	0.0	1.6	0.8	0.5	4.2	0.5	0.5	4.9	0.0	1.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.6	36.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.1	10.1	13.4	1.6	8.3	10.4	9.5	21.7	5.2	13.4	12.9
UPK3B	"FLJ32198, MGC10902, p35, UPIIIb"	ENSG00000243566	"Uroplakin 3B"	Q9BT76	7	76510428-76516521	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 28.5;esophagus: 40.2;lung: 34.1;lymphoid tissue: 25.0"	"Cell line enhanced"	"Detected in some"		"A549: 7.7;CAPAN-2: 27.8;HaCaT: 5.7;RT4: 19.0;T-47d: 15.9"	"Group enriched"	"Detected in many"	12	"ovarian cancer: 64.6;urothelial cancer: 78.4"	"Region enriched"	"Detected in single"	58	"pons and medulla: 5.8"	"Cell type enriched"	"Detected in single"	6	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.2"									HPA010506	Approved									"HPA010506: AB_1080479"	"unprognostic (8.33e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.62e-3)"	"unprognostic (2.26e-3)"	"unprognostic (7.87e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.03e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.06e-2)"	"unprognostic (8.37e-9)"	"unprognostic (3.56e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.34e-2)"	28.5	0.3	0.0	7.1	0.0	0.4	0.3	0.0	0.3	1.5	6.9	0.1	0.0	0.3	0.8	7.9	40.2	2.8	3.0	9.4	0.0	0.0	0.3	0.4	34.1	0.4	0.0	0.0	13.2	0.3	0.3	0.1	0.3	5.8	1.4	0.3	0.8	1.4	0.3	0.4	1.1	0.5	1.5	0.2	0.4	0.6	6.1	0.0	0.2	0.3	6.1	25.0	20.5	2.1	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.6	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	27.8	0.0	0.2	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	0.0	0.0	0.2	2.3	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0
VWF	F8VWF	ENSG00000110799	"Von Willebrand factor"	P04275	12	5948874-6124770	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 91.7"	"Cell line enriched"	"Detected in some"	57	"HUVEC TERT2: 111.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB001694, HPA001815, HPA002082, CAB072874, CAB072875"	Supported				"Secreted to blood"	6400000000	6400000000			"CAB001694: , CAB072874: AB_2665726, CAB072875: , HPA001815: AB_611880, HPA002082: AB_1080575"	"unprognostic (3.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.91e-3)"	"unprognostic (7.09e-2)"	"unprognostic (4.63e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.92e-2)"	"unprognostic (4.69e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavourable (2.31e-4)"	"unprognostic (1.55e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.73e-3)"	91.7	3.1	6.1	9.7	8.1	0.8	41.5	3.7	8.6	19.7	13.9	7.3	6.8	6.6	21.5	16.7	14.4	15.1	15.3	38.7	7.4	5.0	4.6	1.5	41.2	9.9	9.4	7.1	13.6	5.8	17.7	2.6	36.4	10.2	18.7	5.1	26.3	7.2	10.5	28.9	8.1	11.8	22.1	7.4	19.0	9.6	12.7	5.9	1.8	18.6	13.2	6.5	18.9	35.0	0.0	0.0	1.3	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	111.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.8	6.1	8.1	3.7	8.6	7.4	5.0	9.4	7.1	10.2	5.9
WNT11		ENSG00000085741	"Wnt family member 11"	O96014	11	76186325-76210736	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 25.9;breast: 24.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 20.3;CACO-2: 6.5;CAPAN-2: 9.7;EFO-21: 32.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	6	"NK-cell: 6.6"	"Lineage enriched"	"Detected in many"	6	"NK-cells: 6.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA050101, HPA063569"	Uncertain		Approved	Centrosome,Cytosol	"Secreted to extracellular matrix"			Cytosol	Cytosol	"HPA050101: AB_2681015, HPA063569: AB_2685044"	"prognostic favourable (5.97e-4)"	"unprognostic (9.27e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.87e-2)"	"unprognostic (8.43e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.88e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.16e-3)"	"unprognostic (1.09e-3)"	25.9	14.1	0.8	1.6	1.0	0.9	24.1	1.8	0.9	3.4	7.6	1.4	0.7	2.6	1.9	6.0	4.7	3.1	3.4	7.2	0.4	0.4	1.2	8.5	4.8	2.3	0.5	0.1	4.3	7.8	0.5	2.3	6.3	2.2	4.0	1.2	1.0	3.4	1.3	11.1	4.5	7.9	3.1	0.3	3.5	0.7	3.7	0.5	0.3	10.8	5.4	0.7	4.6	10.2	0.0	0.0	0.8	0.1	6.6	1.1	0.4	0.0	0.0	0.0	0.0	1.7	0.1	20.3	0.0	0.0	0.0	0.1	6.5	9.7	0.0	32.2	0.0	3.0	0.6	0.0	0.0	2.9	1.1	1.6	0.7	1.2	0.0	0.0	0.2	0.1	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.0	1.6	0.2	0.0	1.2	0.1	0.0	0.0	0.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.8	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.4	0.8	1.0	1.8	0.9	0.4	0.4	0.5	0.1	2.2	0.5
ZNF366	FLJ39796	ENSG00000178175	"Zinc finger protein 366"	Q8N895	5	72442652-72507727	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 24.3"	"Cell line enhanced"	"Detected in some"		"A549: 2.4;HUVEC TERT2: 4.1;RH-30: 2.0;TIME: 4.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	10	"myeloid DC: 14.5"	"Lineage enriched"	"Detected in many"	10	"dendritic cells: 14.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023128, HPA023526"	Uncertain									"HPA023128: AB_1859223, HPA023526: AB_1859224"	"unprognostic (3.49e-1)"	"unprognostic (8.44e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.27e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.95e-3)"	"unprognostic (9.25e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.29e-2)"	24.3	2.4	4.6	6.1	8.1	0.7	9.3	2.5	6.6	8.4	3.1	2.4	2.9	2.7	6.3	2.9	3.7	5.0	4.4	7.2	4.9	3.4	5.8	3.0	8.0	7.1	4.5	2.2	2.7	2.5	2.0	2.2	14.7	5.0	4.2	2.7	5.1	3.2	2.9	8.7	3.6	3.8	7.2	4.3	10.5	2.9	1.5	5.2	4.2	5.9	6.5	6.2	4.4	10.8	0.1	14.5	0.4	1.5	0.1	0.1	0.6	0.1	2.4	0.3	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.2	0.2	1.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	4.1	0.0	0.5	0.7	0.0	0.1	0.3	0.2	0.1	0.7	2.0	0.2	0.0	0.0	0.2	0.1	0.0	0.1	0.2	0.2	0.1	4.6	0.8	0.1	0.6	0.1	0.2	0.1	0.1	0.1	0.4	0.1	0.0	1.5	0.0	0.0	0.7	0.0	0.1	0.0	0.1	14.5	0.0	0.0	0.0	0.4	0.1	0.0	0.3	0.0	0.6	4.6	8.1	2.5	6.6	4.9	3.4	4.5	2.2	5.0	5.2
